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SUMMARY
Actinobacillus actinomycetemcomitans is a Gram-negative rod, which has been 
implicated in the aetiology of periodontitis especially, juvenile periodontitis and also 
with non-periodontal diseases e.g. endocarditis, brain abscesses and soft tissue 
abscesses.
The aims of the study described in this thesis, were to (i) investigate the strain 
diversity of a collection of A.actinomycetemcomitans held at Glasgow Dental 
Hospital and School and (ii) develop a rapid and accurate method to screen 
A.actinomycetemcomitans strains for the production of leucotoxin which is regarded 
as an important virulence factor.
The A.actinomycetemcomitans collection consisted of 96 A.actinomycetemcomitans 
isolates (85 clinical strains and 11 reference strains). The clinical isolates were 
collected between 1985 and 1990 and included multiple strains from a number of 
individuals and reflect a variety of clinical conditions, including juvenile periodontitis, 
chronic periodontitis and prepubertal periodontitis. The majority of these strains were 
stored as freeze dried ampoules and had been used in experimental studies including 
adhesion, hydrophobicity and leucotoxicity activity.
Strain diversity was investigated in two ways. The entire collection was screened for 
the presence of plasmids and demonstrated that 47% (40 out of 84) of clinical isolates 
and 9% (1 out of 9) of reference strains harboured plasmids. The number of plasmids 
found in plasmid positive strains varied between 1 and 3; 31% of all strains contained 
only a single plasmid. These results contrast with several published studies which 
have reported that very few strains of A.actinomycetemcomitans harbour plasmids.
A subset of 17 strains was selected, on the basis of leucotoxic status, single or 
multiple isolates from single individuals and plasmid profile and investigated in detail. 
The strain diversity of the 17 strains of A.actinomycetemcomitans was further 
studied by the determination of whole cell DNA restriction endonuclease
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fragmentation patterns (REFPs) with 3 different 4 base restriction enzymes - HinfL, 
Sau3Al and HaeIII.
Type strains isolated in America were shown to be genetically very similar to each 
other. Additionally, these American Type strains showed very little genetic similarity 
to the Danish Type strain and to the clinical strains isolated in Glasgow, which 
suggested a different clonal origin for the American and European strains. In addition, 
the REFP results showed that it was possible for an individual to be infected by at 
least two different strains of A.actinomycetemcomitans.
The second aim of the investigation was to produce a rapid method to screen strains 
of A.actinomycetemcomitans for leucotoxin production. Two methods were 
compared, one of which had not been previously used to investigate the toxicity of 
A.actinomycetemcomitans. The first involved the exposure of HL-60 cells (derived 
from human monocytes), to whole and sonicated cells of A.actinomycetemcomitans. 
Cell death was measured by trypan blue exclusion. The second, novel, method was a 
chemiluminescence assay, which had been used to previously investigate the activity 
of the adenylate cyclase toxin of Bordetella pertussis. The toxins from both 
A.actinomycetemcomitans and B.pertussis are known to disrupt the cell membranes 
of human polymorphonuclear leucocytes (PMNLs). Healthy PMNLs will normally 
phagocytose bacteria with the production of a burst of light, which can be enhanced 
and measured. However, when exposed to toxin producing bacteria, which kills or 
disrupts the PMNL membrane, the cell can no longer phagocytose and therefore little 
chemiluminescent activity results. The chemiluminescence and cytotoxicity assays 
were compared and in both cases, the same five strains of A.actinomycetemcomitans 
were shown to be toxic. However, variation was seen in the rank order of toxicity. 
When outer membrane protein preparations of A.actinomycetemcomitans were 
probed with a monoclonal antibody (MCA 9D4) to the related toxin, adenylate 
cyclase toxin produced by B.pertussis, the presence of a protein with a molecular 
weight approximately equivalent to that of the A.actinomycetemcomitans toxin was
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found.
The overall conclusions of the thesis are :
(i) there was no association of plasmid status with either the production of a 
toxin or a particular form of periodontal disease.
(ii) analysis of whole cell DNA REFPs, suggested a distinct clonal origin for 
American Type strains, compared to European Type and wild strains.
(ii) the novel chemiluminescent assay is as accurate a method of determining 
toxicity status as the older method of HL-60/trypan blue exclusion assay. Although 
the two methods are very similar, when large numbers of strains have to be screened, 
the chemiluminescence method is faster than and the results obtained comparable to 
the trypan blue exclusion assay
(iii) the monoclonal antibody to the B.pertussis toxin, recognises an outer 
membrane protein with approximately the same molecular weight as the 
A.actinomycetemcomitans leucotoxin despite the low (less than 50%) homology 
between the two toxins. This result suggests the view that the leucotoxin is present in 
the outer membrane and supports the findings of other groups.
Future work to be carried out on the collection of A.actinomycetemcomitans strains 
held at the Glasgow Dental Hospital and School could include further investigation 
into the clonal structure of the collection - using both whole cell and plasmid DNA. 
The use of techniques such as polymerase chain reaction could be used as an 
alternative method to restriction enzyme analysis. Additionally, the leucotoxic status 
of the whole collection could now be found out rapidly, using the chemiluminescence 
assay and the hypothesis that the majority of the remainder of the strains are 
non-toxic, confirmed or rejected.
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CHAPTER 1 
LITERATURE REVIEW
1.1 TAXONOMY
The genus Actinobacillus was first described by Lignieres and Spitz in 1902 and the 
species Actinobacillus actinomycetemcomitans in 1912 by Klinger (Topley and 
Wilson, 1990). Actinobacillus, with the genera Pasteurella and Haemophilus, form 
the family Pasteurellaceae (Sneath and Johnson, 1973), all of which are taxonomically 
similar to each other but difficult to classify. With the exception of some strict 
anaerobes, the Pasteurellaceae family comprises the majority of the endogenous 
parasites among the nonenteric, fermentative Gram-negative rods associated with 
animals and man (Kilian, Frederiksen and Biberstein, 1981). They are very important 
pathogens both in human and veterinary medicine. Some species are responsible for 
life-threatening infections while others are commensals of the mucosal membranes of 
both man and animals.
A.actinomycetemcomitans has been shown to have more similarities to the genus 
Haemophilus than to Actinobacillus (Potts, Zambon and Genco, 1985) and it was 
proposed by Potts et al (1985) that A.actinomycetemcomitans should be reclassified 
as Haemophilus actinomycetemcomitans on the basis of DNA-DNA hybridisation 
studies. Further support for this reclassification was later presented by Chuba et al 
(1988) who partially sequenced the 16S rRNAs of seven members of the 
Pasteurellaceae, from which the approximate phlyogenic relationships of these 
species was inferred. A.actinomycetemcomitans clustered with Haemophilus. Potts et 
al (1985) also used serological techniques to classify A.actinomycetemcomitans and 
determined that it could be associated with either the genera Haemophilus or 
Actinobacillus, as it does not fulfil all the criteria for inclusion into either genus 
completely. Biochemically it is urease and beta galactosidase negative, both of which 
are requirements for inclusion in the Actinobacillus genus. In addition it does not
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require either haemin (X factor) or NAD (V factor) for growth, which are 
requirements for inclusion in the Haemophilus genus. This is not an absolute 
requirement, as Haemophilus aphrophilus requires neither of these factors (Potts et 
al, 1985).
A.actinomycetemcomitans and H.aphrophilus were shown by King and Tatum (1962) 
to be related to each other by biochemical and morphological analysis. Jantzen, Berdal 
and Omland (1980) studied the cellular fatty acid composition of 
A.actinomycetemcomitans and Haemophilus species and were unable to distinguish 
between them. Subsequently, however, different authors have used various parameters 
and techniques e.g. composition of bound fatty acids (Brondz and Olsen, 1984a) and 
the lipid and carbohydrate content of lipopolysaccharides (LPS - Brondz and Olsen 
1984b, 1989) to characterize A.actinomycetemcomitans and it has been shown that 
A.actinomycetemcomitans differs from other Actinobacillus and Haemophilus species 
- even those which have morphological similarities, e.g. H.aphrophilus. 
A.actinomycetemcomitans and H.aphrophilus were further investigated by Brondz, 
Olsen and Sjostrom (1990) using biochemical analysis, which included lysis kinetics 
and methylene blue reduction. Both A.actinomycetemcomitans and H.aphrophilus 
characterised differently from all other Haemophilus and Pasteurella species analysed. 
Caugant, Selender and Olsen (1990) studied the genetic relationship of 
A.actinomycetemcomitans, H.aphrophilus and H.paraphrophilus. They demonstrated, 
by the use of multilocus enzyme electrophoresis, that overall, there was no genetic 
similarity between A.actinomycetemcomitans and the other members of the genus 
Haemophilus.
The DNA base ratio (G+C content) of A.actinomycetemcomitans and several 
Haemophilus species were determined by Potts and Berry (1983) who found 
A.actinomycetemcomitans to have a G+C content between 44.9 and 46.6%. This 
range was greater than and distinct from the ranges obtained for other Actinobacillus 
and Haemophilus species, which had G+C contents of below 42%. Coykendall,
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Setterfield and Slots (1983) showed that the G+C content of 
A.actinomycetemcomitans was between 46.7 and 48.7%. Likewise, the G+C values 
obtained for H.aphrophilus was higher (44.5 - 46.5%) with other Actinobacillus 
species having a G+C content between 43.2 and 44%.
DNA probes from A.actinomycetemcomitans strains Y4 and NCTC 9710 had 
homology to H.aphrophilus and H.paraphrophilus of only 25 to 37%, while a DNA 
probe from H.aphrophilus had homology to A.actinomycetemcomitans of between 30 
to 39% and homology to H.paraphrophilus, of between 73 to 77% (Potts and Berry, 
1983). Potts and Berry (1983) suggested that this indicated a very close relationship 
between the two Haemophilus species which does not exist between 
A.actinomycetemcomitans and H.aphrophilus. Other haemophili and actinobacilli 
showed homology to the two test probes of 10% or less (Potts and Berry, 1983).
The degree of homology between two regions of DNA, from the same or a different 
genome, is determined by the target sequence of DNA. The origin of the probe 
sequence of DNA is important and it would be of interest to know if it was obtained 
from a plasmid, a ribosomal gene, structural gene, or from either a conserved or 
divergent region? Each of these parameters would have an effect upon the percentage 
homology seen between the probe and the target. The authors did not give any 
indication as to the origin of the probe, other than the strain designation of the 
A.actinomycetemcomitans used.
Hybridisation studies by Coykendall, Setterfield and Slots (1983) and Potts et al 
(1986) found A.actinomycetemcomitans formed a group distinct from H.aphrophilus 
and other Actinobacillus species.
Thus, the current taxonomic position of A.actinomycetemcomitans remains unclear 
and although it is justifiably classified as a species within Actinobacillus, it shares few 
characteristics with other members of the genus. It has many of the biochemical 
characteristics of the genus Haemophilus, but on the basis of DNA-DNA homology, it 
remains distinct from this genus as well.
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1.2 MORPHOLOGY
1.2.1 Colony morphology
When freshly isolated A.actinomycetemcomitans strains are cultured upon a solid 
medium, they tend to form small, circular colonies, 0.5 to 1.0 mm in diameter 
(Scannapieco et al, 1987) with a rough or smooth appearance. The smooth colonies 
usually have an internal morphology which has been described as "stellate" 
(Colebrooke, 1920) or "crossed-cigars" (Heinrich and Pulverer, 1954). Rough 
colonies have ellipsoidal structures distributed randomly throughout, are firmly 
attached to the surface of the agar and when removed leave behind an imprint of both 
colony and internal structures (Blix et al 1990). Stereo-microscopy, scanning and 
transmission electron-microsopy have demonstrated that, in cross-section, the colony 
structure resembled a "jelly-fish" with pseudopod-like protrusions of various sizes on 
the lower surface of the colony. These become embedded in the agar (Blix et al 1990) 
and at the colony-agar interface a large number of "vesicles" have been identified : the 
centre of the protrusions appears to be composed of cells which are devoid of cell 
contents. No explanation for either the large number of vesicles or "empty cells" has 
been given.
Blix et al (1990) suggested that the pseudopods may have been responsible for the 
attachment of A.actinomycetemcomitans to agar, a hypothesis which was supported 
by the observation that, on repeated subculture pseudopods and fimbriae (section
1.2.3 Fimbriae) were lost as colonies of A.actinomycetemcomitans became less firmly 
attached to the agar. This corresponded with a change in colony morphology, from 
translucent to opaque and from rough to smooth.
Cultures of A.actinomycetemcomitans grown under anaerobic conditions appeared to 
be more adhesive to the surface of the agar than those grown aerobically. In addition, 
colonies from anaerobic cultures were of a firmer consistency and when grown in a 
fluid medium, had a greater tendency to clump, compared with colonies grown, under 
aerobic conditions (Scannapieco eta l, 1987).
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A summary of the morphological characteristics is give in Table 1.1.
1.2.2 Light microscopy
When viewed by light microscopy, A.actinomycetemcomitans was shown to be a 
nonmotile, Gram negative coccobacillus which occurred as single cells (0.7 ±0.1 by 
1.0 ± 0.4 pm) in pairs or in clumps (Zambon, 1985). Extended incubation (up to 16 
days) led to shortening and rounding of the cells (Holt et al, 1980).
1.2.3 Electron microscopy
There have been several studies reported in the literature concerning the surface 
morphology of A.actinomycetemcomitans using transmission electron microscopy 
(TEM) and scanning electron microscopy (SEM).
Transmission electron microscopy (TEM)
The cell wall and membrane of A.actinomycetemcomitans was described by Holt et al 
(1980) and Lai et al (1981) as typically gram-negative. The periplasm was poorly 
defined and in some cases could not be distinguished from either the outer or 
cytoplasmic membranes. Both groups cultured A.actinomycetemcomitans on similar 
media, although Holt et al (1980) used Ruthenium red to stain the samples, while Lai 
et al (1981) stained the samples with uranyl acetate and lead citrate.
Surface structures
Lai et al (1981), in a TEM study of 14 strains of A.actinomycetemcomitans, found a 
correlation between vesicle production and strains previously designated as toxic to 
PMNs. In addition, cells grown on agar media were covered with adherent 
exopolymeric material and demonstrated more outer membrane associated vesicles, 
both attached to and separate from the outer membrane, than cells grown in a fluid 
medium Lai et al (1981).
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MORPHOLOGY OF 
A. actinomycetemcomitans ON 
INITIAL ISOLATION
Rough colonies 
Starshaped inner structure
MORPHOLOGY OF 
A. actinomycetemcomitans ON 
CONTINUED SUBCULTURE
Smooth colonies 
Inner structure disappears
SIZE OF
A. actinomycetemcomitans RODS
Small, gram negative rods 
1.5 - 1.7 pm by 0.55 pm
SURFACE Membrane vesicles 
"Blebs" attached to 
surface
Table 1.1 Morphological characteristics of A. actinomycetemcomitans 
(After Hammond and Stevens, 1982)
29
The vesicles appeared to have been shed from the outer membrane surface. It has 
since been demonstrated that the leucotoxin from A.actinomycetemcomitans is located 
in either the cell envelope and/or in the membranous vesicles on the bacterial cell 
surface (DiRienzo et al, 1985. Berthold et al, 1992).
It is known that some Gram negative bacteria elaborate vesicles associated with the 
outer membrane e.g. Neisseria meningitidis (DeVoe and Gilchrist, 1973). During 
normal log phase growth of N. meningitidis, a large numbers of vesicles or "blebs1’ are 
released and it was suggested by DeVoe and Gilchrist (1973) that this could be the 
mechanism by which the endotoxin of N. meningitidis is released into the environment.
Fimbriae
Holt et al (1980) and Inouye et al (1990) reported the presence of surface associated 
fimbriae, which appeared as long hair-like appendages which originated from the outer 
membrane and appeared to link cells in close proximity to one another. Rosan et al 
(1988) estimated fimbriae to be 5 nm in width and reaching several pm in length as 
demonstrated by TEM.
It has been reported that some forms of bacterial adhesion are mediated by fimbriae 
(Beachey, 1981). McGee et al (1979) suggested that the fimbriae of N.meningitidis 
play a role in the attachment of these bacteria to host cells. They demonstrated that 
the loss of membrane associated fimbriae after repeated subculture corresponded to a 
change in morphology and a reduced ability to adhere.
Variations in fimbrial expression in Neisseria have been shown to be subject to phase 
variation in which the fimbria (and certain outer membrane proteins) are reversibly or 
irreversibly switched on or off. (Saunders, 1986). Phase variation in Neisseria 
gonorrhoeae is recognised by alterations in colonial morphology, when cells are 
grown on a clear agar. Colonies of fimbriated gonococci are recognized by the small, 
dense colonies they produce, while the unfimbriated gonococcal colonies are larger 
and more diffuse (Swanson, 1984). It was suggested by Saunders (1986) that the
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ability to modulate between different forms (fimbriated and unfimbriated) may be 
advantageous to N.gonorrheae in population terms, enabling the organism to adapt 
and survive within a variety of different environments.
Both Rosan et al (1988) and Preus et al (1988) have postulated that fimbriae are an 
important factor in the colonisation and survival of A.actinomycetemcomitans in 
anaerobic periodontal pockets perhaps by mediating adherence to epithelial cell 
surfaces (Preus et al, 1988. See section 1.7.1).
Rosan et al (1988) reported that A.actinomycetemcomitans cultured on solid media 
possessed fimbriae which were produced under both aerobic or anaerobic conditions. 
This is at variance with the findings of Scannapieco et al (1987) who demonstrated 
that anaerobic conditions, favoured the production of fimbriae. However, since only a 
small number of strains were investigated by Scannnapieco et al (1987) and the 
number studied by Rosan et al (1988) was not recorded, the effect of atmospheric 
conditions on fimbriae remains uncertain.
Inouye et al (1990) described three colonial forms of A.actinomycetemcomitans 
namely transparent-smooth, transparent-rough and opaque-smooth. Both types of 
transparent colonies were shown to be both adhesive to the agar surface and highly 
fimbriated, while opaque colonies were neither adhesive nor fimbriated. These 
workers suggested that the transparent-rough colonies were intermediate between 
transparent-smooth and opaque-smooth, as colonies upon repeated subculture, 
eventually changed from transparent-smooth to opaque-smooth, in a process which 
appeared to be irreversible.
Scanning electron microscopy
There has been only one reported SEM study of A.actinomycetemcomitans (Holt et 
al, 1980). A.actinomycetemcomitans strains possessed a thick amorphous layer that 
appeared to cover and join neighbouring cells. Holt et al (1980) suggested that this 
was due to an artefact in the preparation of the cells for examination. Fimbriae, which
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were seen under transmission electron microscopy were not observed by scanning 
electron microscopy. Thick fibrous strands which appeared to join cells which were 
separated by large distances, were seen. These appeared to be associated with the 
outer membrane of the cell and were demonstrated to be morphologically different to 
the short, thick fimbria which connect adjacent cells.
1.3 BIOCHEMICAL CHARACTERISATION
There have been several investigations into the biochemistry of 
A.actinomycetemcomitans. Slots (1982) examined 136 strains and Sneath and Stevens 
(1985) 3 A.actinomycetemcomitans strains (in a much wider study of 89 
Actinobacillus strains, in a total of 261 different strains of Actinobacillus, Pasteurella 
and Yersinia). The results are summarised in Table 1.2.
All A.actinomycetemcomitans strains investigated were catalase positive, oxidase 
negative and required neither X nor V factors. Growth in all cases was favoured by 
C02. All strains reduced nitrate to nitrite and produced strong alkaline and acid 
phosphatases. A.actinomycetemcomitans fermented glucose, fructose and mannose 
with variable fermentation of dextrin, galactose, maltose, mannitol and xylose. 
Conflicting results have been reported for the fermentation of galactose. King and 
Tatum (1962) and Page and King (1966) described it as positive, whereas Slots 
(1982) reported it as negative.
1.4 INTERACTIONS WITH THE IMMUNE SYSTEM
1.4.1 Neutrophil chemotaxis
There is conflict in the literature with regard to defects in neutrophil chemotaxis. Early 
work suggested that neutrophil chemotaxis dysfunction was involved in the 
pathogenesis of juvenile periodontitis and rapidly progressive periodontitis (Clark, 
Page and Wilde, 1977. Lavine et al, 1979. Van Dyke et al, 1980). Later work 
described the defect as either elevated levels of chemotaxis - seen in patients with
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(A) SUGAR FERMENTATION
POSITIVE Glucose Fructose Mannose
NEGATIVE Adonitol Amygdalin Arabinose 
Cellobiose Glycerol Inositol 
Lactose Melibiose Rhamnose 
Ribose Salicin Sorbitol 
Sucrose
VARIABLE Dextrin Maltose Mannitol 
Xylose
(B) OTHER
POSITIVE Peroxidase breakdown 
Nitrate reduction 
NaF resistance
NEGATIVE Oxidase reduction 
Proteolysis reduction 
Haemin requirement 
NAD requirement
(C) GASEOUS REQUIREMENT
Aerobic plus 5% C02 
Anaerobic (N2only) 
Anaerobic plus 5% C02
Good growth 
Little or no growth 
Growth variable
Table 1.2 Biochemical identification tests for 
A. actinomycetemcomitans 
After Hammond and Stevens (1982)
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rapidly progressive periodontitis or as depressed levels of chemotaxis, seen most 
frequently in patients with juvenile periodontitis (Van Dyke et al, 1980). During 
episodes of bacterial infection an increase in the level of chemotaxis was seen (Hill et 
al, 1974). Van Dyke et al (1980) reported a decrease in chemotaxis but did not 
collect or report any microbiological data.
Kinane et al (1988a, 1988b) used different techniques (e.g. a Boyden chamber) to 
assess PMNL locomotion. They failed to show any evidence for depressed PMNL 
locomotion and when the PMNLs were exposed to different doses of 
N-formyl-methionyl-leucyl-phenylalanine (FMLP - a chemoattractant) an enhancement 
in the level of PMNL locomotion was seen (Kinane et al, 1988a). Further more, it was 
suggested that although PMNs from patients with early-onset forms of periodontal 
disease may have abnormal PNM locomotion (either enhanced or inhibited) the 
differences may in part be explained by the differences in the laboratory techniques 
used (Kinane et al, 1988b). With the use of time-lapse video analysis, single-cells 
examined with the under-agarose technique showed no differences in locomotion 
between PMNLs from control or experimental groups.
Van Dyke et al (1982c) suggested two basic causes of PMNL dysfunction; either the 
PMNL was inherently defective or an extra-cellular factor was present which acted as 
an inhibitor. Van Dyke et al (1982a) demonstrated that neutrophil chemotaxis could 
be inhibited by a soluble product of certain oral bacteria including 
A.actinomycetemcomitans, Fusobacterium nucleatum and certain Bacteroides 
species. Although not characterised, the bacterial factor was shown to be a 
non-chemotactic, soluble product which competed for the chemotactic receptors on 
the neutrophil.
The ability of A.actinomycetemcomitans to evoke in vivo chemotaxis of rabbit 
PMNLs was investigated by Holm, Kalfas and Holm (1989). They demonstrated a 
factor responsible for the increase in chemotaxis, found in both viable and heat-killed 
A.actinomycetemcomitans. The factor was not fully characterized but certain
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properties (e.g. the active factor was found in heat killed bacteria) distinguished it 
from leucotoxin.
Holm et al (1989) were able to demonstrate the effect of the chemotactic 
enhancement factor from A.actinomycetemcomitans on rabbit PMNLs, while Van 
Dyke et al (1982a) demonstrated a chemotactic inhibitory factor from 
A.actinomycetemcomitans on human PMNLs. The normal environment for 
A.actinomycetemcomitans is the sub-gingival plaque in man, which may partially 
explain the contradiction between the results of Van Dyke et al (1982a) and Holm et 
al (1989) who worked on rabbit PMNLs.
The work of Van Dyke et al (1982a) was supported by Ashkenazi, White and 
Dennison (1992) who demonstrated a bacterial extract which was a non-endotoxin, 
heat-labile protein, that was chemotactic for neutrophils. However, when PMNLs 
were preincubated with the bacterial extract, chemotaxis was inhibited.
Van Dyke, Horoszewicz and Genco (1982b) suggested that chemotaxis inhibition 
could be the result of a decrease in the rate of migration of the population of 
neutrophils and not a decrease in the number of PMNLs. Van Dyke et al (1982c) 
suggested that individuals with normal neutrophil function may be affected by 
bacterial products which interfered with the binding of chemotactic factors, linked to 
the neutrophil surface by a mechanism of high affinity.
The reduction in the number of chemotaxic receptors on PMNLs in individuals with 
juvenile periodontitis was further demonstrated by Van Dyke et al (1990). They 
suggested that the reduction in FMLP receptors was specific in cases of localised 
juvenile periodontitis which exhibit neutrophil chemotaxic abnormalities.
Ashkenazi et al (1992) investigated different mechanisms which could be responsible 
for the inhibition of neutrophil chemotaxis when exposed to an extract from 
A.actinomycetemcomitans e.g. the binding of FMLP and cytoskeletal changes caused 
by F-actin polymerisation. The bacterial extract itself was shown to be chemotactic for 
PMNLs, but when PMNLs were incubated with the extract, chemotaxis towards
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various stimuli, in different assays, was inhibited. None of the mechanisms investigated 
was shown to cause an inhibition in chemotaxis.
It was suggested by Ashkenazi et al (1992) that discrepancies between their results 
and those of Van Dyke et al (1982) could be attributed to differences in (i) the 
preparation of the bacterial extract, (ii) the A.actinomycetemcomitans strains used and 
(iii) the method of calculation of the bacterial extract protein concentration.
1.4.2 Immune suppression and mitogenic effects of A.actinomycetemcomitans 
Shenker, Tsai and Taichman (1982a, 1982b) characterised an immunosuppressive 
effect of A.actinomycetemcomitans on the proliferation of human peripheral blood 
lymphocytes (HPBL), following exposure to mitogens and antigens. In addition, they 
demonstrated that the exposure of HPBL to A.actinomycetemcomitans sonicated 
extracts caused suppression of both T and B-cell functions. They suggested that this 
could be mediated through a common mechanism e.g. the activation of T-suppressor 
cells. This could cause a reduction in the response of an individual's immune system, 
which in turn could lead to an augmentation in the pathogenicity of 
A.actinomycetemcomitans.
When HPBLs from healthy individuals were exposed to purified leucotoxin from 
A.actinomycetemcomitans, for 90 minutes, the response of the HPBLs to mitogens 
was significantly reduced (Rabie, Lally and Shenker, 1988). They demonstrated a 
decrease in the number of viable monocytes, however it would appear that the 
leucotoxin also had non-lethal effects upon lymphocytes. Rabie et al (1988) suggested 
that the leucotoxin did not directly affect all lymphocytes but only a subset. If this 
subset included T regulator cells, which were then activated, as suggested by Shenker 
et al (1982b), this could contribute to the pathogenicity of A.actinomycetemcomitans. 
Yoshie et al (1985) demonstrated that B cells proliferated in vitro in response to 
whole A.actinomycetemcomitans cells. This proliferation was observed at days 1 and 
2 of culture and was shown to be of equal magnitude in cells from immunised normal,
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naive normal and nude rats. It was later determined by Eastcott et al (1990) that this 
proliferation was due to Lipopolysaccharides (LPS). It was suggested by Eastcott et 
al (1990) that LPS could have an in vivo effect of inducing local B cell proliferation 
which was independent of any specific immune response to either 
A.actinomycetemcomitans or its products.
1.4.3 In vivo killing of A. actinomycetemcomitans
Miyasaki et al (1986) showed that although A.actinomycetemcomitans was resistant 
to the bactericidal action of serum and oxidant injury, opsonized 
A.actinomycetemcomitans could be killed by neutrophils under both aerobic and 
anaerobic conditions. Oxidative killing, which is dependent on 0 2, H20 2 and 0 2‘, was 
shown to be cyanide sensitive, which indicates a myeloperoxidase mechanism (Weiss, 
Lampert and Test, 1983). Non-oxidative killing was dependent upon a variety of 
lysosomal enzymes, peptides and proteins Miyasaki et al (1986), but the precise 
mechanism of killing of A.actinomycetemcomitans is uncertain.
Miyasaki, Bodeau and Fleming (1991) and Miyasaki and Bodeau (1991) demonstrated 
that A.actinomycetemcomitans was sensitive to the bactericidal effects of different 
neutrophil granule components and the bactericidal effects of neutral serine proteases. 
Neutrophil granule extracts were gel filtered and seven fractions were obtained. The 
killing of A.actinomycetemcomitans by the fraction which contained cathepsin, was 
shown to be independent of oxygen and neutral serine protease activity.
1.4.4 Immunological response to A. actinomycetemcomitans
Individuals with juvenile periodontitis have been shown to have elevated levels of IgG, 
IgAl and IgA2 antibodies to antigens of A.actinomycetemcomitans (Ebersole et al, 
1982).
Zambon (1985) compiled data from several studies and concluded that 69 to 90% of 
localised juvenile periodontitis patients had higher serum antibody titres against
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A.actinomycetemcomitans compared with lower levels (3 to 13%) in healthy subjects 
or people with different forms of periodontitis. Wilson (1991) demonstrated that sera 
from localised juvenile periodontitis patients had IgG antibodies directed against the 
major outer membrane protein (29kDa) of A.actinomycetemcomitans, a protein found 
in all strains of A.actinomycetemcomitans examined.
IgA has two subclasses IgAl and IgA2 in both monomeric and polymeric forms 
(Brown et al, 1991). IgAl is susceptible to protease cleavage by microorganisms 
which may have compromised the host immune system (Kilian and Reinholt, 1986). 
Serum from juvenile periodontitis patients taken prior to, during and after treatment 
showed both forms of IgA antibody to A.actinomycetemcomitans were present, 
although the IgAl form was more common (Brown et al, 1991). High levels of IgAl 
antibodies could be neutralised by A.actinomycetemcomitans proteolytic enzymes 
which negated the protective effect offered by IgAl.
1.4.5 Serotypes of A. actinomycetemcomitans
There have been at least five serotypes of A.actinomycetemcomitans described : a to 
e. Saarela et al (1993) studied a collection of 515 clinical isolates from a Finnish 
population. The most common serotype present was serotype c (41% of the sample 
population). Serotypes a and b were found in 25% of the population, with the 
remaining isolates being characterised as serotypes d, e or unclassified. Saarela et al 
(1992) showed that it was possible for multiple infection by different serotypes of 
A.actinomycetemcomitans within the same individual.
Slots and Genco (1983) isolated serotype b more frequently than serotypes a and c in 
North American localised juvenile periodontitis patients: Asikainen et al (1991) found 
serotype b predominated in Finnish periodontal patients.
1.5 PLASMIDS
Bacterial plasmids are covalently closed circular DNA molecules, significantly smaller
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than (but co-existing with) the bacterial genome. Although not essential for the cell's 
survival, they may confer ancillary phenotypic functions that are advantageous to the 
host cell, e.g. antibiotic and heavy metal resistance (Watanabe, 1963. Schottel, 1987) 
and virulence (Hovi et al, 1988. Woodward, McLaren and Wray, 1989). They 
replicate independently of the host genome and some are capable of cell to cell 
transfer within a population.
Since bacterial populations are generally regarded as having a clonal structure 
(Selender & Levin, 1980. Levin, 1981. Orskov & Orskov, 1983. Miller & Hartl, 1986) 
the plasmid profile (number and size of plasmids harboured by a given strain) is often 
taken to reflect its history. Thus, generally :
(i) Strains of the same organism with different histories may have accumulated 
different combinations of plasmids.
(ii) Conversely, identical plasmid profiles among strains is often taken as 
evidence of epidemiological relatedness.
There are, however, exceptions to this. Some Salmonella species have plasmids which 
are exceptionally stable (Brown, Munro and Platt., 1986). There are, conversely, 
plasmids which display a high degree of rearrangement (Chart et al, 1989).
1.5.1 History
Plasmids were first discovered in Shigella species by Japanese researchers in 1959 
(cited by Watanabe, 1963). Ochiai et al (1959) had shown that it was possible to 
transfer multiple drug resistance between Shigella strains in vitro. Watanabe called the 
transferable genetic elements "episomes".
Previously, Lederberg (1952) had used the term "plasmid" to describe any 
extrachromosomal hereditary determinant which included chloroplasts in plants and 
mitochondria in eukaryotes. The term was eventually used exclusively to describe 
extrachromosomal DNA elements.
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1.5.2 Structure
Plasmids are double stranded circular molecules of DNA, usually in the form of a 
covalently-closed circle (CCC), which is then twisted to form supercoiled DNA. Open 
circle (OC) is a form of plasmid molecule with a single-stranded nick and is thus in a 
relaxed state. Other conformations of plasmid molecules include di- and tri-mers. 
Plasmids can be classified by many criteria e.g. size; failure to coexist with related 
plasmids (incompatibility - Datta, 1979; Timmis, 1979); specification of phenotypic 
traits such as antibiotic resistance genes (Holmberg et al, 1984), virulence factors 
(Hovi et al, 1988. Woodward, et al, 1989) and metabolic capacities.
Plasmids with a molecular weight less than approximately 15 kb are dependent upon 
the host cell for most of the enzymes involved in replication, but encode the 
housekeeping genes which govern their segregation and copy number. Plasmid size 
and incompatibility is related to the regulation of copy number of each plasmid found 
in the host cell. For example, large plasmids may have a copy number of only 1 or 2 
per genome equivalent whereas smaller plasmids are typically multicopy (15 - 50 per 
cell). The latter plasmids are under relaxed replication control, which means they 
accumulate in large amounts (upto 1000 copies per cells) when the bacteria stop 
growing (Lewin, 1985).
Plasmids have been found in almost every bacterial species in which they have been 
sought including A.actinomycetemcomitans (Olsvik & Preus, 1989; LeBlanc et al, 
1993; Poulsen et al, 1994) and are described in more detail in Chapter 3. Some have a 
narrow or limited host range and are able to replicate only within a single species : 
others have a broad range of genera in which they are stably maintained.
1.6 HABITAT AND TRANSMISSION
1.6.1 Habitat
A.actinomycetemcomitans is found predominantly in subgingival dental plaque and 
periodontal pockets (Slots and Genco, 1984) although it will colonise the oral
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mucosal surfaces (Slots etal, 1980. Van der Velden, 1986. Christersson etal, 1987). 
Mandell and Socransky (1981) reported the recovery of A.actinomycetemcomitans 
from patients with juvenile periodontitis only, while Slots, Reynolds and Genco (1980) 
recovered A.actinomycetemcomitans from healthy individuals. However, Van der 
Velden et al (1986) reported that in periodontally healthy young adults, who abstained 
from oral hygiene in one quadrant of their mouths for 23 days, no 
A.actinomycetemcomitans was recovered.
Asikainen, Alaluusua and Saxen (1991) recovered A.actinomycetemcomitans from 
saliva, tongue and subgingival sites of both healthy individuals and those with 
periodontal disease. Such sites could thus act as a potential reservoir for the 
recolonisation of subgingival areas.
1.6.2 Transmission of A. actinomycetemcomitans
The precise mode of transmission of A.actinomycetemcomitans is unknown. 
Christersson et al (1985) showed that it was possible to transfer 
A.actinomycetemcomitans from diseased periodontal sites to healthy ones, within an 
individual mouth, by means of a periodontal probe. These newly infected sites were 
sampled for three weeks before colonisation and up to twelve weeks after. However, 
after two weeks the newly infected sites were found to be negative for 
A.actinomycetemcomitans. This short period of colonisation (1 to 2 weeks) could be 
due to (i) antagonistic interactions among the resident plaque microflora and 
A.actinomycetemcomitans, (ii) the development of an inhibitory immune response or
(iii) competition for available nutrients. Muller, Lange and Muller (1989) examined 
the toothbrushes of individuals infected with A.actinomycetemcomitans, and 
demonstrated immediately after tooth cleaning the presence of 
A.actinomycetemcomitans on 62% of the brushes. The number of 
A.actinomycetemcomitans isolated correlated weakly with the degree of periodontal 
destruction. In addition, when A.actinomycetemcomitans could be recovered from
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saliva and mucosal membranes, the number of A.actinomycetemcomitans isolated on 
toothbrushes was significantly increased.
Studies by Zambon, Christersson and Slots (1983) and Alaluusua, Asikainen and Lai 
(1991) suggested that A.actinomycetemcomitans could be transmitted within families. 
Zambon, Christersson & Slots (1983) studied 5 families and claimed that each member 
of the same family had the same strain of A.actinomycetemcomitans on the basis of 
sero- and biotype. It was also suggested by Gunsolley et al (1990) that 
A.actinomycetemcomitans might be transmitted between members of the same family 
in which one or more has an early-onset form of periodontitis. However the sample 
populations used in all these experiments were very small and therefore no great 
reliance can be placed upon these results. Saarela et al (1993) studied the transmission 
of oral bacteria, including A.actinomycetemcomitans, between spouses, all of whom 
suffered from advanced periodontitis. They demonstrated that 2 of the 4 couples 
studied shared A.actinomycetemcomitans and Streptococcus mutans strains with the 
same sero- and ribotypes and suggested that transmission of oral bacteria between 
spouses was possible.
Familial transmission of A.actinomycetemcomitans and Porphyromonas gingivalis in 4 
families was investigated by Pettit et al (1993). Most of the adults in the study and all 
the children suffered from some form of periodontal disease and on the basis of 
restriction endonuclease restriction patterns, Pettit et al (1993) suggested that both 
A.actinomycetemcomitans and P.gingivalis were transmitted between parents and 
children.
Preus and Olsen (1988) isolated A.actinomycetemcomitans from 2 members of the 
same family with Papillon-Lefevre syndrome, as well as from their dog and an 
unrelated (healthy) 12 year old. On the basis of restriction endonuclease analysis, they 
stated the strains were identical. The only connection between the two families were 
that the dogs they owned had come from the same litter. Preus and Olsen (1988) 
stated that in both cases the dogs were the source of the A.actinomycetemcomitans.
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This has been the only reported incidence of this potential source of 
A. actinomycetemcomitans.
1.6.3 Association between A. actinomycetemcomitans and other bacteria.
A.actinomycetemcomitans appears to be found most often in active periodontal sites 
and there have been several theories to explain the relationship. Zambon, Christersson, 
& Slots (1983b) hypothesised that a host response occurred at the sites which are first 
colonised by A.actinomycetemcomitans, but as the immune response develops 
A.actinomycetemcomitans is inhibited from colonising other sites. Alternatively, the 
colonisation of A.actinomycetemcomitans may be inhibited by other bacteria present in 
the site of potential disease. Hillman and Socransky (1982) demonstrated unnamed 
oral bacteria, from healthy individuals, which were inhibitory in vitro, to the growth of 
A.actinomycetemcomitans strain Y4. Patients, however, with periodontitis were 
shown to lack these inhibitory organisms.
Hammond et al (1984) demonstrated in vitro killing of A.actinomycetemcomitans by a 
bacteriocin produced by Streptococcus sanguis. Hillman, Socransky and Shivers 
(1985) described bacterial interactions in plaque from periodontitis patients: the higher 
the proportion of S. sanguis found in a site, the less chance of also locating 
A.actinomycetemcomitans. Later, Hillman and Shivers (1988) found that S.sanguis 
produced hydrogen peroxide, which was inhibitory to the growth of 
A.actinomycetemcomitans. Thus the presence or absence of bacteria capable of 
inhibiting A.actinomycetemcomitans in certain areas of the mouth could help explain 
the localised nature of some forms of the disease.
1.7 POTENTIAL VIRULENCE FACTORS OF A. actinomycetemcomitans 
A number of potential virulence factors have been described for 
A.actinomycetemcomitans, which are thought to (i) enable it to colonise the mouth 
and periodontium (e.g. adhesion - Winkler et al, 1988); (ii) adversely affect the host
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defence mechanisms (e.g. lipopolysaccharide - Saglie et al, 1990) and (iii) cause tissue 
destruction (e.g. collagenase activity - Robertson et al, 1982. Uitto, Suomalainen and 
Sorsa, 1991). The factors are listed in Table 1.3. Another important factor is a 
leucotoxin which will be discussed in detail later (1.8).
It is possible that the virulence factors act either alone or in conjunction with one or 
more of the other factors, which would allow A.actinomycetemcomitans to survive 
and grow in the mouth by evading the host defence mechanisms.
With the exception of the leucotoxin, which has been the most widely studied of the 
virulence factors, relatively little work has been done on the others.
1.7.1 Adhesion of A. actinomycetemcomitans
The ability of A.actinomycetemcomitans to adhere to and invade the tissues of the 
mouth is (obviously) important in the colonisation of this environment. 
A.actinomycetemcomitans appears to have the ability to adhere to different oral 
surfaces - buccal epithelial and tissue culture cells, as well as tooth enamel and 
hydroxyapatite. There have been several studies into the adhesion of 
A.actinomycetemcomitans, however, different experimental methods have been used, 
which make accurate comparisons difficult.
Winkler et al (1988) demonstrated, in vitro, that certain Gram-negative 
periodontopathic, anaerobes bind to periodontal surfaces in larger numbers than 
Gram-positive organisms. They suggested that the initial step in binding could be the 
adhesion of the bacterial fimbriae to the cell membrane. A.actinomycetemcomitans has 
been shown to possess fimbriae (Blix et al, 1990) which would enable it to adhere to 
the periodontal surfaces (see section 1.2.3).
A preliminary study by Rosan et al (1988) showed that two fimbriated 
A.actinomycetemcomitans strains adhered to hydroxyapatite in higher numbers ( 3 - 4  
fold differences) than non-fimbriated strains.
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VIRULENCE FACTORS REFERENCE
ADHESION Winkler et al, 1988 
Rosan etal, 1988 
Winkler e/ al, 1988 
Taher and MacFarlane, 1991a 
Taher and MacFarlane, 1991b
PENETRATION Sagliee/tf/, 1982 
Gillett & Johnson, 1988
ALVEOLAR BONE 
RESORPTION
lino & Hopps, 1984 
Wilson, Kamin & Harvey, 1985 
Yoshi eetal, 1987 
Kamin, Wilson & Harvey, 1985
COLLAGENASE Robertson et al, 1984
Kamin etal, 1986
Uitto, Suomalainen & Sorsa, 1990
LIPOPOLY SACCHARIDE Sveen & Skang, 1980 
lino & Hopps, 1984 
Nishihara et al, 1989 
Saglieeftf/, 1990
BACTERIOCIN Hammond, Lillard & Stevens, 1987 
Stevens, Lillard & Stevens, 1987
Table 1.3 Potential virulence factors (excluding leucotoxicity) produced 
by A, actinomycetemcomitans
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Further investigation by Rosan et al (1988), however showed no variation in adhesion 
between strains.
Continued subculture would appear to have more effect upon the adherence of 
A.actinomycetemcomitans to hydroxyapatite in vitro than other factors, such as the 
composition of growth medium (Kagermier and London, 1985). There is evidence 
that continued subculture can produce non-fimbriated strains with a consequent 
reduction in adherence. Kagermier and London (1985) further demonstrated that 
when hydroxyapatite was coated with saliva the ability of A.actinomycetemcomitans 
to adhere was greatly reduced. Rosan et al (1988), however suggested that this was 
not in fact the case. Taher and MacFarlane (1991a) studied the ability of 33 strains of 
A.actinomycetemcomitans (both Type and clinical strains) to adhere to buccal 
epithelial cells. The adhesion of A.actinomycetemcomitans was not altered by the 
addition of saliva (confirming the results of Rosan et al, 1988) however the addition 
of human serum did have a significant inhibitory effect. It was suggested that human 
serum had an effect upon the bacterial cell surface and not the host surface, as this 
effect was seen on a variety of surfaces. The same strains were further examined for 
their hydrophobic effect (Taher and MacFarlane, 1991b). They demonstrated a 
hydrophobic effect in all strains studied which was unaltered by repeated subculture, 
variation in the suspension medium or time of incubation.
Very little has been published on the colonisation of the oral epithelium by 
A.actinomycetemcomitans. Cell surface carbohydrates which are present on the 
surface of A.actinomycetemcomitans as a microcapsule may aid colonisation of the 
periodontal surfaces (Holt et al, 1980). Taher and MacFarlane (1991a) suggested that 
A.actinomycetemcomitans has the ability to adhere to the buccal mucosa before 
colonisation of the gingival area.
1.7.2 Penetration of the oral epithelium by A. actinomycetemcomitans
In 1982 Saglie et al and Gillett and Johnson (1982) reported finding
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A.actinomycetemcomitans in the gingival tissue and periodontium. Immuno-stained 
bacteria were found in the soft tissue and it was suggested that these bacteria were 
A.actinomycetemcomitans. No traumatic damage was observed in the tissue 
surrounding the bacteria, which suggested to Gillett and Johnson (1982) that this was 
not an artefact, i.e. the bacteria were present in the periodontal tissue before it was 
sectioned for staining. Later Saglie et al (1985) demonstrated the presence of 
A.actinomycetemcomitans and other oral bacteria in the oral epithelium in tissue from 
juvenile periodontitis patients, with immunoperoxidase techniques. Saglie et al (1985) 
demonstrated different staining patterns of the bacteria which included "spots" and 
more diffuse areas. They suggested that the diffuse regions were areas where bacterial 
products were deposited, while the size and shape of the spots were consistent with 
individual bacteria. The possibility that the presence of bacteria in the epithelium was 
an artefact was discounted by Saglie et al (1985) since they demonstrated a pattern of 
bacterial invasion i.e. the bacteria were found in "chains" and wider intracellular 
spaces. Although the bacteria were found in both healthy and diseased tissue, 
periodontal diseased tissue showed bacteria in greater than 99% of the sections, while 
56% of normal tissues demonstrated bacteria.
Meyer et al (1991) reported the ability of A.actinomycetemcomitans to invade a 
human oral cell line (KB - derived from a human oral epidermoid carcinoma). Thirty 
nine different A.actinomycetemcomitans strains were investigated and several factors 
were thought to have an effect upon the ability of A.actinomycetemcomitans to invade 
tissue. These included (i) the effect of temperature, (ii) the presence of either 
cytochalasin D (an inhibitor of microfilament formation and phagocytic like activity) 
and (iii) cycloheximide (an inhibitor of mammalian cell protein synthesis - but not of 
prokaryotic protein synthesis). A reduction in the invasion of 
A.actinomycetemcomitans was seen after incubation with Cycloheximide and at a 
reduced temperature. Meyer et al (1991) concluded from these results that 
metabolically active cells (both bacterial and host cells) were needed for invasion to
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occur. The addition of cytochalasin D inhibited invasion of the monolayer by up to 
99%, which suggested that invasion by A.actinomycetemcomitans occurs through a 
microfilament-dependent, phagocytic process. A negative control consisting of
H.aphrophilus was used and neither the addition of cytochalasin D nor cycloheximide 
reduced the percentage invasion of A.actinomycetemcomitans to the level recorded 
for this negative control. Differences in the ability of rough and smooth colonies of 
A.actinomycetemcomitans to invade the KB monolayer was also investigated; smooth 
variants derived from rough strains invaded the cell line to a greater degree than did 
the original rough strains.
I.7.3 Collagenase activity of A. actinomycetemcomitans
The collagenolytic activity of Porphorymonas gingivalis has been studied in some 
detail, but very little has been reported for A.actinomycetemcomitans. Robertson et al
(1982) investigated A.actinomycetemcomitans and a number of other oral bacterial 
species for their collagenolytic status. They found that only A.actinomycetemcomitans 
and Bacteroides species showed any collagenase activity. This activity was found in 
the supernatant of the cultures in which the strains were grown and in the supernatant 
of cell sonicates. It was inhibited by the addition of EDTA and by boiling for 3 
minutes and characterised as being heat-labile and partially inhibited by serum. In 
addition the collagenase activity could be enhanced by growth in a peptide-depleted 
medium.
There are two potential pathways for collagen loss in periodontal disease (i) a 
decrease in production (Page and Schroder 1973) or (ii) a reduction due to an 
increase in collagenase activity by bacterial components (Robertson and Simpson, 
1976. Uitto, Suomalainen and Sorsa, 1990). Suomalainen and Sorsa (1991) studied 10 
freshly isolated strains of A.actinomycetemcomitans and found collagenase was 
released from normal human PMNLs when exposed to the A.actinomycetemcomitans 
in vitro.
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1.7.4 Cellular effects of capsular material and lipopolysaccharides (LPS) from 
A. actinomycetemcomitans 
Capsular material and LPS from A.actinomycetemcomitans were isolated by Kamin et 
al (1986) and examined for their effect upon gingival fibroblasts. These workers 
demonstrated that capsular material had a potent inhibitory effect upon fibroblast 
proliferation, whereas LPS had very little effect. The capsular material inhibited both 
DNA and collagen synthesis - and increased cell size. This result agreed with the 
previous work of Shenker, Kusher and Tsai (1982c) and Stevens, Gatewood and 
Hammond (1983) who concluded that the fibroblast-inhibitory activity was due to 
neither an endotoxin nor a leucotoxin. Stevens et al (1983) demonstrated that the 
fibroblast-inhibitory material irreversibly inhibited cell proliferation in the presence of 
serum. Also DNA synthesis was decreased, but RNA and protein synthesis were 
unaffected. Although the cells appeared to be intact and viable, no proliferation of 
fibroblasts was seen.
It was reported by Saglie et al (1990) that low concentrations of LPS from 
A.actinomycetemcomitans stimulated human macrophages to produce interleukin-1 
(IL-1) and tumour necrosis factor (TNF) mRNA. Protein levels of IL-1 and TNF also 
increased, both of which are potent monokines that mediate inflammation and 
resorption of bone. It was suggested by Saglie et al (1990) that macrophages which 
migrate to the site of periodontal infection are stimulated by the LPS of 
A.actinomycetemcomitans to produce IL-1 and TNF, which mediate gingival 
inflammation and alveolar bone resorption. It was suggested by Rifkind and Hiejl 
(1979) that macrophages were involved in bone destruction characteristic of 
periodontal disease.
Bacterial products (e.g. LPS) which may enter the periodontium via the gingival 
crevice have been related to bone resorption (lino and Hopps, 1984). The loss of bone 
could be due to mediators of bone resorption e.g. lymphokine and prostaglandins 
released during an immune response or may have been the direct effect of bacterial
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products e.g. LPS.
Capsular material, extracted from A.actinomycetemcomitans was demonstrated to be 
a potent bone resorption mediator (Wilson, Kamin and Harvey, 1985) active at 
concentrations one thousand-fold lower than the minimum concentration of 
lipopolysaccharide found to stimulate bone resorption (Wilson et al 1985. lino and 
Hopps 1984). The capsular material, although not completely defined, was shown to 
be a mixture of protein and carbohydrate.
Lipopolysaccharides from other oral bacteria are known to resorb bone (Sveen and 
Skang, 1980). lino and Hopps (1984) demonstrated the in vitro release of calcium 
from cultivated living bones, by the application of LPS from 
A.actinomycetemcomitans, while there was no release of calcium from dead bone. 
They suggested that bone-resorption mediated by LPS was dependent upon 
mechanisms in the living cell. lino and Hopps (1984) noted that although the chemical 
composition of the LPS from oral bacteria differed from that of the enterobacteria, the 
potency of the different LPSs were about the same.
The effect of antibodies, directed against LPS of A.actinomycetemcomitans, upon the 
mitogenic responses of murine spleen cells to LPS and lipid-A of 
A.actinomycetemcomitans was studied by Nishihara et al (1989). This antiserum was 
shown to inhibit the mitogenic effect - as did normal rabbit serum, but a negative 
reaction was found with normal rabbit immunoglobulin. Nishihara et al (1989) 
speculated that the effect of serum from humans would be inhibitory but no evidence 
was presented. They also suggested that antibodies against A.actinomycetemcomitans 
LPS could modify the immune response of lymphocytes at periodontally diseased 
sites.
1.7.5 Bacterocin activity of A. actinomycetemcomitans
The virulence factors of A.actinomycetemcomitans which have been most fully studied 
are those which have an effect upon the human host defence mechanisms. However, a
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bacteriocin, active in vitro against certain Streptococci, Actinomyces and other 
A.actinomycetemcomitans strains was isolated from A.actinomycetemcomitans strain 
Y4, by Hammond, Lillard and Stevens (1987). This was purified by Stevens, Lillard 
and Hammond (1987) and shown to be a protein comprising of 2 subunits, with 
molecular weights of 50 000 and 70 000 kDa respectively. The bacteriocin from 
A.actinomycetemcomitans interfered with the colonisation and growth of certain 
Streptococcal species e.g. S.sanguis and was also antagonistic to the growth of other 
A.actinomycetemcomitans strains (Hammond et al, 1987). The bacteriocin appeared 
to share some similarities with leucotoxin; the molecular weight of each is 
approximately the same and both consist of two subunits (the subunits have 
approximately the same molecular weights). As with the leucotoxin, the bacteriocin is 
heat inactivated and sensitive to proteolysis (Hammond et al, 1987). However, 
Hammond et al (1987) concluded that the bacteriocin and leucotoxin were different 
from each other because of the different target cells involved.
1.8 LEUCOTOXIC ACTIVITY OF A. actinomycetemcomitans
Baehni et al (1979) demonstrated that a strain of A.actinomycetemcomitans 
(designated Y4) which was derived from a patient with juvenile periodontitis was 
toxic to human polymorphonuclear leucocytes in vitro. This was later shown by Tsai 
et al (1979) to be due to a heat and protease sensitive, soluble product, toxic only to 
human PMNs and monocytes. Human lymphocytes, platelets and fibroblasts as well as 
rabbit, rat, chicken and mouse leucocytes were unaffected by this substance (Baehni et 
al, 1979., Tsai et al, 1979.). The toxic effect of the material was shown to be heat 
labile, (Baehni et al, 1979), and dose and time dependent (Tsai et al, 1979., Taichman, 
Dean and Sanderson, 1980).
Taichman et al (1980) stated that as the leucotoxin was inhibited by heat, it was not a 
lipopolysaccharide. Studies of A.actinomycetemcomitans by Taichman et al (1980) 
also demonstrated that the leucotoxin bound to the target cell membranes, which
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resulted in morphological and biochemical changes and ultimately in cell death. This 
led Taichman et al (1980) to propose 3 stages in monocyte-killing by the leucotoxin. 
The first, occurred within the first five minutes of exposure of the cells to the 
leucotoxin and resulted in the cessation of normal cell movement. After approximately 
15 minutes, cells which had been labelled previously with 86Rb and 51Cr, were shown to 
have released all 86Rb activity which was accepted as an early indicator of cell damage. 
The second phase, which lasted for up to an hour, was characterised by the lack of 
appreciable cytoplasmic leakage, cell movement and the formation of cytoplasmic 
threads which emanated from the cell. The final phase was characterised by the release 
of the cytoplasmic contents - measured by LDH, lysozyme and 51Cr release. It was 
postulated that the early release of 86Rb, indicated that damage had occurred in the 
Na/K transport system. (Taichman et al, 1980). Toxin was also shown to bind to cells 
at +4°C and after extended incubation, cell death was observed. Endocytosis was 
suppressed by the addition of cytochalasin B and incubation at +4°C which indicated 
that the toxin may not require to be internalised for cell lysis to occur, although small 
amounts of toxin could still have entered the cell by micropinocytosis (Taichman et al,
1980).
Taichman et al (1991) showed that the likely site for the action of the leucotoxin was 
the plasmalemma, where its action resulted in the formation of pores (approximately 1 
nm) with subsequent colloid lysis. The finite pore size would allow only small 
molecular weight solutes to equilibrate between the cytoplasm and medium (Iwase et 
al, 1990), which is the typical action of an RTX toxin (Repeats in ToXins - see 1.8.7). 
The toxic effect of the Y4 leucotoxin was altered by the addition of heated or 
unheated sera from either healthy or juvenile periodontitis patients, (McArthur et al,
1981). The presence of heated/ unheated healthy human and rabbit sera enhanced the 
toxic effect, but sera from juvenile periodontitis patients and immune rabbit serum 
resulted in neutralisation of the toxin.
The degree of enhancement or inhibition of the toxin varied with the concentration of
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serum used. Certain juvenile periodontitis sera at concentrations below 2.5% (v/v) 
enhanced the toxic effect, but above this level toxicity was inhibited (McArthur et al,
1981). The inhibitory activity in juvenile periodontitis sera was shown to be due to an 
IgG antibody whereas the factor which was responsible for enhancement of activity 
was found to be a large molecular weight protein. No further work on this factor has 
been reported to date.
Baehni et al (1981) tested whole cell and sonicates of Type cultures and fresh isolates 
of A.actinomycetemcomitans (14 strains in total), for their toxic activity on PMNs, as 
determined by LDH release. They demonstrated that leucotoxicity could be enhanced 
or inhibited by the presence of normal or juvenile periodontitis/ rabbit 
anti-^ 4.actinomycetemcomitans sera respectively. They also demonstrated that strains 
of A.actinomycetemcomitans, which were leucotoxin positive, possessed antigens 
which were not identified in non-leucotoxic strains. Also, the majority (ten out of 
fourteen) of their isolates were toxic and suggested that the variation seen could be 
due either to the presence of plasmids or to bacteriophage infection although they 
offered no evidence for either. The presence of bacteriophage in 
A.actinomycetemcomitans strains was later shown by Preus, Olsen and Namork
(1987), in a very small sample but was not correlated to the toxic activity of the 
infected strains of A.actinomycetemcomitans.
Zambon et al, (1981) used the promyelocytic HL-60 cell line, derived from a 36 
year-old Caucasian woman, with acute promyelocytic leukaemia (Collins, Gallo & 
Gallagher, 1977., Gallagher et al 1979) as an alternative to human PMNs to 
demonstrate the toxicity of A.actinomycetemcomitans, as determined by the release of 
LDH. With the tissue culture cell line the effect of the leucotoxin was shown to be 
dose and temperature dependent and inhibited by the addition of anti- 
A.actinomycetemcomitans rabbit serum. However, enhancement of the toxic effect 
was not seen in HL-60 cells, when human serum was added. Taichman et al (1980) 
speculated that the enhancement of the toxic effect seen in human PMNs was due to
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the presence of host cell receptors. It was suggested by Zambon et al (1983) that 
these surface receptors were not present on HL-60 cells, which may have become 
altered when the cell line became established. Alternatively, one of the growth factors 
in the medium used for the cultivation of the HL-60 cells may have inhibited 
enhancement of toxicity by, for example, binding to the neutrophil receptors proposed 
by Taichman et al (1980).
1.8.1 The frequency of isolation of toxic stains of A, actinomycetemcomitans
The presence of leucotoxic strains of A.actinomycetemcomitans in plaque samples 
from healthy gingival sites suggested that the role of the organism in periodontal 
disease is not a simple cause and effect relationship. Zambon et al (1983) 
demonstrated leucotoxicity in 16% of A.actinomycetemcomitans isolated from healthy 
subjects. No age was given for these subjects. This contrasts with Tervahartiala et al
(1988) who reported that 50% of the A.actinomycetemcomitans strains isolated from 
healthy children, were toxic. A decrease in the prevalence of leucotoxic strains with 
age was demonstrated by Tsai and Taichman (1986), who showed that younger 
juvenile periodontitis patients (age 6 - 1 2  years of age) had more leucotoxic strains, 
than older patients (13 - 25 years of age. Tervahartiala et al, 1988). All patients, 
however, had antibodies to the leucotoxin. The overall sample population used by 
Tervahartiala et al (1988) was smaller than the population of Zambon et al (1983) - 
only 19 isolates (6 from healthy children) compared with 100 isolates (11 from healthy 
subjects).
Seventy-five percent of A.actinomycetemcomitans strains isolated from insulin 
dependent diabetes mellitus periodontal patients, were shown to be toxic to healthy 
PMNLs (Zambon et al, 1983). However, the population size used by Zambon et al
(1983) was only 4 patients. Mashimo et al (1988) demonstrated 
A.actinomycetemcomitans infrequently in diabetics.
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1.8.2 Extraction of leucotoxin from A. actinomycetemcomitans
The toxin from A.actinomycetemcomitans was isolated by Tsai et al (1984) who 
demonstrated that it had a molecular weight of 115 kDa, by SDS PAGE analysis. It 
was extracted using polymyxin B, in an adaptation of a method to solubilize the 
enterotoxin of E.coli. Polymyxin B is a cyclic decapeptide that disrupts membranes, 
which indicated that the toxin was associated with the cell surface. This was further 
demonstrated by the work of Ohta et al (1991) who used both RNAase and DNAase 
to release the toxin bound to the bacterial cell surface. Here the nucleases probably 
had the same function as the polymyxin B, as nucleases do not work exclusively upon 
nucleic acid but also recognise and disrupt basic bonds. Thus it is likely that basic 
bonds on the bacterial cell surface are broken during extraction, releasing the toxin, 
rather than by disruption of leucotoxin complexes in the nucleic acid on the cell 
surface as suggested by Ohta et al (1991). Furthermore, there is no evidence that the 
latter complexes occur on the surface of A.actinomycetemcomitans and the evidence 
for their presence in other bacterial species is slight. Whereas DNA has been found 
internalised in membrane vesicles from Haemophilus influenzae - these were resistant 
to digestion by external nucleases (Kahn, Barany and Smith, 1983). The vesicles 
produced by N.gonorrhoeae are associated with DNA and are hydrolyzed by external 
DNAase. However these vesicles are not associated with leucotoxin, but with the inter 
cell transfer of genetic material (Dorward, Garon and Judd, 1989).
1.8.3 Effect of bacterial and colonial morphology upon leucotoxicity of 
A. actinomycetemcomitans
Ohta et al (1987) studied A.actinomycetemcomitans strains with different colonial 
morphology (e.g. rough-surfaced, umbonate-shaped colonies and smooth-surfaced, 
convex-shaped colonies) to determine any correlation between morphology and 
leucotoxin production. None was found. Tervahartiala et al (1989) found a similar 
lack of correlation between the leucotoxic activity of A.actinomycetemcomitans
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strains and the numbers of outer membrane vesicles present or the original source of 
the strain (e.g. juvenile or adult periodontitis or healthy children).
1.8.4 The effect of A. actinomycetemcomitans leucotoxin on T cells.
The in vitro effect of the leucotoxin on PMNs has been well studied, but the period of 
exposure of PMNs to the leucotoxin, in vitro, has generally been limited to a few 
hours. Mangan et al (1991) studied the in vitro effect of the leucotoxin on T 
lymphocytes over a 2 day period. Cell death of 70% was demonstrated and occurred 
in a time and concentration dependent manner.
1.8.5 Localisation of leucotoxin on A. actinomycetemcomitans.
Berthold et al (1992) localised the leucotoxin of A.actinomycetemcomitans to either 
the cell envelope and/ or membrane vesicles on the outer surface of the bacterial cell, 
using monospecific polyclonal antibody with electron microscopy and 
immunocytochemical techniques. Lai et al (1981) had previously noted that vesicles 
were more common on the cell membrane of toxic strains, than non-toxic.
1.8.6 Effect of A. actinomycetemcomitans on Macaca fascicularis - animal model
Taichman et al (1984) reported that monkeys (Macaca fascicularis) with no evidence 
of periodontal disease harboured A.actinomycetemcomitans in subgingival plaque 
samples. However no information was presented concerning the population size, the 
percentage of monkeys positive for A.actinomycetemcomitans or the number of 
A.actinomycetemcomitans isolates found. Ebersole et al (1990) found 
A.actinomycetemcomitans in approximately 40% of the monkey population they 
examined.
Monkey PMNs were killed when exposed to sonic extracts of 
A.actinomycetemcomitans from leucotoxic positive isolates. Furthermore, sera from 
human juvenile periodontitis patients were also shown to be able to inhibit the
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leucotoxic killing of monkey PMNs. The ability of monkey sera to inhibit leucotoxic 
activity was shown to be due to IgG antibodies (Taichman et al, 1984). As a result it 
was suggested that these monkeys could act as an animal model for studying the 
host-A.actinomycetemcomitans relationship. Taichman et al (1987), later studied 
twenty one different non-human primate species (one hundred and twelve individual 
monkeys) which encompassed New and Old World monkeys and Greater and Lesser 
Apes. A.actinomycetemcomitans was recovered from both New and Old World 
monkeys (no statistics were given). All A.actinomycetemcomitans isolated from the 
non-human primates were shown to provoke a dose-dependent release of 51Cr from 
labelled human PMNs and HL-60. The leucotoxin had no effect upon PMNs from the 
New World monkeys and Lesser Apes, however it was toxic to PMNs from the Great 
Apes and most Old World Monkeys. With the exception of lemurs and cebus 
monkeys, all the primates possessed neutralising antibodies against the leucotoxin.
1.8.7 A. actinomycetemcomitans leucotoxin and other pore forming toxins
The A.actinomycetemcomitans leucotoxin belongs to a group of toxins called RTX 
(Repeats in Toxin) (Welch, 1991) characterised by a glycine-rich C-terminal repeat 
unit at the end of each protein (Strathdee & Lo, 1989). Further features include the 
creation of pores in the cell membrane of target cells (Iwase et al, 1990), although this 
is not an exclusive feature as the haemolysins of Proteus mirabilis and Serratia 
marcescens are both pore-forming cytolysins but do not belong to the RTX group 
(Uphoff and Welch, 1990). The operon of the genes involved in all aspects of 
synthesis, activation and toxin secretion, are located together on the chromosome 
(Kraig, Dailey and Kolodrubetz, 1990). A.actinomycetemcomitans leucotoxin differs 
from the other RTX toxins, as, unlike the other RTX toxins, it remains associated with 
the bacterial cell (Lally et al, 1991b). The mechanism for secretion has not yet been 
determined (Brogan et al, 1994).
The toxins which have been shown to belong to this family are produced by several
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pathogenic Gram negative bacteria, and cover a wide range of organisms and toxins 
e.g. E.coli - haemolysin (Felmlee and Welch, 1988), Pasturella haemolytica - 
leucotoxin (Strathdee and Lo, 1989), Actinobacillus pleuropneumoniae - haemolysin 
(Frey and Nicolet, 1988) and Bordetella pertussis - adenylate cyclase (Glasser et al, 
1988). These bacteria produce cytotoxins of 102 - 177 kDa, which are major virulence 
factors for each organism - see Table 1.4.
Despite the high degree of DNA homology seen between the different RTX genes, the 
LktA protein from A.actinomycetemcomitans is very much more basic than the E.coli 
HktA protein. This may be due to the evolutionary divergence of 
A.actinomycetemcomitans, from the other bacteria which form the RTX group. The 
differences may have a role in the pathogenicity of A.actinomycetemcomitans in the 
gingival crevice (Ebersole et al, 1990., Kraig et al, 1990). Possible differences may be 
related to target cell specificity, mode of secretion of the toxin (Kraig et al, 1990) or 
localisation of the leucotoxin in the periplasm (DiRienzo et al, 1985).
1.8.8 Structure of leucotoxin operon
The original classification of the RTX toxins was on the basis of the glycine-rich 
repeat units at the C-terminal end of the protein (Strathdee, 1989). The glycine-rich 
repeat unit sequences are a conserved feature of RTX toxins, although the number of 
repeat units varies between toxins e.g. A.actinomycetemcomitans has 14 repeat units, 
E.coli has 13 repeat units and P.haemolytica has 8 repeat units (Lally et al, 1991a). 
Each repeat unit, of nine amino acids, has been represented by the overall consensus 
sequence of L-X-G-G-X-G-N-D-X (Lally et al, 1991a. Forestier and Welch, 1991. 
Welch, 1991), when arranged in a tandem manner with other units in the protein. At 
the amino acid level, the consensus sequence is highly conserved (Lally et al, 1991a). 
This region is thought to be important in the toxicity of the A.actinomycetemcomitans 
leucotoxin - a view strengthened by the observation that a panel of seventeen 
monoclonal antibodies, selected on the basis of inhibition of leucotoxin activity
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Bacterium Toxin Number of 
amino acids
Molecular
Weight
(kDa)
Total
number of 
Glycine Repeats
(a) Aa Leucotoxin
(LktA)
1055 116 14
(b) Bp Adenylate
cyclase
(CycA)
1706 177 41
(c) Ec Haemolysin
(HlyA)
1023 110 16
(d)Ph Leucotoxin
(AktA)
953 102 12
(e) Ap Haemolysin
(AppA)
956 103 9
Table 1.4 Features of the Cytotoxins of the RTX Group
(a)
(b)
(c)
A.actinomycetemcomitans : Lally et al, 1989
Kraig, Dailey & Kolobetz, 1990 
Lally et al, 1991
B.pertussis:
E.coli
(d) P.haemolytica:
(e) A.pleuropneumoniae:
Glasser etal, 1988
Lausch, Paulaitis & Friedman , 1990
Femlee, Pellet & Welch, 1986 
Mackman et al, 1986 
Femlee & Welch, 1988
Strathdee & Lo, 1987 
Strathdee & Lo, 1989
Frey & Nicolet, 1988 
Chang, Young & Stuck, 1989 
Lalond eetal, 1989
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(Direnzo et al, 1985) all recognise this region in the homologous protein as well as in 
deletion mutations of the E.coli -haemolysin (Felmlee & Welch, 1988). It was 
suggested by Ludwig et al (1988) that the repeat domain of the E.coli -haemolysin 
was responsible for the Ca2+ dependent binding of the toxin to erythrocytes. Lally et al 
(1981) showed the repeat units from A.actinomycetemcomitans bound Ca2+ in a dose 
dependent manner, which could be inhibited by heat or the addition of SDS or 
mercaptoethanol.
The role of the repeat unit and Ca2+ ions for the haemolytic activation of the toxin 
from E.coli has been investigated more thoroughly. The removal of one unit resulted 
in a requirement for an elevated Ca2+ ion concentration, while the removal of three 
units resulted in a protein with no haemolytic activity, even in the presence of very 
high Ca2+ ion concentrations.
The most widely studied toxin of the family is the haemolysin (Hly A) of E.coli. This 
is a 110 kDa protein, the product of the hly A gene, which is secreted across the 
cytoplasm and outer membranes, and which required the product of two further genes, 
hlyB and hlyD. The gene hlyC produced a protein which has been shown to be 
responsible for post-translational conversion of the protein from the inactive to the 
active form (Welch and Pellet, 1988).
All members of the RTX family show a high degree of sequence homology to the hly 
operon of E.coli- Figure 1.1- with B.pertussis showing variation in the cycA and cycC 
gene arrangements. It also has an additional gene, cycE contiguous to cycABD 
(Coote, 1992). The gene for the leucotoxin was cloned first by Kolodrubetz et al 
(1989) then by Lally et al (1990). Kraig, Dailey and Kolodrubetz (1990) sequenced 
the IktA gene and showed it was linked to the IktC gene. The homology between the 
proteins from different RTX toxins was found and these are listed in Table 1.5.
Chang, Young and Struck (1991) demonstrated that A.pleuropneumoniae haemolysin
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Hydrophobic Glycine
domain repeats
A -C Z Hllllll '111 K ~  I I
cycC cycA cycB cycD cycE
hlyC hlyA hlyB hlyD
c
i 111 i- r  i
IktC IktA IktB IktD
aktC aktA aktB aktD
appC appA appB
Figure 1.1 Gene arrangements of the RTX cytotoxin determinants
A : B.pertussis - adenylate cyclase 
B : E.coli - haemolysin 
C : P.haemolytica - leucotoxin 
D : A.actinomycetemcomitans - leucotoxin 
E : A.pleuropneumoniae - haemolysin
In each case, the A gene is the toxin structural gene; C is required for toxin activation 
and the BDE gene products are required for toxin secretion
Arrows indicate direction of transcription.
After Coote, 1992
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Protein A Ec Ap Ph
Aa 51% 42% 43%
Protein B Ec
Aa 67%
Protein C Ec Ap Ph
Aa 70% 55% 55%
Protein D Ec
Aa 72%
Table 1.5 Homology between the cytotoxin proteins
From: Ebersole e/a/, 1990
Kraig, Dailey & Kolodrubetz, 1990
A a: A.actinomycetemcomitans 
Ec : E.coli
Ap : A.pleuropneumoniae 
P h : P.haemolytica
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genes appBD do not lie downstream from the haemolysin structural genes appA, 
although there is a high degree of homology at the DNA and amino acid sequence 
level of these genes and the characterised BD genes from other RTX toxins.
1.8.9 Transcription
Variation seen in leucotoxin production from A.actinomycetemcomitans may be 
partially explained due to the lack of expression of one of the genes IktB, or IktC 
responsible for the secretion of the toxin (Spitznagel et al 1991). Leucotoxin negative 
variants appear to be very common amongst A.actinomycetemcomitans strains 
(greater than 80% ; Zambon, 1985).
Spitznagel et al (1991) examined a total of 5 leucotoxin positive and negative strains 
and all were shown to possess the entire operon. Leucotoxin positive strains, by RNA 
blot hybridisation analysis, were shown to produce two RNA transcripts, one of 9.3 
kb in length, the other 4.3 kb, which encodes IktCABD and IktCA, respectively. The 
predominant mRNA of 4.3 kb encode IktC and IktA and terminates at a 
rho-independent transcriptional terminus, situated between IktA and IktB (Lally et al, 
1991b. Spitznagel et al, 1991). The less abundant 9.3 kb mRNA encodes for 
IktCABD, results when transcription fails to terminate this at the rho-independent 
transcriptional terminator and continues to transcribe through IktB and IktD. This 
results in a lower level of IktB and IktD. When leucotoxic negative strains were 
examined by RNA blot hybridisation, they demonstrated a 50-fold lower level of the
4.3 kb IktCA transcripts and no 9.3kb IktCABD transcripts.
Brogan et al (1994) compared the Ikt promoters of JP2, a highly toxic strain, to a 
strain which demonstrated little toxicity, and demonstrated variation in the promoters. 
They found that the JP2 Ikt operon was transcribed from two promoters, whereas the 
non-toxic strain only had one promoter. Additionally, there appeared to be a domain 
of 530 base pairs in the non-toxic promoter, not found in the JP2 Ikt operon. They 
suggested that the JP2 Ikt promoter could have arisen from the deletion of a 530 base
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pair sequence found in the non-toxic strain. Brogan et al (1994) suggested that the 
level of toxicity appeared to be related to the Ikt promoter structure, but they could 
not rule out the effect of other factors, such as trans-acting proteins, from having an 
effect upon the expression of the Ikt operon.
The leucotoxic effect of A.actinomycetemcomitans strains was shown by Spitznagel et 
al, (1991) to be related to the growth phase. High levels of the RNA transcript were 
demonstrated in positive strains during the mid- to late log phase, which corresponded 
to high levels of toxin activity. Both levels decreased during stationary phase, which 
could suggest that an environmental factor is also involved in the expression of the 
toxin. This is similar to the situation in E.coli where the haemolysin toxin peaks in late 
exponential growth, then declines (Nicaud etal, 1985).
Spitznagel et al (1991) suggested that the growth phase is important in determining 
the toxicity of A.actinomycetemcomitans. ATCC 29523, previously reported as 
variable for toxin production (Baehni et al, 1981., Zambon et al, 1983., Zambon,
1985) demonstrated low levels of toxic activity when the strain was grown to late log 
phase. The leucotoxin, when compared to JP2 leucotoxin (a very toxic strain) 
(Spitznagel et al, 1991) was shown to be 30-fold less active than the most active JP2 
extract.
The maximal levels of Ikt mRNA in ATCC 29523 were found in the same sample that 
had leucotoxic activity.
A previously designated leucotoxic negative strain, ATCC 33384 (Zambon, Slots and 
Genco, 1983b) was shown to have at most l/90th of the leucotoxic activity of the 
most active JP2 sample. The maximal level of Ikt mRNA from ATCC 29523 is slightly 
higher than the level of Ikt mRNA from ATCC 33384, which could explain why 
ATCC 29523 had detectable levels of leucotoxic activity while ATCC 33384 did not. 
These results led Spitznagel etal {1991) to conclude that different levels of leucotoxin 
activity found in different strains of A.actinomycetemcomitans are due to differences 
in the levels of Ikt mRNAs.
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The P.haemolytica leucotoxin gene has been shown to be regulated at the 
transcriptional level by changes in temperature, pH and iron concentration (Strathdee 
and Lo, 1989b). All of these could contribute to the variable toxicity in vitro by 
differences in growth medium. There is no published data to suggest that this is the 
method of regulation of the leucotoxin from A.actinomycetemcomitans.
1.8.10 Activation
The mechanism for activation of leucotoxin in A.actinomycetemcomitans has not been 
widely studied, but information is available about other RTX toxins.
However, the precise mechanism for activation of the toxins is unknown. The toxins 
are synthesised as inactive products from the respective genes, which are then 
modified by the C gene product, to the active form. The C gene products are highly 
conserved (Kraig et al, 1990) and it is possible for the C, B and D gene products from 
E.coli to activate and export the inactive toxins of P.haemolytica and 
A.pleuropneumoniae in vivo (Forestier and Welch, 1991,. Gyri et al, 1990., 
Highlander, Engler and Weinstock, 1990).
The activation of the E.coli haemolysin has been studied most fully and an 
understanding of this process has been achieved. Hardie et al (1991) showed in vitro 
activation of the E.coli haemolysin to be post transcriptional, cytoplasmic and 
requiring a cellular factor. The latter could be removed by dialysis and was identified 
as an acyl carrier protein (Issartel, Koroakis and Hughes, 1991) which donates an acyl 
fatty acid to the prohaemolysin. Although the activating factor was specific for the 
enterobacteria only, it is most probable that the process of activation is the same with 
the other RTX toxins.
Without modification, the toxins from E.coli, P.haemolytica and B.pertussis, are 
unable to bind to the target cell membranes. (Cruz et al, 1990., Boehm, Welch and 
Snyder, 1990., Oropeza-Wekerle et al, 1989). Pellet et al (1990) showed the change 
from the inactive to active form to be a conformational one. Modified HlyA protein
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was bound by a specific monoclonal antibody, in the region of the Ca2+ binding repeat 
domains. Pellet et al (1991) suggested that an interaction may have occurred at the 
Ca2+ binding repeat domains, which may have created the final conformation required 
for binding and membrane insertion of the toxin.
1.8.11 Toxin secretion
One major difference between the A.actinomycetemcomitans leucotoxin and the other 
RTX toxins is in the method of secretion. A.actinomycetemcomitans leucotoxin 
(LktA) is located in the periplasm (DiRienzo et al, 1985. Berthold et al, 1992). Many 
of the basic amino acids which give LktA the pi value 9.7 (Ebersole et al, 1990) - 
compared to pis of approximately 6.2 for the IktA protein from other bacteria - are at 
the C-terminal end (Kraig et al, 1990). The carboxy terminal 250 amino acids of the 
haemolysin from E.coli are essential for the secretion and lytic activity of the 
haemolysin (Felmlee and Welch, 1988). The least conserved region between the E.coli 
haemolysin and A.actinomycetemcomitans leucotoxin extends over the last 200 amino 
acids of LktA, which may be responsible for the different properties that LktA has 
been shown to possess e.g. target cell specificity and localisation to the periplasm 
(Tsai et al, 1984. Simpson et al, 1988).
The export of the IktA protein from E.coli has been studied in some detail. In the two 
step process, translocation of the protein to the periplasm is accompanied by loss of 
the leader protein followed by the transfer of the protein across the outer membrane 
by a specific mechanism (Pugsley and Schwartz, 1985., Hirst and Welch, 1988., 
Holland, Blight and Kenny, 1990).
The products of hlyB and hlyD genes and the tolC (the tolC gene is unlinked to the 
operon) are involved in secretion ofHlyA (Welch, 1991) from E.coli. hlyB, hlyD and 
tolC are thought to form a pore in the bacterial cell membrane for the export of the 
toxin.
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1.8.12 Mode of action
Iwase et al (1990) demonstrated that the association of the toxin with the target cell 
membrane was insufficient for cell lysis to occur, as it could be inhibited by the 
addition of monoclonal antibodies directed against the toxin, or by washing the toxin 
from the cells, during the first five minutes of toxin interaction with the plasma 
membrane. The addition of cations e.g. Ca2+ and Zn2+ appeared to minimise the extent 
of the toxin-mediated membrane damage. Certain saccharides, dependent upon size, 
were able to act as osmotic protectants e.g. maltose almost completely inhibited 
cytoplasmic release. This led to the theory that the leucotoxin of 
A.actinomycetemcomitans had a membranolytic activity, capable of producing pores 
in the target cell membrane with a diameter approximately that of maltose - 0.96 nm. 
Other RTX toxins produce pores with diameters of 0.6 - 3.0 nm (Ehrmann et al, 
1991,. Clinkbeard, Mosier and Confer, 1989., Lalonde et al, 1989., Bhakdi et al,
1986).
1.8.13 Evolution of RTX toxins
On the basis of similarity between the toxins of A.actinomycetemcomitans and E.coli - 
(Table 1.5) Kraig et al (1990) suggested that a recent transfer of the leucotoxin gene 
must have occurred, as A.actinomycetemcomitans belongs to the same family as 
P.haemolytica and A.pleuropneumoniae. Some strains of E.coli carry a plasmid copy 
of the haemolysin gene, but this does not resemble the A.actinomycetemcomitans 
leucotoxin (Kraig et al, 1990., Hess et al, 1986). The G+C value of the hkl 
determinant on plasmids has a value of 39% which contrasts with that of 50% for the 
rest of the genome (Femlee, Pellet and Welch, 1986).
More recently, Welch (1991) suggested that the RTX family as a whole evolved as a 
fusion of a number of different elements. The adenylate cyclase toxin of B.pertussis, 
however, may have undergone a unique rearrangement, separating the C and A genes. 
The pseudogenes found in A.pleuropneumoniae (Chang et al, 1991) show homologies
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to different RTX toxins. The RTX A pseudogene upstream from appB most closely 
resembles the hlyB gene from E.coli. Chang et al (1991) suggested that the appCA 
and appBD operons were derived from different ancestral RTX determinants.
The genes which encode the Ca2+ independent-haemolysin of P.mirabilis have been 
shown to have a similar operon structure and close amino acid sequence with 
S.marcescens, despite a large difference in the G+C value of each organism, which 
suggested the genes diverged a long time ago (Uphoff and Welch, 1990). While 
P.mirabilis and S.marcescens are not members of the RTX family, they may represent 
another family of virulence factors (Welch, 1991). The reason why the RTX toxins 
should have different target cell specificities from each other is unknown. It may be 
due to protein folding which could influence its interaction with cell receptors or 
alternatively the protein shape may affect its ability to create pores in cell membranes 
of different compositions. The type of receptors involved in the target cell membrane 
for the toxin recognition/ binding are not known.
1.8.14 Leucotoxicity assays
A number of different assays, have been developed to investigate toxin production by 
A.actinomycetemcomitans. Whole bacterial cells, sonicates of whole cells or purified 
leucotoxin have been used with freshly isolated human polymorphonuclear cells 
(Baehni et al, 1979., Baehni et al, 1981) or cultivated human tissue cell lines e.g. 
HL-60 (Zambon et al, 1983., Simpson, Berthold and Taichman, 1988). Cell death has 
been determined by trypan blue exclusion (Ohta et al, 1987); lactate dehydrogenase 
release (Zambon et al, 1983); lysosomal elastase release (Tervahartiala et al, 1989); 
release of 51Cr (Simpson et al, 1988) and fluorescent spectroscopy (Ohta et al, 1991). 
Comparison of the methods is difficult, as the level of cell death at which a strain is 
designated toxic, varies between the different methods.
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1.9 INFECTION DUE TO A. actinomycetemcomitans,
A.actinomycetemcomitans can cause a range of infections in humans e.g. periodontal 
disease (1.10), endocarditis, brain abscesses, soft tissue abscesses, septicaemia, urinary 
tract infection, chest abscesses and pneumonia (King and Tatum, 1962., Page and 
King, 1966., Vandepitte, De Geest and Jousten, 1977., Kaplan et al, 1989., Bowker, 
Connellan and Freeth, 1992.) - see Table 1.6
The most common non-periodontal infection reported was bacterial endocarditis, with 
58 cases in the literature since 1962 (Kaplan et al, 1989., Bowker et al, 1992). 
Infection due to A.actinomycetemcomitans may go undetected as it is an unusual 
organism which may not grow on non-selective media, or may be undetected due to 
its small size.
1.10 PERIODONTAL DISEASE
The periodontium is the collective term given to the tissues that support the teeth in 
the jaws. It consists of the gingiva, periodontal ligament, cementum and alveolar bone. 
The periodontium has several functions which include
(a) the attachment of the teeth to the alveolar bone;
(b) the resistance and resolution of the forces generated by the movement of the 
teeth during eating and speech;
(c) the continual adjustment of structural changes associated with wear and 
ageing by continuous regeneration of the tissue (Schulger et al, 1990).
Schulger et al (1990) classified the diseases of the periodontium (periodontitis) into 4 
distinct entities, on the basis of age of onset, rate of progression, microbial flora, 
distribution of lesions and history, as follows :
(a) Prepubertal periodontitis
(b) Juvenile periodontitis
(c) Adult or Chronic periodontitis
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Disease Number of cases Reference
Infective 23 Page & King, 1966
Endocarditis 1 Vandepitte et al, 1977
1 Schack et al, 1984
1 Bowker et al, 1992
Actinomycosis 4 Page & King, 1966
Meningitis 1 Page & King, 1966
Septicaemia 1 Page & King, 1966
Soft tissue abscess 2 Kaplan et al, 1989
Facial abscess 2 Page & King, 1966
Sinusitis 1 Page & King, 1966
Brain abscess 1 M artin i al, 1967
Empyema 1 Kaplan ef al, 1989
Chestwall abscess 1 Kaplan etal, 1989
Urinary tract infection 1 Kaplan etal, 1989
Table 1.6 Human infection due to A. actinomycetemcomitans
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(d) Rapidly progressive periodontitis 
Many studies have tried to relate microbial (see section 1.10.1), immunological (see 
section 1.4.1) and biochemical factors (e.g. hormonal changes associated with puberty 
and pregnancy) to active disease with a view to obtaining markers to identify 
individuals at high risk of developing chronic inflammatory periodontitis (See Reviews 
by Johnson et al, 1988., Wilton et al, 1988., Maiden et al, 1990).
A number of oral bacterial species have been associated with the different forms of 
periodontal disease e.g. Prevotella intermedius (B.intermedius), Porphorymonas 
gingivalis (B.gingivalis), Capnocytophaga species and A.actinomycetemcomitans 
(Tanner et al, 1979., Mashimo et al, 1983., Moore et a l , 1982., Page et al, 1985., 
(review) Slots and Listgarten, 1988. Slots and Rams, 1990. Slots, Feik and Rams, 
1990.). While these bacteria maybe important in the progression of the disease, this 
review will be concerned only with A.actinomycetemcomitans.
1.10.1 Involvement of A. actinomycetemcomitans in periodontal disease.
Asikainen, Alaluusua and Saxen (1991) recovered A.actinomycetemcomitans from the 
saliva, tongue and subgingival sites of both healthy individuals and those with 
periodontal disease. Zambon et al (1983) argued that active periodontal sites might 
represent the first site colonised by A.actinomycetemcomitans. As the host defence 
system is stimulated, A.actinomycetemcomitans may be inhibited from colonising 
other sites. Alternatively, A.actinomycetemcomitans may be inhibited by other bacteria 
present in the sites of potential lesions. The loss or reduced expression of virulence 
factors from A.actinomycetemcomitans may result in sites, which although colonised 
by A.actinomycetemcomitans do not become diseased (Zambon et al, 1983).
It has been reported that A.actinomycetemcomitans is difficult to eliminate from 
periodontal pockets (Christersson et al, 1985a., Komman and Robertson, 1985., 
Rodenburg et al, 1990). Indeed, Rodenburg et al, reported an increase in the numbers 
of A.actinomycetemcomitans recovered after treatment consisting of supra- and
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subgingival debridement. It has been suggested that the apparent ability of 
A.actinomycetemcomitans to survive in vivo maybe related to its reported ability to 
invade host tissue (Slots and Genco, 1984., Christersson et al, 1984). However, 
although the appearance of A.actinomycetemcomitans in tissues may be due to 
invasion, the possibility that it is an artefact in the preparation of the tissue for both 
light and electron microscopy cannot be excluded.
1.10.2 Prepubertal periodontitis
Prepubertal periodontitis has its onset during or immediately after the eruption of the 
primary dentition. It has two forms - localised and generalised - which differ in 
progression and features, as summarised in Table 1.7.
1.10.3 Involvement of A. actinomycetemcomitans in prepubertal periodontitis.
There is very little published evidence for any involvement of 
A.actinomycetemcomitans in prepubertal periodontitis. Crossner et al (1990) studied 
periodontitis in the primary dentition, associated with A.actinomycetemcomitans 
infection, in two siblings (male and female). They suggested that 
A.actinomycetemcomitans might trigger a phagocytic dysfunction of PMNLs since the 
eradication of A.actinomycetemcomitans from the subgingival region, restored the 
phagocytic activity of PMNLs to normal levels. The reduced phagocytic activity of the 
PMNLs was measured as the capacity to ingest IgG-coated latex particles. After 
reinfection two and half years later, the phagocytic activity of the PMNLs was again 
reduced, but this reversed after antibiotic therapy.
1.10.4 Juvenile periodontitis
Juvenile periodontitis differs from the adult form of the disease by the age of onset and 
the absence of plaque and calculus related to tissue destruction. The features are 
summarised in Table 1.8. Family studies have revealed an apparent genetic
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Common Features of Prepubertal Periodontitis
1. Onset during or after eruption of primary dentition
2. Swollen and inflamed gingiva, with the accumulation of gross 
subgingival plaque and calculus, although these clinical signs may be 
absent.
3. The aetiology of the disease is not fully understood, however it has 
been associated with Papillon-Lefevre syndrome.
4. It has also been found in clinically healthy children, which suggests 
that may be a clinical disease.
5. It has been associated with defects in neutrophil and monocyte 
function.
Table 1.7 Common features of prepubertal periodontitis
From : 1. Ngan, Tsai & Sweeney, 1985
Page et al, 1983
2. Sonis, 1979 
Page et al, 1983
3. Fourel, 1974
Van Dyke et al, 1984 
Preus & Gjermo, 1974 
Bimstein et al, 1990
4. Melnick, 1974 
Baer, 1984 
Page et al, 1983
5. Shurin et al, 1979 
Bowden et al, 1982 
Page, 1983
Page et al, 1983 
Kinane et al, 1988a 
Kinane et al, 1988b
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involvement, consistent with it being either an X-linked dominant or autosomal 
recessive trait (Saxen, 1980a., Saxen, 1980b). Hart et al (1992) re-examined the 
evidence for X-linked dominant inheritance and found that the number of females 
which were affected by juvenile periodontitis was greater than the number of males 
because a greater number of females were included in the studies. When the 
proportions of affected males and females were examined rather than the absolute 
numbers of affected individuals, the proportions were similar (Hart et al, 1991). Two 
studies have been made, where there is evidence of father to son transmissions 
(Boughman et al, 1986., Saxby, 1987). Hart et al (1992) concluded that some 
X-linked forms of the disease do occur, but that this is not the most important mode 
of inheritance.
1.10.5 Involvement of A.actinomycetemcomitans in juvenile periodontitis
There have been several epidemiological studies which have related 
A.actinomycetemcomitans infection to juvenile periodontitis in particular populations 
(Alauusua and Asikainen, 1988., Slots et al, 1980., Eisenhann, 1983., Gunsolley et al, 
1988). Eisemann et al, (1988) suggested that A.actinomycetemcomitans was found in 
60% of the young adult population of Panama, which had a high incidence of juvenile 
periodontitis. Alauusua and Asikainen (1988) found A.actinomycetemcomitans in 13% 
of the young Finnish population, which they claim had one of the lowest levels of 
juvenile periodontal disease in the world. The high incidence of juvenile periodontitis 
within one racial group may suggest that environmental and/ or genetic determinants 
maybe important factors. In a review, Slots and Listgarten (1988) concluded that 
three Gram negative bacterial species were important pathogens in periodontitis in 
man. These were P.gingivalis, P.intermedins and A.actinomycetemcomitans. The 
latter has been found in 85 - 100% of localised juvenile periodontitis (Slots, Reynolds 
and Genco, 1980., Slots et al, 1982., Zambon, Christersson and Slots, 1983., 
Asikainen et al, 1986, 1987. Slots, Feik and Rams, 1990).
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Common Features of Juvenile Periodontitis
1. Age of onset between 11 and 21 years of age, but diagnosis can be 
made at any age beyond puberty upto mid-to-late twenties.
2. Lesions initially localised to the periodontium around the first molar 
and incisor, may then progress to other areas, which results in the 
generalised form of the disease.
3. Little plaque deposits seen, however probing of the periodontal 
pockets, results in bleeding.
4. Worldwide variation in the prevalence of the disease. Europe has a 
low prevalence of 0.1 percent, whilst the negro population has been 
shown to have a prevalence as high as 55 percent.
5. Clinical studies suggest that the disease is more common in females 
than in males.
6. Familial distribution consistent with X-linked dominant or an 
autosomal mode of inheritance.
7. Most affected individuals have functional defects in either 
neutrophils or monocytes.
8. Lesions maybe highly active immediately following puberty, but 
subsequent destruction maybe slow or spontaneously cease 
("burn-out").
Table 1.8 Common features of juvenile periodontal disease
From : 1. Manson & Lehner, 1974
2. Liljenberg & Lindhe, 1980
3. Davies, Smith & Porter, 1985
4. Saxen, 1980a, 1980b 
Saxby, 1984
Manson & Lehner, 1974
5. Saxby, 1984
6. Saxen, 1980a, 1980b 
Page et al, 1985
7. Schulger e t , 1990
8. Schulger e t , 1990
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Several authors have either failed to find A.actinomycetemcomitans associated with 
juvenile periodontitis (Okuda et al, 1984. Vandesteen et al, 1984. Naiming et al, 
1991) or isolated them in very small numbers (Moore et al, 1985. Mandell et al, 1986. 
Mashimo et al, 1988). Moore et al (1985) suggested that the prevalence of 
A.actinomycetemcomitans may differ in different geographical areas.
1.10.6 Chronic adult periodontitis
Adult periodontitis is the most common form of periodontitis - the common features 
of which are listed in Table 1.9.
1.10.7 Involvement of A. actinomycetemcomitans in adult periodontitis
Slots (1986) summarised the work of three studies into the bacterial specificity in 
adult periodontitis. A.actinomycetemcomitans was found in 50% of the progressive 
lesions in each of the three studies. However, when the sites were in remission, it was 
present in only 6% of samples collected from previously active lesions. In addition, 
A.actinomycetemcomitans was found in only 2.1% of sites which were 
non-progressive (Slots, 1986).
Wolff et al (1985) carried out a study of 284 adults (aged 20 - 40 years of age) whose 
periodontal status ranged from healthy to moderate chronic periodontitis. Overall, 
A.actinomycetemcomitans was found in 13% of subgingival and 4.9% of supragingival 
plaque samples for individuals.
When the pocket depth was greater than 5 mm, the numbers of colonies of 
A.actinomycetemcomitans recovered from the pocket were significantly reduced. 
Dahlen et al (1989) studied a population of 20 Kenyan adults (30 to 65 years of age) 
and recovered A.actinomycetemcomitans in 40% of the sample population and in 28% 
of the sites sampled. However there was no evidence of periodontal disease in this 
group of volunteers.
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Common Features of Chronic Adult Periodontitis
Age of onset is usually 30 to 35 or older.
Not confined to first molar or incisors, but these are more commonly and 
severely affected than are the canines and premolars.
The disease usually affects many teeth.
Conditions enhancing plaque accumulation are present and the quantity of 
microbial deposits are linked with the severity of the lesions
Serum, neutrophils and monocyte abnormalities generally not present.
The extent and distribution of bone loss are highly variable; both vertical 
and horizontal patterns maybe seen.
Acute inflammation with marginal proliferation of the gingivae is usually 
not seen.
Lesions are not as amenable to treatment with antibiotics as with other 
forms of periodontitis.
Acute destruction and exacerbation can occur at one or more sites.
Table 1.9 Features of chronic adult periodontitis
After Schulger et al, 1990
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1.10.8 Rapidly progressive periodontitis
The term rapidly progressive periodontitis was first used by Crawford, Socransky and 
Brathhall (1975) to describe highly active lesions at specific sites for which there was 
radiographic evidence of rapid bone destruction. The common features are given in 
Table 1.10. Rapidly progressive periodontitis is most commonly seen in young adults 
in their early twenties, but has been shown to be present in individuals upto thirty-five 
years of age. During the active phase, the gingival tissues become extremely inflamed 
with haemorrhage, proliferation of the marginal gingiva and exudation. Tissue 
destruction is rapid and most bone loss appears to occur within a few weeks or 
months (Page etal, 1983).
The quiescent phase of the disease is characterised by the presence of clinically normal 
gingivae, accompanied by very advanced bone loss and deep periodontal pockets. This 
phase may be permanent or transient.
1.10.9 Involvement of A.actinomycetemeomitans in rapidly progressive 
periodontitis
There has been very little published data on the relationship between 
A.actinomycetemcomitans and rapidly progressive periodontitis. Page et al (1983) 
found serum antibodies to various Actinobacillus species in rapidly progressive 
periodontitis and also reported that most of the patients with this disease had defects 
in neutrophil or monocyte chemotaxis.
1.11 AIMS
It would appear that there is some dubiety within the literature regarding the number 
of plasmid harbouring strains of A.actinomycetemcomitans. Whilst most workers have 
found plasmids, variations in the frequency of occurrence of plasmid positive strains, 
in the different studies exist. (Olsvik & Preus, 1989; LeBlanc et al, 1993; Poulsen et 
al, 1994). These variations may, in part, be due to the temporal and geographical
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Common Features of Chronic Periodontitis
Age of onset between puberty and 35.
Lesions affect most of the teeth.
Some patients may have had juvenile periodontitis previously.
Evidence of severe and rapid bone destruction, after which the destructive 
process may cease spontaneously or markedly slow down.
During the active phase, the gingival tissue is acutely inflamed with
marginal proliferation : during the arrested phase, the tissues may 
appear free from inflammation.
The amounts of microbial deposits are highly variable.
Most of the patients have functional defects in neutrophils or 
monocytes.
Some individuals are remarkably responsive to treatment by curettage 
coupled with antibiotic administration e.g. tetracycline, while a 
small portion is refractory to any known form of therapy.
Table 1.10 Common features of rapidly progressive periodontitis
After Schulger et al, 1990
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isolation of the strains under investigation.
The first aim of this thesis was to investigate the strain diversity of the collection of 
A.actinomycetemcomitans strains held at the Glasgow Dental Hospital and School. 
These strains were collected over a 5 year period and included Type strains which 
were originally isolated in America and Denmark. The initial stage of the investigation 
into clonality was to determine the frequency of strains of A.actinomycetemcomitans 
which harboured plasmids and to use this information (in addition to information 
known previously about the collection) to determine which strains would be studied in 
the subsequent experimental investigations.
The clonality of A.actinomycetemcomitans strains has been investigated previously, 
however, these have tended to be American studies, of American strains and therefore 
much information is known regarding the clonality of American isolates and relatively 
little about European strains. One European study (Haubek et al, 1995), suggested 
that the A.actinomycetemcomitans strains of Europe were less virulent than those of 
America, suggesting a different clonal origin. It was intended that the generation of 
RFLPs for a subsection of the Glasgow Dental Hospital collection would reveal more 
information of the clonality of European A.actinomycetemcomitans isolates.
There have been several studies into the toxic effects of A.actinomycetemcomitans on 
e.g. freshly isolated human polymorphonuclear cells (Baehni et al, 1979., Baehni et al, 
1981) and cultivated human tissue cell lines e.g. HL-60 (Zambon et al, 1983., 
Simpson, Berthold and Taichman, 1988). Cell death has been determined by trypan 
blue exclusion (Ohta et al, 1987); lactate dehydrogenase release (Zambon et al, 1983); 
lysosomal elastase release (Tervahartiala et al, 1989); release of 51Cr (Simpson et al, 
1988) and fluorescent spectroscopy (Ohta et al, 1991). Because there are many 
different assaying systems, comparisons of the different methods is difficult. The 
second aim of this investigation, was therefore to devise a rapid, accurate method, to 
determine toxicity. It was hoped that this standardised protocol would enable the 
rapid screening of the A.actinomycetemcomitans collection for toxic activity and the
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number of toxic strains within the collection found.
It is intended that by investigating the clonal origin and leucotoxic status of 
A.actinomycetemcomitans, the epidemiology of this important human pathogen be 
further understood.
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CHAPTER 2 
GENERAL METHODS
CHAPTER 2 
GENERAL METHODS
2.1 GROWTH OF A.actinomycetemcomitans
All constituents and the preparation of the media are shown in Appendix 1.1
2.1.1 Solid media (Constituents and preparation in Appendix 1.1)
Throughout the study, strains of A.actinomycetemcomitans were first grown on 
Columbia Blood Agar (CBA) at 37°C, 5% C02 for 48 hours, and thereafter inoculated 
into Trypic Soya broth (TSB - Oxoid) as required.
2.1.2 Broth media (Constituents and preparation in Appendix 1.1)
In preliminary DNA fingerprinting investigations Brain Heart Infusion (BHI - Oxoid) 
broth was used : in later investigations this was changed to TSB .
TSB was prepared in either 100 or 400 ml volumes, autoclaved and stored at room 
temperature until required. Aseptic techniques were used throughout.
Twenty millilitre volumes of TSB were used routinely for growth of the organism for 
DNA profiling (Chapters 4 and 5) and leucotoxicity studies (Chapter 7). Volumes of 
400 ml were used in the isolation of outer membrane proteins (Chapter 6).
Before inoculation, broths were aliquoted into 20 ml volumes and stored at 37°C, in 
5% C02 in air for 4 - 5 hours, with the lids slightly loose, to saturate the media with 
carbon dioxide. After inoculation broths were returned to 37°C, in a 5% C02 
incubator (LTE, Greenfield, Oldham).
Broth was inoculated with a heavy suspension of A.actinomycetemcomitans - typically 
the total growth from 1 CBA plate per 20 ml of broth or from 5 plates per 400 ml, 
using sterile cotton wool swabs.
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2.1.3 Atmospheric requirements
Attempts to enhance growth in broth by the addition of sodium bicarbonate (BDH) as 
a source of carbon dioxide did not increase the yield of cells compared with those 
grown in a C02 incubator.
Candle extinction jars were used to culture A.actinomycetemcomitans on solid media 
prior to the determination of plasmid profiles. In all other investigations, to avoid 
spillage and contamination of liquid media, broths were incubated in a C02 incubator 
(LTE, Greenfield, Oldham), as were all agar plates.
Unless otherwise stated, all cultures of A.actinomycetemcomitans were grown in air 
supplemented with 5% C02, at 37°C.
2.2 STORAGE OF A.actinomycetemcomitans
2.2.1 Freeze-dried ampoules.
A.actinomycetemcomitans strains, which had been isolated previously, were stored in 
freeze-dried ampoules. Bacteria were revived, by the addition of 200 - 300 pi of BHI 
to the ampoules and the resultant suspension plated out for single colonies onto one 
CBA plate and incubated at 37°C in 5% C02 for 72 hours.
Single colonies were subcultured and identification was confirmed using the API 20A
strip (API/Bio Merieux, England), catalase reaction (Roche, England) and stellate 
morphology.
2.2.2 Protect beads
After a total of 2 subcultures from revival, a heavy suspension of 
A.actinomycetemcomitans was made into "Protect beads" (Lab M, England) in 
duplicate. One ampoule was stored at -20°C, the other at -70°C.
Revival of the culture involved removal of beads from the frozen vial as quickly as
possible, to minimise "ffeeze-thaw" stress on the stock culture.
A maximum of 2 beads were removed to CBA plates (two plates per strain) and
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roughly spread across the agar. These were incubated in in air, supplemented with 5% 
C02, at 37°C for 48 hours before being examined for growth. A sweep was made from 
these plates, which was then spread for single colonies on CBA and were grown for 
48 hours as before. These were then used as stock plates in subsequent studies. Stock 
plates were stored at 4°C. Thus the inoculum used in each investigation comprised 
bacteria that had been subcultured three times from revival. Plates were stored for a 
maximum of three weeks at 4°C before freshly revived strains were used.
2.3 ISOLATES OF A. actinomycetemcomitans
The Oral Microbiology Unit in Glasgow Dental Hospital and School had a collection 
of 96 A.actinomycetemcomitans isolates that comprised 85 clinical strains and 11 
reference strains.
The clinical strains had been collected over a number of years (1985 - 1990) and 
included multiple strains from a number of individuals. The characteristics of the 
strains are shown in Tables 2.1a to 2.1c. The strains reflect a variety of clinical 
conditions, including juvenile periodontitis, chronic periodontitis and prepubertal 
periodontitis.
The majority of these strains were collected by I. Taher and used in experimental 
studies including adhesion, hydrophobicity and a leucotoxicity assay (Taher, 1989). 
The freeze-dried ampoules which were opened and subsequently used throughout, 
were prepared by I. Taher.
A subset of these strains were used subsequently in epidemiological and leucotoxicity 
studies, as detailed in Table 2.2.
2.4 HL-60 CELLS
HL-60 cells provided an easy and convenient substrate for the leucotoxicity assay. 
They were obtained from The European Collection of Animal Cell Cultures (Porton 
Down, Wiltshire, England). This cell line was derived from a 36 year-old Caucasian
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woman, with acute promyelocytic leukaemia (Collins, Gallo & Gallagher, 1977., 
Gallagher et al 1979). Cells were grown in 100 ml volumes in RPMI 1640 (Life 
Technologies, Scotland) supplemented with 10% Fetal Calf Serum (FCS - 
Globepharm England - Appendix 1.1), in 260 ml "Nunc" Tissue culture flasks (Life 
Technologies).
For passage, cells were transferred aseptically to sterile plastic universals, centrifuged 
gently (500 rpm for 10 minutes) and the supernatant discarded. The cells were then 
resuspended in freshly prepared media and returned to a C02 incubator, at 37°C 
supplemented with an atmosphere of air and 5% C02 (Grant, England)
The method recommended by the suppliers involved decanting the RPMI 1640 
medium from the sedimented cells and its replacement with fresh RPMI 1640/ FCS, 
which thus avoided the need to replace the tissue culture flasks at each passage. This 
method, however resulted in a large numbers of cells per flask, which led to the rapid 
utilisation of the nutrients in the media and required the cells to be passaged more 
frequently. This in turn led to an increase in the volume of media which was used. This 
method predisposed to contamination. Thus it was decided to use the techniques 
described previously.
Three flasks of HL-60 cells were grown at any one time, each at a slightly different 
stage of development. The concentration of cells was not allowed to increase beyond 
a density of 3 - 4 X 107 cells ml'1, which thus ensured the availability of cells for use in 
the assay.
2.5 HAEMOCYTOMETER
The haemocytometer (BDH) provided a method for counting animal cells grown in 
culture. It consisted of a large slide with a series of lines etched upon its surface 
dividing it into 9 large squares. The centre square was divided further into 25 squares 
which were then subdivided into 16 squares each. The large squares had an area of 1 
mm2. After slight wetting of the sides of the chamber, a coverslip was placed on top,
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resulting in patterns of interference. The depth of the chamber at this point was 1mm, 
which gave a total volume of 10-4 ml. The wells of the chamber were filled with HL-60 
cells diluted 1 in 20 with PBS containing trypan blue (BDH - Appendix 1.5) by 
capillary action. All cells, in the 4 comer squares only, were counted, both stained 
(dead) and clear (viable). The number of cells per ml of suspension was calculated 
using the following formula :
Number of = 104 n y
cells 4 where 104= multiplication factor
n = number of cells in 4 squares 
y = dilution of cells (1 in 10)
4 = number of squares
HL-60 cell viability was expressed as the percentage of live cells, calculated using the 
following formula:
CELL VIABILITY = TOTAL CELLS - TOTAL DEAD CELLS X 100%
TOTAL CELLS
2.6 SITES FOR EXPERIMENTAL STUDIES
Due to the availability of equipment, it was not possible to carry out all the 
experimental work at a single location. The different University Departments are listed 
below, with the experimental study carried out there noted along side.
Department of Oral Sciences, Glasgow Dental Hospital and School
Within the Department of Oral Sciences at the Glasgow Dental Hospital and School, 
stocks of A.actinomycetemcomitans were maintained, for use in all the experimental 
work (Chapters 3 - 7 ) .  The appropriate cultures were removed to the Department
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where the work was to be carried out on petri dishes and these cultures used as a 
stock. All petri dishes were sealed with tape prior to removal from the Dental 
Hospital.
HL-60 cells were also grown and maintained here (Chapter 7).
Blood, used to prepare PMNLs for use in the chemiluminescence experiments, was 
obtained from volunteers in the Oral Medicine Department (Chapter 7).
Department of Bacteriology, Glasgow Royal Infirmary
Within the Department of Bacteriology at Glasgow Royal Infirmary, the work 
described in Chapters 3 - 5  was carried out, with the exception of the use of the 
spectrophotometer, which was carried out in the Department of Oral Sciences.
Department of Cell Biology, Glasgow University
Within the Department of Cell Biology, PMNLs were prepared from the blood taken 
from volunteers at the Dental Hospital, prior to use in chemiluminescence studies 
within the Department of Microbiology (Chapter 7).
Department of Microbiology, Glasgow University
The experimental work described in Chapter 6 and the chemiluminescence studies 
described in Chapter 7 were carried out within the Department of Microbiology, 
Glasgow University.
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Identification
number
Source Site of isolation
1 GDH R8529/85 Cp
2 GDH 143/85 Cp
3 GDH 156/85 Cp
4 GDH 216/85 Cp
5 GDH 471/85 Cp
6 GDH 1954/85 Cp
7 GDH 105/86 Cp
8 GDH 107/86 Cp
9 GDH 114/86 Cp
10 GDH 117/86 Cp
11 GDH 119/86 Cp
12 GDH 121/86 Cp
13 GDH 125/86 Cp
14 GDH 127/86 Cp
15 GDH 129/86 Cp
16 GDH 1014/86 Jp
17 GDH 1028/86 Cp
18 GDH 1114/86 Cp
19 GDH 1115/86 Cp
20 GDH 1116/86 Cp
21 GDH 1123/86 Cp
22 GDH 1125/86 Jp
23 GDH 1212/86 Jp
24 GDH 1224/86 Jp
26 GDH 2351/86 Jp
27 GDH 1214/86 Cp
28 GDH 28/87 Cp
29 GDH 33/87 Jp
30 GDH 39/87 Jp
31 GDH 110/87 Cp
32 GDH 228/87 Cp
33 GDH 310/87 Jp
34 GDH 312/87 Cp
35 GDH 510/86 Cp
36 GDH 87034/87 Pp
89 GDH 877/90 HIV or
90 GDH 589/90 HIV or
91 GDH 592/90 (1) HIV or
92 GDH 592/90 (2) HIV or
95 GDH 2102/91 241 HIV or
96 GDH 2212/90 213 HIV or
Table 2.1a : Single strains of A.actinomycetemcomitans isolated from individual 
patients attending the Glasgow Dental Hospital
GDH : Glasgow Dental Hospital
Cp : Chronic periodontitis Jp : Juvenile periodontitis
Pp : Prepubertal periodontitis HIV or : HIV oral rinse
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Identification
number
Source Site of isolation
37p GDH 130376 261 C1S1 Cp
38p GDH 130376 261 C2S Cp
39p GDH 130376 261 Cl Cp
40p GDH 130376 261 C3S1 Cp
41p GDH 130376 476 CIS Cp
42p GDH 130376 476 C2S Cp
43 p GDH 130376 476 C3 Cp
44/ GDH 213705 163 C188 Cp
45/ GDH 213705 163 C288 Cp
46/ GDH 213705 163 C388 Cp
47/ GDH 213705 163 C488 Cp
48a¥ GDH 225843 224 1-1 Cp
49£¥ GDH 225843 224 1-2 Cp
50a¥ GDH 225843 224 1-3 Cp
51a¥ GDH 225843 224 Cl-S Cp
52a¥ GDH 225843 224 Cl-S Cp
53&¥ GDH 225843 224 C4-S Cp
55£0 GDH 225843 426 1 Cp
56a0 GDH 225843 426 2 Cp
51U GDH 225843 426 3 Cp
54£ft GDH 225843 465 1 Cp
58afl GDH 225843 465 2 Cp
594fl GDH 225843 465 3 Cp
60£fi GDH 225843 465 1-1 Cp
61£fi GDH 225843 465 1-2 Cp
626 GDH 226824 166 C188 Jp
636 GDH 226824 166 C2S Jp
64x GDH 227916 116 Cp
65x GDH 227916 263 Cp
66x GDH 227916 334 Cp
67x GDH 227916 366 Cp
68x GDH 227916 456 Cp
69P GDH 229075 126 Cp
70P GDH 229075 144 Cp
71P GDH 229075 273 Cp
72P GDH 229075 314 Cp
73P GDH 229075 344 Cp
74U GDH 229473 114 Jp
75U GDH 229473 164 Jp
76U GDH 229473 376 Jp
77U GDH 231293 124 Jp
93> GDH 2102/90 161 HIV or
94> GDH 2102/90 181 HIV or
Table 2.1b Multiple strains of A.actinomycetemeomitans isolated from individual 
patients attending the Glasgow Dental Hospital, including multiple 
strains from the same periodontal pocket
GDH : Glasgow Dental Hospital
Cp : Chronic peridontitis HIV or : HIV oral rinse
Jp : Juvenile periodontitis
The symbols p /  a o x P U < >  indicate strains from the same individual.
The symbols ¥ 0 n indicate strains from the same pocket.
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Identification
number
Source Country 
of origin
Year of 
isolation
Site of 
isolation
78 ATCC 29522 USA Mandibular abscess
79 ATCC 29523 Denver Blood
80 ATCC 29524 Seattle 1970 Chest aspirate
81 Y4 USA Juvenile periodontitis
82 NCTC 9709 USA Abscess
83 NCTC 9710 Denmark 1949 Abscess
84 NCTC 10979 USA Mandibular abscess
85 NCTC 10980 USA Blood
86 NCTC 10981 USA Neck abscess
87 NCTC 10982 Seattle 1970 Chest aspirate
*88 JP2 Juvenile periodontitis
Table 2.1c Reference and Type strains of A.actinomycetemcomitans held in the 
Glasgow Dental Hospital collection with city/ country and year of 
isolation, if known
ATCC : American Type Culture Collection 
NCTC : National Collection of Type Cultures 
* : obtained from N.S. Taichman 
data from ATCC/ NCTC catalogues
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Identification
number
Plasmid
status
Leucotoxicity 
status, preassay
1 + ve Unknown
8 + ve Unknown
24 + ve Positive *
#29 + ve Unknown
32 - ve Unknown
33 - ve Unknown
36 - ve Unknown
55 + ve Unknown
56 + ve Unknown
57 + ve Unknown
74 - ve Unknown
75 - ve Unknown
76 - ve Unknown
79 - ve Positive **
80 - ve Negative ***
81 + ve Variable ****
83 - ve Unknown
88 - ve Positive *****
Table 2.2 Leucotoxic status (prior to assay) of A.actinomycetemcomitans strains 
used in all experimental studies
* Taher, 1989
** Baehni et al, 1981. Spitznagel, Kraig & Kolodrubetz, 1991. Zambon etal, 1983.
* * * Baehni et al, 1981. Zambon et al, 1983.
**** Tsai etal, 1979.
***** Tsai etal, 1983.
#29 This strain was only used in the experimental work detailed in Chapters 4 and 5.
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CHAPTER 3
PREVALENCE OF PLASMIDS IN A. actinomycetemcomitans
3.1 INTRODUCTION
Plasmids have been demonstrated in a small number of A.actinomycetemcomitans 
strains (Olsvik & Preus, 1989; LeBlanc et al, 1993; Poulsen et al, 1994). These 
authors suggested the global expansion of very few clones on the basis of detection 
of similar plasmids of similar size in unrelated strains.
The molecular epidemiology of bacterial strains can be investigated in three ways. 
The first is to demonstrate plasmid content. Further analysis of plasmid DNA by 
digestion with restriction enzymes to generate a restriction enzyme fragmentation 
pattern (REFP) or "plasmid fingerprint", distinguishes plasmids of similar size and 
provides scope for the assessment of plasmid relatedness (Platt and Smith, 1991. 
Chapter 5). An alternative (and sometimes complementary) approach applicable to 
both plasmid free and plasmid carrying strains of bacteria, involves similar treatment 
- purification and digestion - of the entire genome to generate a REFP.
The work which is discussed in this chapter, was the demonstration of the plasmid 
content of the entire A.actinomycetemcomitans collection held at the Glasgow Dental 
Hospital and School, 91 strains in total, by the method of Platt, Heraghty and Taggart 
(1988), which has been used successfully on a number of different bacteria, 
(Therlfall et al, 1985; Platt et al, 1986; Coia, Nor-Hussain and Platt, 1988., Platt, 
Heraghty and Taggart, 1988; Platt and Smith, 1991).
3.2 MATERIALS AND METHODS
3.2.1 Crude isolation of plasmids
The determination of plasmid profiles was carried out by the method of Platt, 
Heraghty and Taggart (1988).
An overnight culture of each of the 95 strains of A.actinomycetemcomitans
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investigated, grown on CBA, at 37°C, 5% C02, was harvested with a dry swab into 
300gl Tris borate (TBE - Appendix 1.2) in an eppendorf. An equal volume of a 10% 
solution of sodium dodecyl sulphate (SDS - Appendix 1.2) was then added. The tube 
was mixed by inversion and left at 55°C for 5 minutes until the contents had become 
clear and viscous, which indicated that the cells had lysed. The samples were then 
centrifuged for 15 minutes at 13000 rpm in a microcentrifuge (Andermann, England). 
The pellet was removed, to leave a clear supernatant. From this clear supernatant, 
lOOpl was removed and 5 pi of gel loading buffer added (Appendix 1.2) .
This procedure was repeated on 3 separate occasions for each strain.
3.2.2 Electrophoresis
Agarose gels of 0.7% were prepared from Type II agarose (Sigma, Poole) in TBE. 
Samples of lOOpl were loaded under TBE buffer. The gels were run at 100 V for 1 
hour, then at 200 V (4 vcm'1) for a further 4 hours.
3.2.3 Visualisation of plasmids
The gels were stained in TES which contained ethidium bromide (Appendix 1.2), for 
15 minutes and viewed using an ultraviolet light transilluminator at 365 nm (Ultra 
Violet Products, Cambridge, England) and photographed using Polaroid type 665 
Land film. The molecular length of the plasmids was determined by reference to a 
molecular length standard E.coli 39R861 (NCTC 50192 - Threlfall, 1986) that 
harboured plasmids of 147, 63, 37 and 7 kb.
3.2.4 Rationale for the interpretation of plasmid profiles
Plasmid profiles can provide a base for epidemiological studies in the following ways
(i) As a method of assessing the diversity of bacterial populations.
(ii) As a method of comparing strains from defined epidemiological
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situations.
The contribution of plasmid profiles in epidemiological investigations derives from
(i) ease of determination
(ii) the size and diversity of the plasmid pool in many bacterial genera.
The plasmid complement (or profile) generally reflects the recent history of a 
bacterial strain because some have the ability to be transferred between bacteria and 
are of variable stability, with the result that some organisms will lose plasmids, 
whilst others accumulate them and on this basis the source of many infections can be 
traced. Whereas the demonstration that different strains of bacteria which carry 
plasmids of different molecular length suggests that the strains may be unrelated, the 
demonstration that two strains harbour plasmids of the same size does not necessarily 
indicate that they are epidemiologically related. This requires verification by further 
investigation and forms the basis of molecular epidemiology and ideally knowledge 
of the long term stability of the plasmids.
Plasmid REFP generation (Chapter 5) not only discriminates between plasmids of 
different molecular lengths, but also between plasmids of the same molecular length, 
which have different conformations i.e. linear, OC and CCC.
Plasmids of the same molecular length can only be distinguished from each other by 
the generation of a REFP. Plasmids which differ only in conformation will have the 
same REFP. The information which is obtained from plasmid profiles is therefore 
limited.
3.3 RESULTS
Plasmid profiles were obtained for the clinical and Reference strains listed in Table 
2 . 1.
Figures 3.1a and 3.b demonstrate two gels, which contain both plasmid positive and 
plasmid negative strains.
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Figure 3.1a Plasmid profiles of 4 plasmid positive
and 6 plasmid negative A.actinomycetemcomitans
strains
Figure 3.1b Plasmid profiles of 3 plasmid positive
and 7 plasmid negative A.actinomycetemcomitans 
strains
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Overall, plasmids were detected in 43.2% of the collection: 40 of the 84 clinical 
strains (47.6%) and 1 of the 11 Reference strains - ATCC 29523 - (9.1%) were 
plasmid positive (Tables 3.1a, b and c). Plasmid size ranged from approximately 5 to 
160 kb and the number of differently sized plasmids seen in plasmid positive strains 
varied between 1 and 3. The majority of plasmid positive strains, 73.2%, harboured a 
single plasmid, while 2 plasmids were detected in 24.4% and 3 in the remaining 
2.4%.
Whilst no single plasmid or profile predominated, the distribution of the sizes 
suggested 4 possible clusters at 10 kb (range 5 - 2 0  kb), 30 kb (range 25 - 40 kb), 60 
kb (range 45 - 60 kb) and 80 kb (range 65 - 80 kb).
A total of 11 plasmid profiles were identified as shown in Tables 3.2 and 3.3. This 
did not include plasmid-free strains, which formed a 12th plasmid profile group. The 
molecular length range for each plasmid profile group is given in Table 3.2. These 
results indicate significant diversity of A.actinomycetemcomitans strains, although 
the incidence of plasmid-free strains would argue against the adoption of plasmid 
profiles as a first line technique in epidemiological investigation.
3.3.1 Single isolates
Forty-nine strains were collected from forty-nine different individuals over the period 
1985 - 1991. As only one strain was isolated from each individual, these were termed 
single strains. Plasmid profiles of these strains, separated them into 8 of the 12 
plasmid profile groups described in Table 3.2. This Table demonstrates the 
distribution of these single strains amongst the different plasmid profile groups. 
Plasmid-free isolates accounted for 68.0% of the single strains. Strains with one 
plasmid comprised 22.0% of the single strain group, whilst strains with two plasmids 
comprised the remaining 10.0%. Groups 5, 11 and 12 were not represented amongst 
the 49 single strains.
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Id
No.
Number and 
Size (kb) 
of Plasmids
Year of 
Isolation
Country
of
Origin
1 2 : 30, 60 1985 Scotland
2 0 1985 Scotland
3 0 1985 Scotland
4 0 1985 Scotland
5 0 1985 Scotland
6 0 1985 Scotland
7 1 : 10 1986 Scotland
8 2 : 10, 60 1986 Scotland
9 0 1986 Scotland
10 1 : 10 1986 Scotland
11 0 1986 Scotland
12 1 : 10 1986 Scotland
13 1 : 50 1986 Scotland
14 1 : 30 1986 Scotland
15 2 : 10, 30 1986 Scotland
16 0 1986 Scotland
17 0 1986 Scotland
18 0 1986 Scotland
19 1 : 10 1986 Scotland
20 0 1986 Scotland
21 0 1986 Scotland
22 1 : 30 1986 Scotland
23 0 1986 Scotland
24 1 : 50 1986 Scotland
26 1 : 50 1986 Scotland
27 2 : 10, 50 1986 Scotland
28 0 1987 Scotland
29 2 :60, 140 1987 Scotland
30 0 1987 Scotland
31 0 1987 Scotland
32 0 1987 Scotland
33 0 1987 Scotland
34 0 1986 Scotland
35 0 1986 Scotland
36 0 1986 Scotland
89 0 1990 Scotland
90 1 : 20 1990 Scotland
91 0 1990 Scotland
92 0 1990 Scotland
95 0 1991 Scotland
96 0 1991 Scotland
Table 3.1a Plasmid status of single strains of A.actinomycetemcomitans isolated 
from individual patients attending the Glasgow Dental Hospital
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Id
No.
Number and Year of 
Size (kb) Isolation 
of Plasmids
Country
of
Origin
37p-43p 0 Not known Scotland
44/ 2 60, 140 Not known Scotland
45/ 2 5, 10 Not known Scotland
46/ 0 Not known Scotland
47/ 2 5, 10 Not known Scotland
48a¥ 1 30 Not known Scotland
49a¥ 1 50 Not known Scotland
50a¥ 1 50 Not known Scotland
51a¥ 1 80 Not known Scotland
52a¥ 1 80 Not known Scotland
53a¥ 1 80 Not known Scotland
55a0 1 60 Not known Scotland
56a0 1 60 Not known Scotland
51U 1 80 Not known Scotland
54&fi 1 80 Not known Scotland
58afi 1 80 Not known Scotland
59afi 1 10 Not known Scotland
60dfi 1 80 Not known Scotland
61dfi 1 80 Not known Scotland
626 3 5, 10, 15 Not known Scotland
636 1 5 Not known Scotland
64x - 68x 0 Not known Scotland
69P 1 30 Not known Scotland
70P 2 30, 60 Not known Scotland
7 IP 1 60 Not known Scotland
72P 1 30 Not known Scotland
73P 1 30 Not known Scotland
74U 0 Not known Scotland
75U 0 Not known Scotland
76U 0 Not known Scotland
77U 2 30, 60 Not known Scotland
93> - 94> 0 1990 Scotland
Table 3.1b Plasmid status of multiple strains of A. actinomycetemcomitans 
isolated from individual patients attending the Glasgow Dental 
Hospital, including multiple strains from the same periodontal 
pocket
The symbols p /  a o x P U < >  indicate strains from the same individual.
The symbols ¥ 0 n indicate strains from the same pocket.
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Id
No.
Number and 
Size (kb) 
of Plasmids
Country
of
Origin
78 0 USA
79 1 : 5 USA
80 0 USA
81 0 USA
82 0 USA
83 0 Denmark
84 0 USA
85 0 USA
86 0 USA
87 0 USA
88 0 USA
Table 3.1c Plasmid status of Reference and Type strains
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GROUP
IDENTIFICATION
NUMBER OF 
STRAINS IN 
GROUPS
PLASMID PROFILE
NUMBER OF 
PLASMIDS
MOLECULAR 
LENGTH RANGE 
(kb)
1 34 0 0
2 5 1 5 - 25
3 2 1 30 - 45
4 3 1 50 - 65
5 0 0 70 - 85
6 1 2 5 - 25, 30 - 45
7 2 2 5 - 25, 50 - 65
8 0 0 5 - 25, 140
9 1 2 30 - 45, 50 - 65
10 1 2 50 - 65, 140
11 0 0 5 - 25, 5 - 25
12 0 0 5 - 25, 5 - 25 
5 - 2 5
Table 3.2 Plasmid profiles and frequency of occurrence amongst the 
single strains
The molecular length range is purely arbitory. Where two 
or more ranges are given, plasmids in these ranges have 
been found.
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3.3.2 Multiple isolates from the same patient
Multiple isolates of A.actinomycetemcomitans from 9 individuals were obtained over 
the period 1985 to 1991 (Table 2.1).
Isolates from 8 of these patients could be divided into 8 groups on the basis of 
number and size of plasmids as shown in Table 3.3. This Table shows the 
approximate molecular length range of the plasmids and indicates the range of 
plasmids found in the same individual. Multiple isolates from 4 individuals, strains 
37 - 43; 64 - 68; 74 - 77 and 93 - 94 were all shown to be plasmid-free and are 
included as a single group in Table 3.3. The 14 strains (numbers 48 to 61) which 
were found in the same individual are excluded from these results and are dealt with 
separately. The results for Patients A - D are summarised in Table 3.4 
Strains 44 - 47 (patient A) showed three different profiles, which indicated that of the 
4 isolates there were possibly 3 different strains.
Strains 62 and 63 (patient B) had different profiles, indicating perhaps the presence 
of two different strains.
Strains 69 - 73 (patient C) show three different profiles. The molecular lengths 
(Table 3.3) of these suggest that they may be mono- and di-mer forms of the same 
plasmid.
Strains 74 - 77 (patient D) had two different profiles; 1 plasmid-free (strains 74 - 76) 
and 1 plasmid positive (strain 77) with two plasmids of approximate molecular 
length of 30 and 60 kb. These plasmids could be represent mono- and di-mer forms 
of the same plasmid.
From patient E, 14 different A.actinomycetemcomitans strains were cultured, from 3 
separate pockets. Each isolate possessed only one plasmid. Those in group 5 
predominated (approximate molecular length of 80 kb) with 57.1%. Table 3.5 shows 
the distribution of the plasmids. These isolates were found in association with each 
other i.e. isolates with different plasmid profiles were found in the same pocket with 
each other.
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GROUP
IDENTIFICATION
NUMBER OF 
STRAINS IN 
GROUPS
PLASMID PROFILE
NUMBER OF 
PLASMIDS
MOLECULAR 
LENGTH RANGE 
kb)
1 20 0 0
2 1 1 5 - 2 5
3 3 1 30-45
4 1 1 5 0-6 5
9 2 2 30-45,  50-65
10 1 2 50 - 65, 140
11 2 2 5 - 25, 5 - 25
12 1 3 5 - 25, 5 - 25, 
5 - 2 5
Table 3.3 Distribution of plasmids in multiple strains from 8 
individuals
Patient Number of 
Isolates
Number of 
Profiles
Number of 
Isolates with 
Molecular 
length (kb)
A 4 3 i@ o
2 @ 5, 10 
1 @ 60, 140
B 3 2 1 @ 5
1 @ 5, 10, 15
C 5 3 3 @ 30  
1 @ 60  
1 @ 30, 60
D 4 2 1 @ 0  
1 @ 30, 60
Table 3.4 Plasmid Profiles of Multiple Isolates from Four Individuals, 
A - D, Colonised by More Than One Distinct Isolate
102
GROUP
IDENTIFICATION
NUMBER OF 
STRAINS IN 
GROUPS
PLASMID PROFILE
NUMBER OF 
PLASMIDS
MOLECULAR 
LENGTH RANGE 
(kb)
2 1 1 5 - 2 5
3 1 1 30 -4 5
4 4 1 50 -6 5
5 8 1 7 0 -8 5
Table 3.5 Distribution of plasmids among 14 isolates from 3 gingival 
pockets of a single patient (E)
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Strains were investigated to show the presence, if any, of large - plasmids those with 
a molecular length of 450 kb or more, using a method adapted by Rosenberg et al 
(1982). This did not reveal any such plasmids.
3.4 DISCUSSION
Plasmid profiling has advantages over other typing methods such as phage typing. 
Phage typing requires antisera, a large number of phage and indicator strains and is 
strain specific. Plasmid profiling is a relatively cheap and fast method. The main 
disadvantage of plasmid profiling is the requirement for sufficient differences in the 
molecular lengths of different plasmids which would allow them to separate into 
distinct patterns.
Plasmids have been reported previously in A.actinomycetemcomitans by Olsvik and 
Preus (1989); LeBlanc et al, 1993 and Poulsen et al, 1994. Olsvik and Preus (1989) 
demonstrated the presence of 4 plasmids in 11 fresh clinical isolates, which ranged in 
size from 6 to 30 kb. They also reported the presence of a 30 kb plasmid in 5 
Reference strains they investigated, although the results of this were not shown.
These results differ greatly from those obtained in the present study. Only 1 of 4 of 
the Reference strains investigated by Olsvik and Preus (1989) was shown to possess a 
5 kb plasmid - which was smaller than the one reported by Olsvik and Preus (1989). 
The three smaller plasmids seen by Olsvik and Preus (1989) had approximate 
molecular lengths of 10.55, 7.8 and 6 kb. They were found in all strains with the 
exception of the Reference strains but only when the method of Bimboim and Doly 
(1979) was used. The large 30 kb plasmid was detected only with the method of 
Kado and Liu (1986). The method used to prepare the crude plasmid preparations in 
this investigation was an adaptation of the method of Bimboim and Doly (1979) 
(Platt, Heraghty and Taggart, 1988).
Poulsen et al (1994) suggested that plasmids were rarely found in laboratory strains 
of A.actinomycetemcomitans as they were easily lost upon subculture. LeBlanc et al
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(1993), demonstrated only 2 plasmid positive strains out of 39 strains investigated. 
The majority of A.actinomycetemcomitans strains investigated were shown to be 
plasmid negative - it is thus possible that the plasmids of A.actinomycetemcomitans 
are not stable and are easily lost during subculture or storage.
Plasmid negative strains formed the largest group of the A.actinomycetemcomitans 
collection held at the Glasgow Dental Hospital - greater than 50% (this figure 
included the Reference strains). It is not possible to say if this group forms a single 
clone without further investigation of the genome (Chapter 4). This group will not be 
discussed further.
Plasmid positive strains were shown to have 1 of 11 profiles which encompassed a 
wide range of molecular lengths and combination of plasmids in the strains.
No plasmid or profile appeared to be dominant, although there were four possible 
clusters of plasmids at approximately 10, 30, 60 and 80 kb.
Single strains collected in 1986 showed a large number of plasmids of 10, 30 and 50 
kb, and combinations thereof, but no trends in the period 1985 to 1991 could be 
distinguished.
Multiple strains from individual patients were investigated and fell into a number of 
groups - in no case did all the strains from the same individual have the same plasmid 
profile, with the exception of plasmid negative strains.
Patient A (strains 44 - 47) appeared to be colonised by at least 3 different strains of 
A.actinomycetemcomitans. Two of the four strains shared a common profile, 5 and 
10 kb; one had 2 plasmids of 60 and 140 kb and one had no plasmids at all. This 
patient may originally have been colonised by 3 different strains of 
A.actinomycetemcomitans, with the plasmid profiles as given above. Alternatively, 
colonisation may have occurred with only 2 different strains and the loss (at some 
point in the history of the strain, perhaps as recently as during subculture in the 
laboratory) of the plasmids from a subset of one of the strains would therefore have
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resulted in the negative plasmid profile seen.
Patient B (strains 62 and 63) would appear to have been colonised by 2 strains of 
A.actinomycetemcomitans. This phenotype however could be explained by the 
presence of di- and tri- mer forms of the 5 kb plasmid i.e. the pocket may have 
originally been colonised by 1 strain of A.actinomycetemcomitans, which had 1 
plasmid of 5 kb or by 1 strain with all 3 plasmids, 2 of which were lost.
Three different plasmid profiles were observed in Patient C (strains 69 - 71) which 
would suggest colonisation by 3 strains. However, the size of the plasmids (30 and 60 
kb) suggests that one of two events could have occurred. Originally, the gingival 
pocket may have been colonised by 2 strains of A.actinomycetemcomitans, one with a 
30 kb plasmid, the other with a 60 kb plasmid. A third strain arose by the transfer of 
either of the plasmids to the other strain, which created a third distinct strain. 
Alternatively, 1 strain initially had both plasmids and the loss of either or both 
plasmids would give rise to the profiles observed.
Patient D (strains 74 - 77). The two plasmid profiles seen in this individual would 
suggest, as before, that the site has been colonised by 2 strains of 
A.actinomycetemcomitans. Alternatively, the plasmid-free strains may have arisen 
due to the loss of 2 plasmids.
Patient E (strains 48 - 61) These strains were cultivated from 3 different gingival 
pockets.
Strains 48 - 54 : within this group from the same pocket, 3 different sizes of plasmid 
were seen, 30; 50/ 60 and 80 kb.
Strains 55 - 67 : within this group from the same gingival pocket, 2 different sizes of 
plasmids were seen, 10 and 80 kb.
These data suggest that it is possible for a patient to harbour different 
A.actinomycetemcomitans strains in different sites in the mouth and in the same 
gingival crevice.
There appears to be no correlation between the size of plasmid and the type of
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periodontal lesion from which it was isolated - for example, strain 29, was cultivated 
from a juvenile periodontitis lesion and harboured 2 plasmids of approximately 60 
and 140 kb, whereas 63, was cultivated from a juvenile periodontitis lesion and 
demonstrated 1 plasmid, of approximately 5 kb.
All the Type strains, with the exception of 79 (ATCC 29523) were plasmid free. This 
strain demonstrated one plasmid of 5 Kb. This was not associated with periodontal 
disease, but was originally isolated from blood (Table 2.1).
Plasmids which do not appear to have any known role e.g. either antibiotic resistance 
or toxin production are designated as ’'cryptic”. When the antibiotic sensitivities 
(Taher, 1989) of the A.actinomycetemcomitans collection from the Glasgow Dental 
Hospital were compared to the plasmid profiles, no correlation was seen. As the gene 
for the most studied toxin of A.actinomycetemcomitans has been found and is not 
associated with a plasmid (Chapter 1 and Chapter 7) it is therefore likely that the 
plasmids which were found in A.actinomycetemcomitans are cryptic.
It is not possible to say if the A.actinomycetemcomitans collection held at the 
Glasgow Dental Hospital was derived from the same or different clones, without 
further investigation, as no one plasmid or profile predominated. Greater than 50% of 
the collection is plasmid-free - without further investigation of the genome no further 
information on this group can be made. However, the diversity of plasmid profiles 
argues that the Glasgow Dental Hospital collection of A.actinomycetemcomitans 
strains was derived from more than one ancestral clone.
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CHAPTER 4
STRAIN DIVERSITY OF A. actinomycetemcomitans DETERMINED BY 
WHOLE CELL DNA RESTRICTION ENDONUCLEASE 
FRAGMENTATION PATTERNS (REFPS).
4.1 INTRODUCTION
The cleavage of high molecular weight genomic DNA by appropriately selected 
restriction endonucleases can generate restriction endonuclease fragmentation 
patterns (REFPs) or characteristic fingerprints for individual bacterial strains. It is a 
rapid method which enables large numbers of bacterial isolates to be studied at the 
same time. Strain diversity of strains, both from the same and different individuals can 
easily be assessed and the epidemiology studied.
The use of REFPs in the study of the epidemiology of A.actinomycetemcomitans and 
other oral bacteria linked to periodontitis has been well documented by several 
authors who include Zambon, Sunday and Smukto (1990), Genco and Loos (1991), 
Han et al (1991), van Steenbergen et al (1991) and Poulsen et al (1994). They used a 
variety of techniques which ranged from the generation of REFPs to the hybridisation 
of DNA probes from characterised strains of A.actinomycetemcomitans to separate 
genomic DNA restriction enzyme generated fragments from strains under 
investigation.
With the exception of Han et al (1991) these authors agreed that the population of 
A.actinomycetemcomitans could be divided into subpopulations, which corresponded 
roughly to the serotypes of the strains investigated. Han et al (1991) suggested, 
however, that there were at least ten clones of A.actinomycetemcomitans, in a 
population of twelve strains.
Clonality is a subject which has provoked much debate - every discipline appears to 
have a different definition of "clone". Population geneticists, taxonomists and
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epidemiologists approach the problem of clonality from different points of view and 
there can be some difficulty in determining the point at which a species becomes a 
clone and a clone becomes a strain.
Taxonomists deal with organisms from the order level, down to species; population 
geneticists deal with organisms at the species to strain level, while epidemiologists 
deal with organisms at the strain level. Somewhere within this framework "clones" fit. 
There is no clear definition of a clone. One of the most precise definitions of a 
bacterial clone, is a single cell, its progeny and all subsequent generations which 
represent a "monophyletic branch on an evolutionary tree" (Whittam, 1995). A clone 
is a closed genetic system where variation can only occur through mutation, 
recombination (internal or external, i.e. transformation, where genes from one clone 
can be embedded in genes from another, which results in mosaic genes), deletion etc. 
Because of this, a bacterial clone is not composed of genetically identical bacteria. 
This is the most useful definition of a clone. Orskov and Orskov (1983) defined 
"bacterial clones" as "bacterial cultures isolated independently from different sources, 
in different locations and perhaps at different times, but showing so many identical 
phenotypic and genetic traits that the most likely explanation for this identity is a 
common origin". Whittam's definition could apply equally to an entire strain as to a 
single clone; whilst the definition of Orskov and Orskov (1983) could be applied 
more appropriately at the strain level. The population geneticist considers a clone to 
be close to the species level, whereas the epidemiologist considers the clonality of an 
organism to be near the strain level.
For this study, the definition of a clone was considered to be that defined by the 
epidemiologist i.e. a bacterial strain and a clone are closely related to each other.
The work described in this chapter examined the diversity of a collection of strains of 
known origin using REFP analysis.
The A.actinomycetemcomitans strains investigated comprised a mixture of Type 
strains and freshly isolated clinical isolates from the West of Scotland. The temporal
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and spatial origin was known for the majority of the Type strains and all of those 
isolated in Glasgow. It might be expected that strains isolated in the same location 
would have had a similar clonal origin to each other - and a different clonal origin to 
strains from a different continent. However, there are several possibilities for the 
clonal origin of A.actinomycetemcomitans. For example, the epidemic spread of a 
recently evolved strain of A.actinomycetemcomitans, i.e. worldwide distribution, 
could be facilitated through travel of infected individuals.
Additionally, the same individual could be colonised by different strains of 
A.actinomycetemcomitans, if the strains were very diverse, were easily spread and 
established i.e. the individual was easily colonised.
The West of Scotland strains may or may not belong to a common clone, this would 
depend upon the ease of transmission (Christersson et al, 1985., Preus and Olsen, 
1988., Alaluusua et al, 1991., Zambon et al, 1993) and opportunities for spread e.g. 
the ethnic origin of the transient tourist population.
4.2 MATERIALS AND METHODS
4.2.1 Purification of whole cell DNA
On the basis of plasmid status and previously known information on the 
A.actinomycetemcomitans collection (Table 2.2), a subset of 18 strains was chosen.
All reagents were prepared as described in Appendices 1.3 and 1.4. Twenty millilitre 
overnight cultures of the 18 strains of A.actinomycetemcomitans (Table 2.2) were 
prepared in TSB broth, as previously described (2.1.2). These were centrifuged as 
before, after which the cells were resuspended in 3 ml TE50. This volume was divided 
into 3, 1 ml aliquots, which were washed twice in TE50. After the second wash, the 
cells were resuspended in 500 pi TE50. Twenty-five microlitres of 20% SDS (Sigma) 
was then added individually to each tube, which were immediately mixed by 
inversion. After 5 minutes incubation on ice, the suspension became clear and 
viscous, which indicated that the cells had lysed. Fifty microlitres of proteinase K was
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added and the tubes mixed, by inversion. The lysates were sheared to reduce the 
viscosity of the DNA, by charging and expelling the material through a syringe with a 
0.5 x 25G needle (Microlance Nr. 18). The tubes were then incubated at 37°C for 2 
hours.
The samples were extracted by the addition of 500 pi phenol/ chloroform (BDH), 
with thorough mixing followed by centrifugation at 13000 rpm for 15 minutes, after 
which the aqueous layer was removed to a fresh eppendorf. Five hundred microlitres 
of isopropanol was added and the samples left for 60 minutes at room temperature. 
DNA was pelleted by centrifugation as before and the isopropanol removed. Pellets 
were dried in a 37°C incubator and resuspended in 100 pi of TE10. Triplicate tubes for 
each sample were pooled and to each 300 pi, 100 pi 7.5M ammonium acetate 
(Sigma) was added; the tubes thoroughly mixed. Six hundred microlitres of icecold 
95% ethanol (BDH) was added and the tubes thoroughly mixed. After overnight 
incubation at -20°C the ethanol was removed and the dried pellet resuspended in 300 
pi of TE]0. Twenty microlitres of RNase A was added and the samples were incubated 
at 37°C for 60 minutes. A second phenol/ chloroform extraction was performed as 
before, followed by a further isopropanol precipitation step. The tubes were left at 
room temperature for 60 minutes and the DNA pelleted and dried as before. The 
dried pellet was resuspended in 300 pi TE10 and 100 pi of 7.5M ammonium acetate 
added, followed by 600 pi of 95% ethanol (icecold). The tubes were left overnight at 
-20°C. The DNA was pelleted and dried as before, then resuspended in 100 pi TE. 
From this volume, 3 pi was removed and diluted in 87 pi TE (1 in 30). From the 
diluted fraction, 60 pi was removed and scanned in microcuvettes over the range 310 
to 210 nm, in a UV-8 spectrophotometer (Pye, Unicam, Cambridge, UK.). This was 
then assessed for concentration and purity. The scan gave an indication of any likely 
type of contamination, by comparison with controls of lambda DNA spiked with 
different reagents considered to be the most probable cause of contamination e.g. 
ethanol and phenol.
i l l
DNA purity was estimated from the ratio OD260 : OD280 according to the criteria of 
Maniatis, Fritsch & Sambrook (1991)
Ratio = 1.8 : DNA considered to be pure.
Ratio > 1.8 : DNA contaminated with protein or 
phenol.
Ratio < 1.8 : DNA contaminated with ethanol.
The OD260 reading allowed the calculation of nucleic acid concentration in the sample, 
when pure. An OD260 of 1 corresponded roughly to 50 pgml'1 for double stranded 
DNA (Maniatis et al, 1991). The DNAs were then diluted to an approximate 
concentration of 10 pgml'1.
4.2.2 Restriction enzymes
The generation of restriction endonuclease patterns of whole cell DNA after 
restriction with frequent cutter enzymes i.e. four base cutters, is not widely used 
(Platt, Browning & Candlish, 1996). The use of four base cutters, however, 
overcomes the limitations described by Owen (1989). The resolution of large 
fragments into an open window enables computer analysis of the pattern and 
gel-to-gel comparison to be made. Patterns generated in this fashion enable a degree 
of visual quality control to be carried out, as partial digestion products are easily 
recognisable. This method can be adapted for a disparate range of organisms using a 
range of eight enzymes. The main disadvantage of this method is the small proportion 
of the genome which is analysed.
The restriction enzymes used were chosen from a panel tested in initial experiments, 
which included Pstl, HincHU, Smal, EcoRV, Avail, Sau3Al, HincU and HaeIII (New 
England Biolabs). From this panel three were chosen - Sau3M, Hinfl and Hae III - 
and used exclusively. The three enzymes chosen were 4 base cutters, which give a 
greater frequency of large fragments. Enzymes with a recognition sequence of six 
bases tended to give a peak molecular weight of 5 kb and the remaining DNA has the
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appearance of being smudged, whereas 4 base cutters tended to give a clean area 
("open window") at the top and a smudge at the bottom. The size of the open 
window varied with both enzymes and organism, but generally, DNA of molecular 
weight between 8 and 30 kb is desirable - the enzymes used in this investigation 
resulted in bands with a molecular weight of less than 8 kb being detected.
The enzymes used were unaffected by methylation with the exception of HaeTR 
which did not cleave GGCmC, whereas GGmCC was cleaved.
A 20pi aliquot of each DNA was digested with between 20 and 30 units of enzyme. 
To this, 5 pi of the appropriate reaction buffer (Sau3AI - New England buffer 
*Saw3AI; Hae III and Hinfl - New England buffer 2) was added and the total volume 
made upto 50 pi with distilled water.
Digestion was at 37°C for 4 hours. Parallel digests of lambda DNA were carried out 
to control each enzyme. Additionally, lambda DNA was separately digested with Psil 
and Kpnl enzymes, which were used as gel calibrators. This allowed accurate sizing 
of the restricted fragments (see 4.2.4).
4.2.3 Electrophoresis of whole cell DNA
Restricted whole cell DNA was electrophoresed in 0.8% agarose gels (Appendix
1.3). These were prepared using TBE buffer and cast in BRL Horizon 20.25 tanks.
To each digest volume of 50 pi, 5 pi of gel sample buffer was added and the total 55 
pi was loaded under TBE buffer. The gels were run at a constant current of 20 mA, 
typically for 42 hours, after which they were stained in TES containing ethidium 
bromide, examined under ultraviolet light and photographed as described previously 
(3.2.3).
4.2.4 Digitised REFPs
Photographs of the restricted DNA were digitised as previously described in detail 
(Platt and Sullivan, 1990). This program was run on a 486 computer with Summa
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Graphic II digitising pad. Fragment sizes were calculated by interpolation from the 
calibrators with a robust modified hyperbolic fitting routine derived from Plikaytis et 
al (1986). The Dice coefficient of similarity (Dice, 1945) was used to calculate 
similarities between different REFPs.
The Dice coefficient (SD) was calculated by the equation
SD 2m X 100% m is the number of
a + b matching fragments between
the two tracks, 
a is the total number of
fragments in track a. 
b is the total number of
fragments in track b.
The results generated by Molmatch enabled the number of bands which were different 
between the two compared strains to be found. The total number of fragments in 
each REFP varied, and therefore the percentage value which each contributed to the 
overall Dice coefficient of similarity altered for each comparison. It was important to 
assess the value for each matching band as this would affect the placing of a strain 
within a particular clone.
For example, if a + b equals 100 and m equals 50, then each band contributes 2% to 
the overall similarity coefficient (100%). If m = 45, then the Dice coefficient is 90%. 
However, if a + b equals 40 and m equals 20, then each fragment contributes 5%. If 5 
bands are different then the Dice coefficient is reduced to 75%. Therefore not only is 
the Dice coefficient important, but the total number of different bands is also 
important.
Thus Dice coefficients are not ideal but provide a means of assessment of large 
amounts of data, provided the limitations are recognised and incorporated into the 
overall interpretation. For example, two strains are compared, one of which has a 
large molecular weight band equivalent to 50% of the total genome. If this represents 
the only difference between the two strains, the Dice coefficient will be high, although 
in reality the two strains are not at all closely related.
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Fragment size variation was set at 5% - in preliminary experiments this degree of 
variation was shown to accurately reflect the degree of operator input error.
4.3 RESULTS
The REFPs from the three enzymes were examined both visually and numerically 
using Dice coefficients.
Visual assessment of the REFPs obtained with each enzyme (Figures 4.1 - 4.4) 
allowed a number of different preliminary conclusions to be drawn.
(i) Irrespective of restriction enzyme, there were fragments common to all 
strains.
(ii) There was clear evidence of considerable strain diversity in the REFPs 
from each enzyme.
(iii) The maximum number of common fragments and least discrimination was 
seen in Hinfl REFPs.
(iv) On visual inspection both Haelll and Sau3Al REFPs indicated that 
certain strains were clustered, whereas other strains were quite distinct 
and visual clusters were the same for both enzymes.
These preliminary observations argued in favour of numerical analysis using Dice 
coefficients of similarity.
4.3.1 Dice coefficients 
H aelll
Figure 4.1 demonstrates the REFPs for the 18 strains under investigation, generated 
after digestion with Hae III. It was not possible to produce a REFP for strain 79, 
using this enzyme, despite repeated attempts. This image was digitised and the results 
are shown in Figure 4.2. The Dice coefficients of similarity were found and are shown 
in Table 4.1a. An open window was seen which extended down to approximately 4.0 
kb but exceptionally to 3 .36 kb (strain 83).
115
Variation between the strains ranged from 56.4 (strain 55 compared to strain 33) to 
100% (strain 55 compared to strain 57).
On the basis of Hae III digestion alone, only strains 55 and 57 were completely 
identical with a Dice coefficient of 100%. However, strains 55, 56 and 57 formed a 
distinct cluster of SD greater than 97%. Several other clusters were seen, including,
32 and 33 (SD 96.8%) and 74, 75 and 76 (SD greater than 90%) formed a distinct 
cluster and strain 81 was also related to these (SD greater than 87%).
Hinfl
Figure 4.3 demonstrates the digitised image of the REFP for the strains under 
investigation, generated after digestion with Hina. Dice coefficients for the strains 
under investigation are shown in Table 4. lb.
The Dice coefficients of similarity varied between 72.0 (strain 33 compared to 83) 
and 100% (e.g. strain 75 compared with both 74 and 76) - seven strains demonstrated 
Dice coefficients of 100% (see Table 4b). Other strains notably similar were 32 and
33 (SD 93.6%); 8, 74, 75, 76 and 81 (SD greater than 96.6%); 24, 81 and 88 (SD 
greater than 96.3%); 29, 74, 75, 76 and 80 (SD greater than 93.3%) and 80, 74, 75 
(SD greater than 96.6%) all of which formed distinct clusters.
The open window for this enzyme was very narrow and ranged from approximately 
5.6 to 2.1 kb.
The discriminating powers of the enzymes varied - Hinfl did not discriminate well, 
whilst both Sau3Al and Haelll were highly discriminating. This reflects deeper 
elements of the clonal structure.
Sau3AI
Figure 4.4 demonstrates the digitised image of the REFP for the strains under 
investigation. Of these, only 3 pairings of strains were shown to have Dice 
coefficients of 100% - strains 32 and 33; strains 55 and 57; 29 and 75 (Table 4.1a).
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Other strains notably similar were 55 and 56; 56 and 57 (SD 95.2%); 29, 74 and 76 
(SD greater than 87%); 74, 75 and 76 (SD greater than 88%); 80 and 81 (SD greater 
than 90%) and 83 and 88 (SD greater than 94%) which all formed distinct clusters.
The open window for this enzyme, with these strains, ranged between 6.6 and 
approximately 1.7 kb. Dice coefficients varied between a low of 46.7 (32/33 
compared to 83) and a high of 100% (as described in Table 4.1a).
4.3.2 Hierarchical assessment
The Dice coefficients of similarities for each of the enzymes revealed the following 
clusters of A.actinomycetemcomitans, seen irrespective of the enzyme used.
(i) Strains 29, 74, 75 and 76
(ii) Strains 55, 56 and 57
The following clusters were seen when 2 enzymes (HaeIII and Hinfl) were used
(i) Strains 74 and 81
The following clusters were seen with 2 enzymes Sau3Ad and Haelll
(ii) Strains 32 and 33
The following clusters were seen with 1 enzyme only (Hinfl)
(i) 8 with 29, 74, 75 and 76
The following clusters were seen with 1 enzyme only (Sau3Al)
(i) 24 and 29
(ii) 80 and 81
(iii) 83 and 88
Figure 4.5 demonstrates a proposed hierarchical structure for the strains of 
A. actinomycetemcomitans investigated.
4.3.3 Common bands
Molmatch generated molecular weights for the digitised bands, which could then be 
examined and comparison between the different strains made, to show which bands, if
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Figure 4.1 REFP library for 18 strains of A.actinomycetemcomitans after 
digestion with Hae III
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Hae in
Several bands appeared to be common to several of the strains. 
A.actinomycetemcomitans strains 55, 56, 57, 74 and 88 demonstrated bands of 40 
±1.0 kb (which may have represented unclean and unplasmid DNA).
The majority of the strains demonstrated a band of 25 ± 1.0 kb
(A.actinomycetemcomitans strains 8, 36, 55, 56, 57, 74, 75, 76, 80, 81, 83 and 88.
Strains 32 and 36 were the only strains not to demonstrate bands at 9.7 ± 1.0 kb and 
21 ± 1.0 kb. However, these strains demonstrated unique bands of 16 and 18 kb. 
Some of the tracks on the gel below 6.0 kb could not be digitised and therefore no 
comment can be made regarding commonality.
Hinfl
As with Sau3Al the molecular weights of the bands digitised were very small - 
between a maximum of 5.59 kb and a minimum of 2.14 kb.
The bands which appeared common to the majority of the strains were very small e.g. 
3.92 ±0.04 and 2.52 ±0.07.
Sau3A\
With Sau3AI it was possible to digitise the tracks down to bands with a molecular 
weight of 1.81 ± 0.06. All strains examined, with the exception of 57, possessed this 
band.
Several other bands were common to the majority of the strains, e.g. 1.95 ± 0.05 kb 
and 4.69 ± 0.05 kb.
However, only small molecular weight bands were common to all strains. The largest
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Figure 4.5 Proposed clonal structure of A.actinomycetemcomitans
strains: differential discrimination based upon 3 enzymes. 
The vertical bars represent strains which are identical to 
each other on the basis of restriction endonuclease 
fragmentation patterns with individual enzymes
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bands had a molecular weight of 6.7 kb, which were not seen in all the strains 
investigated.
The REFPs reflected the overall location of restriction sites within the genome and 
thus provided a method to estimate the genetic similarity of different strains of 
bacteria. Differences seen between the restriction patterns of the different strains 
could be due to either the presence of plasmid DNA or mutations which have resulted 
in a variation to the enzyme restriction sites. Spurious bands observed in REFPs from 
plasmid positive strains were compared to plasmid profiles (Table 3.1) and these 
bands discounted. Preparations of plasmid DNA would not be demonstrated to cut 
(see Chapter 5) and it was therefore, assumed that any plasmid DNA which was 
copurifed in genomic preparations had not cut. Bands with a molecular length similar 
to plasmid molecular lengths were found not only in plasmid positive strains, but also 
in other strains.
Although REFPs are relatively rapid to produce, they are not without limitations. 
They are dependent upon the cuttipg frequency of the restriction enzyme (which is 
related to the size of the bacterial genome) and there may be > 50 bands of varying 
sizes. An open window provided a greater degree of flexibility with regard to minor 
variations in DNA concentration and greater amenability for quantition by computer. 
The lower limit for numerical analysis was established empirically and standardised 
for each enzyme for the purpose of calculation of Dice coefficients. Further visual 
assessment of smaller fragments was often possible but was more subjective and 
therefore not included in numerical estimates.
Although windows can occur anywhere within the fingerprint, it is of most value 
when it occurs in the top region of the gel where the largest fragments of DNA have 
separated. This allowed analysis of a larger percentage of the total genome to be 
investigated compared to an open window at the bottom of the gel, where the 
smallest fragments have separated. Moreover, an open window allows visual 
assessment for the presence of partial digestion products and thus provides an
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additional element of DNA quality control. This is particularly important when DNA 
is prepared from organisms that are less easily grown consistently.
4.3.4 Clonal Structure of the Glasgow Dental Hospital A. actinomycetemcomitans 
population
The bacterial population under investigation was derived from mainly patients who 
attended the Periodontal Department of the Glasgow Dental Hospital and School. All 
had periodontal disease (Table 2.1) : some were single strains from unrelated 
individuals, whereas others were multiple strains from the same periodontal pocket. A 
number of the collection were Type strains, originally held both in the USA and UK.
Type strains
Comparison of the Dice coefficients of each Type strain cut with each enzyme, did 
not suggest a single clonal origin for the Type strains. Tables 4. la and 4. lb show that, 
for example, A.actinomycetemcomitans Type strain 80 cut by Haelll is most closely 
related to A.actinomycetemcomitans 81, (SD = 86.5%) , whilst it shared only 76.2% 
similarity with A.actinomycetemcomitans 83. A.actinomycetemcomitans strains 81 
and 88 were the least related of the Type Strains showing only 70% similarity.
When the Type strains were cut by Sau3Al, strains 80 and 81 had a Dice coefficent of 
90.3%. With the same enzyme, strains 83 and 88 had a Dice coefficient of 94.1%. 
When the Type strains were cut by Hinfl 80 compared to 81 and 88 demonstrated a 
Dice coefficient of 89.7%; strains 81 and 88 had a Dice coefficient of 92.9%.
These results did not suggest a single clonal origin for the Type strains of 
A. actinomycetemcomitans.
When the results of Sau3 AI digestion are compared, there is more variation between 
the strains. A.actinomycetemcomitans 79 showed the greatest variation compared 
with strains 83 and 88 with similarity coefficients of 56.3 and 51.6% respectively. 
Once again, 80 and 81 were most similar to each other.
Hinfl restriction did not show the same range in variation as was seen with the other
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enzymes, however, once again strains 80 and 81 were shown to be most closely 
related, as were strains 88 and 80. The least similar strains were 79 and 83.
Clinical isolates
Comparison of the clinical strains with each other revealed that whilst several of the 
strains appeared to be related to each other, major variation existed between others. 
Strains 55, 56 and 57 showed very little variation between each other with each of the 
three enzymes used. When compared to other clinical strains they demonstrated 
similarities which were low - less than 50% similarity (HaeIII, 55 compared to 33, 
SD = 45.2% - Table 4a) to others which were quite high (Hinfl, 57 compared to 76, 
SD = 90.3%). Thus, A.actinomycetemcomitans strains 55, 56 and 57 originally 
isolated from the same patient, belong to the same clone and are consistent with 
multiple isolates of the same strain.
Strains 74, 75 and 76 similarly showed a great deal of similarity to each other, 
however, strain 74 demonstrated a larger degree of variation to strains 75 and 76. 
Additionally, several of the other strains were shown to have Dice coefficients which 
were quite high, although not high enough for the strains to belong to the same clone, 
depending upon the enzyme used to cut the DNA. Strains 75 and 29 were shown to 
have a Dice coefficient of 100% when cut with Sau3Al, but this reduced to 82.1% 
when cut with Haelll. The Dice coefficient of similarity between 29 and 57 when cut 
with Hinfl was 93.3%, although this enzyme generally gave high results.
The degree of similarity of the remaining strains did not suggest a single clonal origin 
for all the strains, with the exception of strains 32 and 33. These 
A.actinomycetemcomitans strains demonstrated a similarity coefficient of 100, 96.8 
and 96.6% with Haelll, Sau3Al and Hinfl respectively. Additionally, they 
demonstrated very little similarity to the other strains.
Type strains versus clinical isolates
Comparison of all the strains to each other did not suggest that the strains had arisen
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from a single clone.
The Type strains isolated in America showed very little similarity to those isolated in 
Glasgow and to the Danish Type strain (A.actinomycetemcomitans strain 83). Type 
strains 83 and 88 demonstrated only 1 band of variation when digested with Sau3Al. 
With Haelll, there was a difference of 9 bands, each has a value of 2.2% - this is 
significant.
There would not appear to be any correlation between clonality and disease e.g. 
strains of A.actinomycetemcomitans associated with juvenile periodontitis do not all 
belong to the same clone.
These results demonstrated that the A.actinomycetemcomitans collection held at the 
Glasgow Dental Hospital and School comprised several clones.
Strains 55, 56 and 57 were derived from one chronic periodontal pocket from one 
individual. This result suggests that an individual pocket could be colonised by the 
one strain/ clone of A.actinomycetemcomitans.
Strains 74, 75 and 76 were derived from three periodontal pockets from within the 
one juvenile periodontal patient. This result would suggest that it is possible for one 
individual to be infected by more than one strain of A.actinomycetemcomitans. This 
could suggest that one clonal type is associated with juvenile periodontal disease. It is 
possible, however, that the individuals from whom these strains originated were 
colonised by more than one clonal type of A.actinomycetemcomitans (as is the 
individual from whom strains 74, 75 and 76 were derived) but that only the one clonal 
type was selected during the initial sampling process.
From the small subpopulation of A.actinomycetemcomitans investigated (18 strains 
from a collection of 96) it would seem that the A.actinomycetemcomitans population 
at the Glasgow Dental Hospital and School is composed of a large number of 
different clones.
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4.4 DISCUSSION
DNA fingerprinting has been used previously in investigations of the clonal origins of 
A. actinomycetemcomitans.
The genetic structure of any given population depends upon the extent of genetic 
recombination within the population. It is also dependent upon the population biology 
of that bacterium Several different studies have investigated the genetic diversity of 
A.actinomycetemcomitans, all of which have produced different results. Each group 
used a different set of restriction enzymes and bacterial strains. Some groups looked 
at the DNA fingerprint, whereas others produced DNA probes which were then used 
in hybridisation studies. Poulsen et al (1994) suggested, on the basis of studying 97 
strains, that the A.actinomycetemcomitans population consisted of a very large pool 
of genotypes, which could be divided into subpopulations - corresponding roughly to 
the serotype of the strain under investigation. However these authors did not properly 
define their interpretation of a "subpopulation". Instead of being a subpopulation, 
they were probably defining a clone. Evidence for this large pool of distinct genotypes 
was demonstrated by the results presented above. Poulsen et al (1994) were unable to 
show any association between a particular genotypic pattern and disease. This has, to 
limited degree, also been shown by the above results. Haubek et al (1995) examined 
88 different strains of A.actinomycetemcomitans and on the basis of multilocus 
enzyme electrophoresis (MEE) and restriction fragment length polymorphisms 
(RFLPs) of the gene IktA (the structural leucotoxin gene) suggested that the species is 
composed of "subpopulations" which correspond to the serotypes of the strains. As 
with Poulsen et al (1994), Haubek et al (1995) were unable to show any correlation 
between periodontal disease and any clone.
Zambon, Sunday and Smutko (1990) used 16 restriction enzymes to digest DNA 
from 124 plaque strains of A.actinomycetemcomitans from North America, Norway 
and Korea. They found the strains from different continents showed little diversity by 
REFP analysis. It probably reflects the inappropriate choice of restriction enzymes
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that failed to discriminate and this was not supported by the results which are 
presented here. Zambon et al (1990) used 2 enzymes (EcoRI and Hindlll) from the 
panel of 16 and found 3 major restriction enzyme patterns. They related restriction 
pattern to the serotype of the strains which Poulsen et al (1994) confirmed. Zambon 
et al (1990) did not show any variation between multiple strains of 
A.actinomycetemcomitans from 1 individual - they reported 15 strains from the one 
individual with the same clonal type, unlike the results which were obtained for the 
strains 74, 75 and 76, which were not only from the same individual but from the 
same periodontal pocket. The variations were minor and probably represent strain 
divergence under the prevailing selection pressure in a chronic infection. Zambon et 
al (1990) also reported that non-human strains of A.actinomycetemcomitans showed 
a high degree of variation and diversity.
DiRienzo et al (1990) used probe specific DNA fingerprinting to show that 
individuals could be colonised by upto 2 clonal types. This technique is highly 
sensitive to minor genetic variations in nucleotide sequences, more so than RFLP 
analysis and is a precise means of characterising species and identifying individual 
strains of closely related bacteria.
The results reported by DiRienzo and Slots (1990) and Zambon et al (1990) differ, as 
Zambon et al (1990) did not find that individuals were infected with more than one 
strain of A.actinomycetemcomitans. The results reported here are similar to the 
results of DiRienzo and Slots (1990), although these results are based upon REFPs 
only.
The choice of enzyme may have resulted in the conclusion of Zambon et al (1990) 
that an individual could only be infected by one clone of A.actinomycetemcomitans. 
They also reported only distinguishing three different clonal patterns while using 2 
different enzymes. This contrasts with the results presented in this thesis in which 
several different clones for Sau3Al alone were produced.
Han et al (1991) used three enzyme Sail, Xhol and Xbal to digest 12 Type strains of
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A.actinomycetemcomitans, and classified these into 10 distinct clonal types. 
However, the open window they examined was at the bottom of the gel where the 
smallest fragments of the DNA have separated - smaller than those demonstrated in 
the results of this investigation. These bands represent a very small fraction of the 
total genome available for digestion (perhaps less than 5% of the total genome).
The DNA fingerprints obtained by Zambon et al (1990) did show variation in an open 
window at the top of several of the gels, as individual bands can be seen. However 
the samples would have benefited from a longer period of electrophoresis to separate 
them out more, and so reveal much more information.
Van Steenbergen et al (1991) investigated three strains of A.actinomycetemcomitans 
which were differentiated from each other on the basis of the fermentation of 
mannitol and xylose. Isolated genomic DNA was digested with several enzymes and a 
double digestion of Pstl and BamHl produced the optimum results on Reference and 
Type strains. However they did not show the results of restriction digest analysis of 
the three strains of A.actinomycetemcomitans which they recovered. They stated that 
the 11 isolates (which included both newly isolated bacteria and Reference strains) 
which were double digested, could be separated into 9 different "types” - but these 
were not defined.
From the published photographs of the results of van Steenbergen et al (1991) there 
would appear to be a lot of smeared DNA bands. The bands were also faint and 
difficult to differentiate.
4.5 CONCLUSIONS
It would appear that the population chosen from the collection is similar in clonal 
structure to that proposed by other researchers.
It is possible not only for an individual to be infected by more than one clone of 
A.actinomycetemcomitans, but also for a periodontal pocket to be colonised by two
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clones of A.actinomycetemcomitans. This conclusion is in line with the results of 
other researchers who have employed hybridisation techniques.
Strains which have been isolated over a period of time, but on the same continent e.g. 
the American Type strains do not show much similarity, although they share a 
common ancestor. The Danish Type strain was shown to be different from both the 
American Type strains and the Glasgow strains. Additionally, there was little 
conservation between the strains from Glasgow and America, indicating that they 
have had a different clonal background.
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CHAPTER 5
PLASMID RESTRICTION ENDONUCLEASE FRAGMENTATION 
PATTERNS OF A. actinomycetemcomitans
CHAPTER 5
PLASMID DNA RESTRICTION ENDONUCLEASE FRAGMENTATION 
PATTERNS OF A. actinomycetemcomitans
5.1 INTRODUCTION
Restriction Endonuclease Fragmentation Pattern (REFP) analysis of plasmid DNA has 
been documented by several authors in the investigation of bacterial epidemiology 
(Threlfall et al, 1985; Platt et al, 1986; Platt, Heraghty and Taggart, 1988; Platt and 
Smith, 1991). The presence of plasmids within A.actinomycetemcomitans has been 
demonstrated (Olsvik & Preus, 1989; LeBlanc et al, 1993; Poulsen et al, 1994), although 
there are no reports of REFP analysis of these plasmids.
Several problems were encountered throughout this investigation, most severely, the 
inhibition of restriction enzyme activity. The work described below is a summary of the 
different lines of investigation undertaken to determine the nature of the inhibition of 
restriction enzyme cleavage.
5.2 MATERIALS AND METHODS
5.2.1 Purification of plasmid DNA
Plasmid DNA was purified using an adaptation of the method of Kraft, Timbury and Platt 
(1987).
A.actinomycetemcomitans strains investigated in initial experiments, were the subset of 
strains listed in Table 2.2 known to be plasmid positive (Chapter 3), which were 
investigated in the strain diversity experiments described in Chapter 4. However, strains 
24 and 29 were used exclusively in later, "problem-shooting" experiments.
Overnight cultures in TSB broth (20mls) were prepared as previously described (2.1.2). 
All the reagents and buffers were prepared as described in Appendices 1.3 and 1.4. The
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broths were centrifuged for 10 minutes at 3000 rpm (MSE, Loughborough, England) and 
the pellet washed twice in 800 pi TE, pH 7.8. The final volume was divided into 4 x 
200pl aliquots and to each, 400 pi alkaline SDS was added. After 5 minutes incubation 
on ice, 300 pi 3M sodium acetate, pH 4.8 was added, the tubes mixed and samples left 
on ice for a further 5 minutes. These were centrifuged for 3 minutes at 13000 rpm in a 
bench top microcentrifuge. The supernatant was removed to a fresh eppendorf tube, to 
which 500pl phenol/chloroform was added. The tubes were mixed vigorously, 
centrifuged as before and the upper aqueous layer removed to a fresh eppendorf tube 
without disruption of the interface. To this, 500 pi isopropanol (BDH) was added and 
the tubes left at room temperature for 60 minutes. These were centrifuged, the pellet 
dried and resuspended in 100 pi TE : quadruplicate tubes were pooled and 100 pi 7.5M 
ammonium acetate, pH 8.0, added and mixed. DNA was precipitated by the addition of 
600 pi, ice cold, 100% ethanol (BDH), after which the tubes were mixed and left 
overnight at -20°C. After centrifugation, the pellets were dried and resuspended in 160 pi 
TE. To this, 18 pi RNAase was added and the tubes incubated at 37°C for 30 minutes, 
followed by the addition of 20 pi 2.5M sodium chloride. A second phenol/ chloroform 
extraction was performed as before, followed by further isopropanol and ethanol 
precipitation steps. The DNA was pelleted, dried then resuspended in 60 pi TE buffer 
and stored at +4°C until required.
The purity and concentration of the DNA suspensions were found as previously 
described (4.2.1).
5.2.2 Restriction enzymes
The restriction enzymes used were chosen from a panel used in initial experiments, 
which included Pst I, Hind III, Sma I, EcoR VI, Ava II, Hinc II and Hae III. After initial 
work, Ava II, Hinc II and Hae III were used exclusively.
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A 20 pi aliquot of each DNA was digested with between 20 and 50 units of enzyme. To 
this, 5 pi of the appropriate reaction buffer was added and the total volume made upto 
50 j l i 1 with distilled water.
Digestion was at 37°C for 4 hours. Parallel digests of lambda DNA were carried out to 
quality control each enzyme and lambda DNA was additionally digested with Pst I 
enzyme, which was run in the gel as a gel calibrator.
5.2.3 Electrophoresis of plasmid DNA
Digested plasmid DNA was separated by electrophoresis in 0.8% agarose gels prepared 
with TBE buffer, which contained ethidium bromide. These were cast in BRL Horizon
11.14 electrophoresis tanks.
To each digest volume of 50 pi, 5 pi of gel loading buffer was added and the 55 pi 
volume then loaded under TBE buffer which contained ethidium bromide. The gels were 
run overnight at a constant current: 25 mA - typically for 18 hours. Gels were examined 
under ultraviolet light and photographed as before, after which they were stained in TES 
containing ethidium bromide, examined under ultraviolet light and photographed as 
described previously (3.2.3).
5.3 RESULTS AND DISCUSSION
Many of the problems which were associated with the generation of plasmid REFPs were 
encountered during the preparation of whole cell DNA REFPs, although these were later 
overcome. The problems encountered during the preparation of whole cell DNA are also 
discussed in this section.
The generation of a REFP is, in principle, a very straight forward and simple one.
The methods of Kraft, Timbury and Platt (1987) were used to produce both plasmid and
136
whole cell DNA. These have been used successfully to generate plasmid and whole cell 
fingerprints from E.coli, Salmonella and Legionella species. The method, however, was 
not without difficulties when applied to A.actinomycetemcomitans.
Problems encountered included the non-cutting of DNA, low yields of DNA and 
smearing of the bands.
5.3.1 Plasmid REFPs
Initial experiments were carried out on a selection of plasmid positive strains, chosen 
from the 18 strains of A.actinomycetemcomitans investigated previously in Chapter 4. 
However, as the full extent of the problems encountered became apparent, 
A.actinomycetemcomitans strains 24 and 29 were used exclusively. (Strain 29 had not 
been used previously in Chapter 4, however, it harboured 2 good sized plasmids (Chapter 
3) and was used for this reason.
5.3.2 Whole cell REFPs
Initial experiments were carried out on the 18 strains of A.actinomycetemcomitans listed 
in Table 2.2. The discussion which follows applies, both to the preparation of plasmid 
and whole cell DNA, except where stated.
5.3.3 Low yields of DNA
This problem was an initial and intermittent one, which was solved by the addition of 1 
full plate of growth by means of a dry cotton wool swab, from an 18 hour CBA plate of 
A.actinomycetemcomitans. Each broth was grown for 18 hours to ensure that the broth 
was in log phase when cultured.
Prior to the inoculation, C02 was added to the broth, by leaving in a C02 incubator with 
the top slightly loose. The choice of media was also important and TSB broth was found
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to give the best yield.
5.3.4 Non-cutting of DNA
This was the greatest problem encountered. It was intermittent and could not be 
predicted. DNA from the same production batch would cut differently on different days 
with the same enzyme.
The non-cutting of the enzymes was not the result of either dam or dcm methylation as 
these enzymes would cut the same DNA intermittently.
The quality of the DNA was investigated spectrophotometrically. DNA was scanned 
over the region OD280 to OD260 and the trace was examined for contamination by protein, 
RNA, ethanol or phenol. DNA was rarely found to be contaminated by any of these. A 
further purification stage was introduced by an addition phenol/chloroform step, followed 
by precipitation by 95% ethanol overnight, then 70% ethanol overnight to remove any 
potential contaminant.
This DNA was then scanned again and if pure it was used in restriction digests. The scan 
also enabled the concentration of DNA to be calculated and adjusted to give a constant 
concentration. This, however did not help to improve the quality of the restriction 
digests.
5.3.5 Cell clumping
(i) Glucose
The effect of clumped cells would have reduced the surface area available for lysis with 
the SDS, and this would therefore have reduced the yield of DNA.
In the earliest experiments it was found that A.actinomycetemcomitans cells clumped 
together when resuspended in TGE. Clumping was seen to be strain dependent - rough 
strains clumped together more than smooth. Microscopic examination showed that the
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cells clumped to a lesser degree when resuspended in TE as opposed to the TGE 
suggested by Kraft et al (1987). Clumping could be reduced by washing the cells in a 
non-glucose containing buffer e.g. TE and reduced by washing in 25mM Tris sucrose. 
This curing effect was reversed if cells were resuspended in TGE.
A.actinomycetemcomitans strains contain a high proportion (22.4%) of glucose in the 
cell wall (Brondz and Olsen, 1989) compared to other carbohydrates such as rhamnose 
(2.6%), galactose (5.2%) and glucosamine/ galactosamine (5.2%). It is possible that 
when A.actinomycetemcomitans cells are suspended in a solution with a high glucose 
content (50 mM), the cells have a tendency to become "sticky" and simply 
co-aggregated, forming the large clumps of cells seen. Although the effect of 
resuspension of A.actinomycetemcomitans cells in a lower concentration of glucose was 
not investigated, A.actinomycetemcomitans strains were suspended in buffers which were 
glucose free, with no lessening in the clumping effect.
(ii) Cations
The effect of cations upon clumping was investigated. Rough and smooth strains 
demonstrated different behaviour when resuspended in the same buffers.
Complete dissociation of smooth strains was observed when they were resuspended in 
CaCl2, whilst molar tris completely dissociated rough strains. Additionally, there 
appeared to be an association with decreasing molarity of EDTA - the lower the 
molarity, the greater the clumping of rough strains seen. This was not an unexpected 
result, as EDTA is a chelating agent, and as such would be expected to result in 
clumping. The presence of cations resulted in the dissociation of smooth strains.
The clumping of A.actinomycetemcomitans cells has been previously investigated. 
Scannapieco et al (1987) suggested that colonies grown under anaerobic conditions were 
of a firmer consistency than aerobic cultures and when grown under anaerobic conditions
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in a fluid medium, had a greater tendency to clump, compared with colonies grown, 
under aerobic conditions. Scannapieco et al (1987) did not suggest any reason for the 
clumping of the bacterial cells, however clumping could be related to the presence or 
absence of pseudopods and fimbriae (Section 1.2.3) and their subsequent interaction. In 
the presence of excess cations, chemical interactions may have occurred with, for 
example, the fimbrial surface layer, which resulted in cells being attracted to each other, 
followed by "interweaving" of the fimbriae and finally bacterial aggregation. As fimbriae 
do not appear to be present on the surface of smooth strains, cations would not have this 
effect. This may explain why chelating agents resulted in the strain specific nature of the 
phenomenon (Section 1.2.3).
The effect of culturing cells under aerobic conditions was not investigated but, the level 
of C02 present in broths was increased as much as possible in order to increase the yield 
of DNA (see DNA Yield).
Mechanical methods for the dissociation of the bacterial cells were investigated e.g. 
A.actinomycetemcomitans cells were passed through a fine bore needle. These were not 
used routinely as it was thought they would result in damage to the DNA.
Sonication of the cells for very brief periods of time (up to 5 seconds) was also 
investigated, but this method was not used, as it could not be guaranteed that the cells 
were only disrupted and not lysed. The latter would have probably resulted in the 
degradation of the DNA by certain cell contents e.g. enzymes.
Resuspension of A.actinomycetemcomitans in 800 pi of TE buffer rather than the 400pl 
suggested by Kraft et al (1987) reduced clumping and improved lysis by increasing the 
available surface area for interaction with SDS.
The effect of reducing clumping resulted in larger DNA yields, but did not have any 
effect upon the quality of the restriction digest.
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5.3.6 DNA Yield
Preliminary experiments suggested that one cause of the lack of DNA REFPs may have 
been due to a low yield of DNA. One way to increase the yield of DNA was to increase 
the number of bacterial cells used. This was achieved by the addition of a larger initial 
inoculum to the growth medium (broth) and by a change in the type of broth used. 
Tryptic soya broth gave a greater yield of bacterial cells than BHI broth.
Additionally, to ensure an adequate supply of C02 for the bacterial cells, C02 was added 
to the broth prior to the addition of bacterial cells by incubation in a 5% C02 incubator 
overnight before inoculation. This increased the yield of A.actinomycetemcomitans cells. 
Also, an increase in the centrifugation time at each stage increased both the size of pellets 
and the resultant DNA extracted subsequently.
The combined effect of these changes from the published method of Kraft et al (1987), 
(including the resuspension in 800 pi TE) produced a visual increase in the size of the 
final pellet and the yield of DNA produced, determined by UV spectrophotometery. The 
frequency of DNA cleavage, however, remained intermittent.
5.3.7 DNA Purity
Additional washes after the phenol/ chloroform stage were performed using chloroform 
alone, to remove any final trace of phenol, which may have been present. This did not 
increase the frequency of DNA cleavage.
The purity and yield of the DNA was checked for contamination by phenols, RNA and 
proteins by scanning over the range 310 to 210 nm, in a UV-8 spectrophotometer, as 
previously described (4.2.1). No contamination of this kind was found.
The possibility of salt contamination was also investigated - DNA was washed and 
precipitated several times in both 95 and 100% ethanol. Again, no plasmid fingerprint 
was obtained.
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It is known that ethanol can interfere with both the reaction buffer and the restriction 
enzyme, so additional care was taken to ensure that all the ethanol was removed by 
drying the pellet for extended periods of time, both at room temperature and in a 37°C 
incubator, before the addition of the TE suspension buffer. These modifications did not 
improve either the quality or reproducibility of the plasmid fingerprint obtained.
5.3.8 Failure of restriction endonucleases to cleave A. actinomycetemcomitans DNA
Enzyme inhibition in the form of dam and dcm methylation was investigated. The 
methylase encoded by the dam gene transfers a methyl group from 
S-adenosyl-methionine to the N6 position of the adenine residues in the sequence GATC 
i.e. GmATC. The second form of methylation is that encoded by the dcm gene. It 
methylates the internal cytosine residues in the sequences CCAGG and CCTGG at the C5 
position i.e. CmC(A/T)GG. These sites are important because some or all of the sites for a 
restriction endonuclease may be resistant to cleavage when isolated from strains of 
bacteria expressing either dam or dcm methylation. If the methylation site overlaps a 
restriction enzyme recognition site then the DNA will not be cleaved.
The recognition sequences of the restriction enzymes {Avail, Haelll and Hincll) used in 
the plasmid investigations were as follows :
Avail 5' G ^ C C  3'
3' c  CtaG aG  5’
Haelll 5' GGACC -—  3'
3* CCTGG 5'
Hincll 5* GTPyAPuAC----- 3'
3*.—  CAPuAPyTG------5'
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Avail is blocked by overlapping dcm methylation, Hae III is not, but is blocked by 
GGmCC. Hincll is unaffected by methylation. Therefore, if the cause of the inhibition is 
dam methylation, then Avail would not cleave the plasmid DNA, whereas Hae III would. 
This was not the case - both Avail and Hae III were shown to cleave the plasmid DNA 
periodically.
There are several factors which influence enzyme activity on both plasmid and genomic 
DNA. These include tertiary DNA structure, base composition of the flanking sequences 
and position of the cleavage sites with respect to each other. The length of the piece of 
DNA being restricted is also important, as smaller lengths of DNA may require more 
enzyme. The units of enzyme used varied between 20 and 50 units, with latter 
experiments exclusively using 50 units of enzyme.
Methylation is important in gene regulation and expression - genes which are not 
transcribed may be methylated, while the absence of methyl groups in some organisms is 
associated with gene expression. It could therefore be possible that the intermittent 
nature of the enzyme restriction could be related to the growth phase of the bacteria. 
Care was taken that all solid cultures were grown for the same length of time before 
broth cultures were inoculated. However, it cannot be excluded that the periodic nature 
of the DNA REFPs could relate to periods of growth, when the DNA was unmethylated 
and in a state which would enable it to be cleaved by enzymes normally affected by 
methylation e.g. Ava II. Nevertheless, this would not explain the intermittent nature fully, 
as enzymes which were unaffected by methylation also showed this phenomenon.
The growth phase of the bacteria would have an effect upon the structure of the DNA. 
Actively dividing cells would have DNA in an open form, i.e. uncoiled, thus, enzymes 
would have access to restriction sites, which may have normally been hidden. Thus, as 
with methylation, cells which were in the stationary phase would not undergo restriction 
enzyme cleavage. This would explain both the intermittent nature of the cutting and also
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the observation that enzymes which were not affected by methylation did not cleave the 
DNA.
5.3.9 Contamination
(i) Protein
The potential effect of protein contamination was minimised by the incubation of DNA 
preparations with proteinase K at a concentration of 10 mgmT1, for 2 hours. The 
proteinase K was added at different stages e.g. before the addition of SDS (to remove 
any surface protein which may have interfered with the action of the restriction enzyme) 
and after the pellet was removed from the sodium acetate stage. The sodium acetate was 
incubated at 55°C on all occasions. As before, there was no improvement on the quality 
of profiles which were obtained. When the purified DNA was scanned in a UV 
spectrophotometer protein was rarely seen. Any protein contamination was removed by 
an additional phenol/ chloroform step, as described above
(ii) Lipopolysaccharide (LPS)
Purification of DNA with the inclusion of CetylTrimethyl Ammonium Bromide (CTAB) 
was carried out to exclude the co-purification of LPS, which if bound to the DNA, would 
have prevented enzyme restriction. This did not improve the quality of DNA which was 
purified and therefore LPS contamination could be excluded.
(iii) Phenol/ chloroform contamination
This potential inhibitor of enzyme activity was removed by ensuring that the interface 
was not disturbed when the top aqueous layer was removed. Again, the UV spectrograph 
traces were checked for this potential contaminant, against standards of lambda DNA, 
both with and without phenol/ chloroform. No contamination of the DNA due to phenol/
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chloroform was found.
5.2.10 Concentration of DNA versus units of enzyme
The possibility that the concentration of DNA was too high was investigated by an 
increase in the number of enzyme units used in each digest, from 50 to 100.
This had no positive effect upon the reproducibility of the plasmid DNA profiles and was 
not continued.
5.3.11 Ethidium bromide (Plasmid only)
Ethidium bromide/ caesium chloride gradients can be used to purify large scale 
preparations of closed circular DNA by centrifugation (Maniatis, Fritsch & Sambrook, 
1982). Ethidium bromide used in these gradients has a final concentration of 600 jigml'1. 
Small scale preparations of plasmid DNA from A.actinomycetemcomitans strains 24 and 
29 were spiked with ethidium bromide at a concentration equivalent to 600 pgml1. 
Ethidium bromide was removed by addition of 1-butanol saturated with distilled water. 
The two phases were mixed vigorously, then centrifuged at 13000 rpm for 3 minutes. 
The lower phase was then removed to a clean eppendorf tube and the extraction repeated 
until all the pink colour had disappeared.
On the first occasion bacterial cell lysates were spiked by the ethidium bromide at various 
stages in the preparation of the plasmid DNA. When this DNA was incubated with 
Hincll, a restriction pattern was observed, although there was only partial digestion of 
the DNA. However, identical results were also obtained from controls of DNA prepared 
from the same cells.
When further aliquots of this preparation of DNA were incubated with ^ 4vaII, which had 
been shown previously to cut A.actinomycetemcomitans DNA, the DNA remained uncut. 
Further preparation of A.actinomycetemcomitans plasmid DNA spiked with ethidium
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bromide did not result in DNA which could be cut with either Avail or HincII, which 
indicated that the periodic cutting/ non-cutting of the DNA could not be resolved by 
preparation of the DNA in an environment which contained ethidium bromide.
5.3.12 Spiked DNA Preparations
Preparations of both whole cell and plasmid DNA were spiked with lambda DNA at all 
stages of preparation, e.g. after addition of alkaline-SDS, sodium acetate, phenol/ 
chloroform etc. on both day 1 and day 2 of the preparation protocol to show that the 
inhibitory effect was not due to the DNA, but due instead to the presence or absence of 
an inhibitory element. This experiment was repeated on a number of occasions with both 
strains under investigation. On every occasion the lambda DNA was cut, irrespective of 
where it was introduced in the protocol, while the native plasmid DNA was not cut. This 
suggested that it was not the result of the co-purification of an agent which inhibited the 
enzyme, but that fault lies with the DNA. Methylation, the most obvious solution, has 
previously been discounted.
5.3.13 Operator error
That the lack of reproducible REFPs was due in part to operator error was also 
investigated. Preparations of E.coli and S.enteriditis plasmid and whole cell DNA were 
made using the methods of Kraft et al (1987). These were run in parallel to the 
preparations of A.actinomycetemcomitans plasmid and whole cell DNA and on all 
occasions, produced REFPs.
5.4 General Discussion
The problem of non-cutting plasmid DNA was an intermittent one, which could not be 
fully resolved. The problem of non-cutting whole cell DNA was overcome. However, it
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proved impossible to produce a method for the preparation of plasmid DNA which could 
be reproduced for any length of time - even day-to-day.
The most likely explanation would appear to be some mechanism which is switched on in 
some preparations and off in others. The most probable mechanism which falls into this 
category is DNA methylation.
There are, however, problems with this conclusion - namely the intermittent nature of the 
DNA cleavage. Had the enzyme Avail not cut the plasmid DNA at all, then this would 
have been an adequate explanation. However, Avail, was one of the enzymes which was 
routinely used, for the very reason that it could be inhibited by methylated DNA, and that 
in preliminary experiments, it was shown to cut A.actinomycetemcomitans plasmid DNA. 
Avail is, however, less sensitive to inhibition due to methylation. Generally, for the DNA 
to be cut by Avail it would have to become unmethylated during certain periods of cell 
growth e.g. during transcription. Great care was taken to ensure that all DNA 
preparations were made with bacterial cells which were in log phase at all times. It 
cannot be excluded, however, that on some occasions cells may have been harvested 
during the stationary or lag phase and not the log phase.
The possibility of contamination by cellular components co-purified with the DNA e.g. 
protein was explored and excluded. Likewise, contamination of the preparations by 
phenol, RNA and carbohydrate.
Operator error was also examined and while it may have contributed to lack of DNA 
REFPs at the beginning of the experimental period it would not explain the lack of 
fingerprints after the long time period involved in the investigation of this problem. It 
was possible to produce plasmid REFPs for two bacterial species unrelated to 
A.actinomycetemcomitans i.e. E.coli and S.enteriditis. It would therefore seen unlikely to 
be due entirely to operator error.
Had more time been available, it may have been possible for another individual to prepare
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plasmid DNA from A.actinomycetemcomitans isolates and to compare their results to 
those given above.
In the A.actinomycetemcomitans literature there is no reference to similar problems 
which have been experienced by other researchers. Problems such as possible 
lipopolysaccharide contamination, have been encountered by other workers, working on 
other bacteria, were dealt with using methods which in the past have been shown to 
remove this form of contamination.
All of the published literature on A.actinomycetemcomitans REFPs to date has been on 
genomic preparations. After initial problems, it was possible to obtain usable genomic 
profiles and therefore the problem of non-cutting was no longer an issue with respect to 
genomic preparations. However, there has been no published data on the REFPs of 
plasmid DNA, which could be the result of either similar problems such as those 
described above, or alternatively, the lack of plasmid positive strains which has been 
reported in the literature may have resulted in researchers overlooking plasmids as a 
means of investigating epidemiology, given their cryptic nature.
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CHAPTER 6
MONOCLONAL ANTIBODY, 9D4, TO THE Bordetella pertussis TOXIN 
ADENYLATE CYCLASE AND ITS POSSIBLE CROSS REACTION WITH 
A.actinomycetemcomitans PROTEINS
CHAPTER 6
MONOCLONAL ANTIBODY, 9D4, TO THE Bordetella pertussis TOXIN 
ADENYLATE CYCLASE, AND ITS POSSIBLE CROSS REACTION WITH 
A. actinomycetemcomitans PROTEINS.
6.1 INTRODUCTION
Since Lally et al (1991a) demonstrated the presence of the A.actinomycetemcomitans 
leucotoxin in the outer membrane, it could be hypothesised that preparations of the 
OMPs from A.actinomycetemcomitans, separated by SDS-PAGE, would contain the 
leucotoxin protein. The toxin could thereafter be detected in two ways, either (i) by 
the presence of a protein band of the correct molecular weight and (ii) indirectly by a 
monoclonal antibody (MCA).
The relationship between the A.actinomycetemcomitans leucotoxin and adenylate 
cyclase toxin from B.pertussis has been discussed (Section 1.8). A MCA, 9D4, to 
adenylate cyclase was made available by Dr. Parton, Department of Microbiology, 
Glasgow University who in turn had received the monoclonal antibody from Professor 
Hewlett, Department of Medicine, University of Virginia. This was used to determine, 
what, if any, relationship existed between the MCA of a related toxin and outer 
membrane protein preparations of A.actinomycetemcomitans.
6.2 METHODS AND MATERIALS
6.2.1 Preparation of outer membrane proteins (OMPs)
OMPs were prepared by an adaptation of the methods of Davies (1991) and Lai et al 
(1981). All reagents were prepared as described in Appendix 1.5. Briefly, preparations 
of the outer membrane proteins from the 17 strains of A.actinomycetemcomitans 
under investigation were separated by SDS-PAGE, Western Blotted and the OMPs 
were visualised by linking the MCA to a horse radish peroxidase complex and 
observing a colour change.
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A.actinomycetemcomitans were grown in duplicate, 400 ml volumes of TSB, as 
previously described (2.1.2). Cells were pelleted by centrifugation at 5000 g for 30 
minutes at 4°C, then washed in 40 ml of 20 mM Tris-HCl and centrifuged as before. 
Cells, resuspended in 10 ml of 20 mM Tris-HCl/ 10 mM EDTA, were sonicated for 3 
minutes on ice at an amplitude of 26 Hz (MSE 150 watt), with a 5 mm diameter 
probe, until the suspension had cleared. An aliquot of 500 pi was removed from each 
sonicated strain and stored at -20°C. This formed the sonicated whole cell fraction or 
total protein preparation and a sample from each aliquot was run as a control in initial 
gels to demonstrate the total protein content of the A.actinomycetemcomitans strains. 
Unbroken cells were removed by centrifugation as before and the total cell envelope 
fraction pelleted by centrifugation, at 83 000 g for 60 minutes at 4°C in a Beckman 
L8-55M ultracentrifuge. The total cell envelope pellet was resuspended in 10 ml of 
0.5% (w/v) sodium N-lauroylsarcosine (Sarkosyl - Sigma) for 20 minutes at room 
temperature which selectively solubilised the cytoplasmic membrane (Filip et al, 
1973). The remaining outer membrane fraction was pelleted by ultracentrifugation, as 
described above, resuspended in 10 ml Tris-HCl, and pelleted once more. The pellet 
was solubilised in 0.5 ml Tris-HCl (pH 6.8) and stored at -20°C, in 100 pi aliquots 
until required.
6.2.2 Adenylate cyclase
A supply of adenylate cyclase was obtained from Dr. Westrobe (Microbiology 
Department, Glasgow University) at a concentration of 40 pgml'1. This was stored 
frozen until required, then thawed slowly at room temperature, when 25 pi was mixed 
1:1 with double strength (2X) sample buffer which contained SDS (1%) and 
2-mercaptoethanol (0.04%), bromophenol blue, glycerol and 0.05 M Tris buffer. In 
addition, 10 pi of the adenylate cyclase was diluted 1:10 with a mixture of equal 
volumes of distilled water and 2X sample buffer. Twenty microlitres of these two 
solutions, 20 and 2 pgml'1, were as a control to detect MCA activity.
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6.2.3 Monoclonal Antibody, 9D4
The monoclonal antibody 9D4 was mouse ascites fluid, which had not been purified 
further (Hewlett, personal communication). Hewlett also indicated that mapping by 
cross-reactivity with E.coli haemolysin indicated that the MCA reacted with the 
glycine-rich nanomeric repeats in the carboxyl terminal region.
This material was used at a dilution of 1:1000 in Western blots.
6.2.4 Determination of protein concentration
The protein concentrations of the sonicated fraction and the OMP preparations were 
estimated by the modified Lowry procedure for determination of membrane proteins 
(Markwell et al, 1987).
Briefly, 100 ml of reagent A (Appendix 1.4) were mixed with 1 ml of reagent B, to 
give Reagent C. From each protein sample, 50 pi was removed and mixed with 3 ml 
of Reagent C. This volume was then mixed with 0.3 ml of the diluted Folin-Cioacalteu 
reagent (Appendix 1.4) and developed at room temperature for 45 minutes, then read 
at OD^ against a blank of distilled water in a UV spectrophotometer (UVP, 
Cambridge).
A standard curve was constructed with bovine serum albumin (BSA - Sigma) of 
known concentrations and the unknown OMPs concentrations determined by 
interpolation. The OMPs from the seventeen strains of A.actinomycetemcomitans 
under investigation were diluted to a final protein concentration of 5 mgml1.
6.2.5 SDS-PAGE separation of proteins
Purified OMPs and sonicated whole cells were separated by SDS-PAGE using the 
SDS-discontinuous system of Laemmli (1970). Briefly, the proteins were solubilised 
by diluting 1:2 in double strength sample buffer, then boiled for 4 minutes and allowed 
to cool to room temperature.
The samples were electrophoresed in a 10% gel, with a 4% stacking gel, both of
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which contained acrylamide. Twenty microlitres of each protein was loaded under 
running buffer. The proteins were run at a constant current of 30 mA per gel through 
the resolving gel. Gels were run in Bio-Rad tanks (Bio-Rad, Virginia, USA), typically 
for 4 hours.
When the dye front reached the lower edge of the plate/ resolving gel, electrophoresis 
was stopped and the gel removed from the plates. Electrophoresed proteins were 
stained with 0.1% Coomassie Blue (w/v) in 45% methanol/ 10% (v/v) acetic acid 
overnight and destained in a 30% (v/v) methanol/ 10% (v/v) acetic acid solution, until 
the background had cleared - typically 3 - 4  days. Protein molecular weight standards 
(Sigma) which ranged from 29 - 205 kDa, as below, were run at either ends of the gel 
and were used to prepare calibration curves from which the apparent molecular 
weights of the OMPs were calculated. Proteins used as standards were :
Carbonic anhydrase 29 kDa
Albumin (Egg) 45 kDa
Albumin (Bovine plasma) 66 kDa
Phosphorylase B (Rabbit muscle) 97.4 kDa
B-galactosidase 116 kDa
Myosin (rabbit muscle) 205 kDa
These were diluted 1:1 in double strength sample buffer, boiled, then stored in 60 pi 
aliquots at -20°C until required. Fifteen microlitres were added to each standard track 
and empty wells filled with sample buffer to prevent protein bands from "expanding" 
laterally to produce band distortions.
Gels prior to Western Blotting, were prepared as described previously (Section 6.2.6) 
and the purified OMPs separated, by SDS-PAGE. The gels were left unstained.
Protein gels run purely as controls - e.g. (i) sonicated whole cell/ total protein 
preparation and (ii) purified OMPs were photographed after they were stained and 
these photographs digitised as previously described (Chapter 5), with the SDS 
markers used as calibrators. Both the protein standard tracks were entered first
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(although they were run at opposite sides of the gel) and the individual tracks entered 
thereafter. Individual bands were assessed visually and graded between 1 and 3 on the 
basis of band intensity. Faint bands scored 1 and dark bands 3. Faint, intermediate and 
dark bands were then entered as appropriate using one of the 3 cursor options.
6.2.6 Western blotting
After separation of the OMPs by SDS-PAGE, the proteins were electroblotted to 
nitrocellulose by the method of Towbin, Knobler and Buchmeier (1984), in a BioRad 
Trans-Blot Cell (Bio-Rad, Richmond, CA, USA). Briefly, the gels were transferred to 
a tray which contained blotting buffer Tris (25 mM) and glycine (192 mM) and left for 
1 hour to equilibrate. Whatmann 3MM paper and nitrocellulose (Sigma) cut to the 
same size as the gels and the fibre pads (from the blotting apparatus) were soaked in 
the blotting buffer for 30 minutes to equilibrate, after which they were transferred to 
the gel holders. These were then assembled carefully to avoid the entrapment of air 
bubbles between the gels, nitrocellulose, filter paper and fibre pads.
A "sandwich" was made as described in the manufacturers instructions. Fibre pads 
were located on the outer edges of the sandwich (the gel holder) and filter paper 
placed on top of the fibre pads. The equilibrated gel was then placed on top of the 
filter paper and the nitrocellulose membrane was placed on top of the gel. The 
sandwich was completed by another piece of filter paper with the fibre pad being 
placed on to the nitrocellulose membrane.
The "sandwich" was located in a gel holder, which was inserted into the blotting tank 
with the membrane towards the anode; the gel towards the cathode. A constant 
voltage of 15 V was applied for 20 hours. The temperature of the tank was kept as 
low as possible by the insertion of a cooling coil attached to a running cold water tap.
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6.2.7 Cross reactivity of OMPs with MCA 9D4
After protein transfer, the nitrocellulose membranes were removed and washed three 
times in PBS (ten minutes for each wash). Gels were stained with 0.1% Coomassie 
blue (w/v) in 45% methanol/ 10% (v/v) acetic acid overnight and destained with 30% 
(v/v) methanol/ 10% (v/v) acetic acid solution, to ensure that all proteins had been 
transferred. A portion, approximately 3 cm in width, of the nitrocellulose membrane 
was removed from the left edge. This corresponded to the region in the gel where the 
molecular weight markers had been separated. The nitrocellulose strip was stained in 
0.1% amido black, then destained after 1 minute with 30% (v/v) methanol/ 10% (v/v) 
acetic acid solution, to (i) show that proteins had been effectively transferred to the 
membranes and (ii) to enable the molecular weight of any A.actinomycetemcomitans 
OMP which cross reacted with the MCA, to be estimated.
Non-specific binding of the MCA to the membrane was blocked by incubation for 1 
hour, at room temperature, in 2.5% (w/v) fat-free skimmed milk in PBS with 0.15% 
(v/v) Tween-20 (Blocking buffer). The membranes were then washed for three 10 
minute periods, in PBS with 0.15% (v/v) Tween-20 (wash buffer) and finally 
incubated overnight in blocking buffer, with the MCA diluted 1 in 1000.
Excess MCA was removed from the membranes by three 10 minute washes in PBS. 
Horseradish peroxidase labelled rabbit anti-mouse conjugate (SAPU, Law, Scotland), 
was then added at a dilution of 1 in 1000 in blocking buffer and incubated for 5 hours. 
The membranes were washed as before in PBS and developed in a substrate solution 
which contained 0.03% (w/v) 3,3'-diamionobenzidine (DAB - Sigma), 0.02% (w/v) 
CoCl2 and 0.1% hydrogen peroxide. Results were visualised within 1 minute and the 
reaction was inhibited by the immersion of the filters in distilled water. Membranes 
were photographed while still damp, to enhance the bands, then stored between filter 
paper in the dark to prevent fading.
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6.3 RESULTS
6.3.1 Total whole cell protein preparation
The sonicated whole cell preparations of the 17 strains under investigation as 
separated by SDS-Page are presented in Figures 6.1 (a) and (b). The protein bands 
demonstrated for each strain were sized and similarities and differences among strains 
recorded.
The total protein preparations show the variation in protein expression of the 17 
strains of A.actinomycetemcomitans under investigation. For example, strains 1, 8, 24, 
74, 75 and 76 expressed 2 proteins with approximate molecular weights of 130 and 
120 kDa. Strains 55 and 56 expressed a protein of approximately 130 kDa, while the 
remaining strains did not express either protein.
The relative intensity of the proteins varied from strain to strain.
6.3.2 Outer membrane proteins
Purified OMPs of the 17 test strains were separated by SDS-PAGE, photographed by 
the photographic department at the Glasgow Dental Hospital and School and digitised 
as previously described (Chapter 4). The digitised images are shown in Figures 6.2 (a) 
and (b).
With the exception of strains 33 and 83, all appeared to lose the majority of the 
protein bands seen in Figures 6.1 (a) and (b) as expected.
Strains 8, 24, 32, 33, 55, 74, 75, 76, 79, 81, 83 and 88 all expressed a protein with a 
molecular weight within 10% of 116 kDa - the molecular weight of the 
A.actinomycetemcomitans leucotoxin.
Strains 76 - 83 appeared to have a greater number of high concentration bands i.e. 
digitised as triplets, or multiple comigrating proteins than the other strains 
Several proteins were seen which were common to most strains. These proteins had 
molecular weights of approximately 29, 38, 41, 50, 65, 97 and 100 kDa.
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Figure 6.1a Total protein preparations of 9 strains of A.actinomycetemcomitans
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Figure 6.2a Graphical output from digitised images of outer membrane
protein preparations of 9 strains of A.actinomycetemcomitans
158
205 ------
Figure 6.2b Graphical output from digitised images of outer membrane
protein preparations of 8 strains of A.actinomycetemcomitans
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By visual assessment of the OMPs, they subdivided into 11 different groups on a 
purely arbitory basis (Table 6.1). No one OMP profile dominated the collection of 
strains studied.
The large number of profiles seen was due, in part, to variation in the protein band 
strength e.g. the OMPs of strain 88 were very weak and although on the basis of these 
results it belongs to its own OMP group, this position could be altered by a higher 
concentration of OMPs, and the possible presence of proteins, which at present are 
too weak to be clearly seen.
6.3.3 Western blotting
Two SDS-PAGE gels which contained the purified OMPs from the seventeen 
A.actinomycetemcomitans strains under investigation were Western Blotted as 
described (6.2.4). Staining with Coomassie Blue showed that all proteins including 
adenylate cyclase at both concentrations, had been successfully transferred. Figures
6.3 (a) and (b) are photographs of the nitrocellulose filters after they were probed with 
the MCA. The molecular weight markers to the left give an approximate molecular 
weight of the crossreactive protein.
Reaction between the MCA and a homologous protein was seen by a distinct, sharp 
line. Where there had been non-specific binding of the MCA to a protein, a more 
diffuse pattern was seen.
All 17 A.actinomycetemcomitans strains showed non-specific binding of the MCA 
with proteins in the region 30 - 40 kDa. These corresponded to the diffuse protein 
bands seen in both the total protein preparation gels and the outer membrane protein 
preparations. There were, however, some distinct bands, which are discussed below. 
Cross reactivity between the MCA and adenylate cyclase was shown to occur with 
both the "neat" and diluted form. The 1 in 10 dilution showed a much clearer band of 
approximately 200 kDa, than did the undiluted sample. There was also a reduction in 
the degree of non-specific binding seen.
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Strain OMP Group
Table 6.1
1 1
8 2
24 3
75 3
76 3
32 4
33 4
36 4
56 4
57 4
80 4
55 5
74 6
79 7
81 7
88 7
83 8
Proposed grouping of A.actinomycetemcomitans on the basis 
of OMP profiles
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Figure 6.3a Reaction between MCA 9D4 , adenylate cyclase and the OMPs 
of 9 A.actinomycetemcomitans strains
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Strains 1 and 8 did not show any distinct, sharp bands.
Strain 24 possessed a number of specific bands. These were seen at approximately 
116, 97 and 95 kDa. There was also a very strong band at 45 kDa. A weaker band at 
66 kDa was also seen. When the molecular weights of the 66 kDa and 45 kDa protein 
were added together the result was 111 kDa - which approximated to the molecular 
weight of the leucotoxin. Strain 76 shared many of the heavier bands with strain 24. 
However, it shared a similar pattern to strains 74 and 75, with its lower molecular 
weight bands.
Strain 33 shared 4 bands in common with strain 24 - 116, 97.4, 95 and 66 kDa. Strain 
33 also appeared to have a band of approximately 45 kDa, although this was not as 
intense as the corresponding band of 24.
Strains 55, 56, 80, 81 and 83 were shown to have similar patterns to each other. All 
had bands at approximately 97 and 95 kDa and a fainter one at 66 kDa.
Strains 74 and 75 were shown to have a similar and unique pattern. Bands - which 
were very faint - i.e. greater than 200 and approximately 116 kDa were seen. There 
were also two bands of between 97.4 and 66 kDa which were very faint. These may 
have represented non-specific binding. Two bands were shown with a molecular 
weight slightly greater than and less than 45 kDa.
Strain 79 demonstrated a unique pattern. The heaviest band seen was at approximately 
97 kDa. There appeared to be bands between 66 and 45 kDa, although these were 
faint and possibly represented non-specific binding.
Strain 88 expressed proteins of approximately 95 and 66 kDa which were very faint. It
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is possible that other proteins were present, which in higher concentrations would 
have been recognised by the MCA.
6.4 DISCUSSION
Outer membrane proteins were prepared from 12 wild type strains of 
A.actinomycetemcomitans and 5 reference strains, separated by SDS-PAGE 
electrophoresis and the cross-reactivity between the OMPs and a MCA to the RTX 
toxin adenylate cyclase, from B.pertussis, investigated.
6.4.1 Whole cell preparation
The protein bands seen for each strain represented a mixture of proteins and as with 
any electrophoretic system, any band seen in an SDS-PAGE gel, may represent one or 
more proteins. Bands which appeared to be of greater intensity than others may have 
represented a protein more highly expressed. Equally, however, it may represent a 
mixture of comigrating proteins. Variation in the expression of proteins may have 
been the result of a genetic deletion or an effect at the expression level of the protein. 
Although care was taken to ensure that all strains of A.actinomycetemcomitans were 
treated equally, it cannot be excluded that variations in the total protein preparations 
and OMP preparations seen between strains was the result of environmental factors 
and not genetic variation.
Outer membrane proteins
The outer membrane of gram negative bacteria provides a variety of different 
functions for the bacterial cell. These include, for example, the provision of a 
protective environment for hydrolytic enzymes; the binding of proteins which are 
present in the periplasm. Outer membranes are also involved in the maintenance of the 
cell integrity (DiRienzo, Nakamura and Inouye, 1978) and serve as phage receptors 
(Datta, Arden and Henning, 1977), diffusion pores and mitogens (DiRenzo et al,
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1978). The methods used by Wilson (1991b) were similar to those employed in this 
study and all strains investigated demonstrated a 29 kDa protein (Figures 6.2 (a) and 
(b)). Wilson (1991a), however, did not use the OMP results for taxonomic studies and 
therefore no protein gels were illustrated. Wilson's main interest was the presence of a 
heat modifiable protein of 29 kDa, and its interaction with antiserum, directed against 
the OmpA protein of E.coli.
Bolstad et al (1990) studied the OMPs from 10 wild strains and 4 reference strains of 
A.actinomycetemcomitans. The methodology for the isolation of the OMPs was 
different from that used in the current study (Bakken and Jensen, 1986, cited by 
Bolstad et al, 1990) : bacteria were freeze-dried and broken in a French pressure cell. 
Unbroken cells and the cell envelopes were removed by centrifugation. After several 
washes, cells were resuspended in a N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic 
acid (HEPES)/ magnesium chloride buffer.
Bolstad et al (1990) found four dominant protein bands of 48, 39, 34 and 28 kDa and 
the presence of a number of less substantial bands with an approximate molecular 
weight of 43, 32.5, 29, 18.5 and 16.5 kDa. They suggested that the OMPs from 10 
wild strains of A.actinomycetemcomitans displayed a great deal of similarity in the 
overall patterns observed. The strains investigated in this study demonstrated proteins 
of approximately 29, 40, 50, 70, 97 and 100 kDa. The variation seen in the molecular 
weights could be due to differences in the methods used to isolate the OMPs.
The aim of Bolstad et al (1990) had been to use OMP profiles as a method of typing 
clinical strains. They demonstrated interspecies differences i.e. between 
A.actinomycetemcomitans and H.aphrophilus and suggested, as had others (Moore et 
al 1980; Tanner 1986), the use of SDS-PAGE techniques to distinguish between 
species in a mixed bacterial population.
Bolstad et al (1990) and Wilson (1991b) both demonstrated the presence of a heat 
modifiable protein of 34 and 39 kDa respectively. The heat modifiable protein referred 
to by both Bolstad et al (1991) and Wilson (1991b), could be the same protein.
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Differences in the preparation of the proteins and gels may also have led to changes in 
mobility and apparent molecular weight. However, in the present study the effect of 
heat upon the electrophoretic mobility of the OMPs from the 17 strains studied was 
not investigated and no conclusions can be made regarding the apparent differences 
seen by Bolstad et al (1991) and Wilson (1991b).
Overall, results of the SDS-PAGE separation of the OMPs from 17 strains of 
A.actinomycetemcomitans appeared to be generally consistent with published work. 
The use of proteins to type bacteria is not universally accepted, as the results can be 
variable, due to for example, environmental conditions. Gaston and Hunter (1986) 
suggested that this approach to typing bacterial strains was error prone, and is now 
used only in very defined circumstances.
Bolstad et al (1990), cultured wild strains of A.actinomycetemcomitans on liquid Slots 
medium and Reference strains in BHI then demonstrated similarities in the OMPs. 
This, they understood, implied that the isolated OMPs were constitutively expressed 
and of great use in taxonomic studies. However, had all the bacterial strains been 
grown under the same nutritional conditions, differences in the OMPs may have been 
seen and consequently the usefulness of OMPs in taxonomic studies reduced. All 
bacterial strains in this study were grown under the same nutritional conditions, which 
could explain the variation seen in the OMPs.
Variation in the OMP concentrations i.e. intensity of the protein bands, may have been 
as a result of operator error, in for example the calculation of the protein 
concentration.
There is no clear relationship between the clinical origins, plasmid status and REFP 
group. On the basis of OMPs, the largest group is 5, with 4 members. When the OMP 
profile grouping is compared to the REFP grouping, there is no clear correlation; 
group 5 corresponds to RFLP groups D, I and K.
One OMP result of interest is the OMP profile of strain 55. This strain types with 
strains 56 and 57; all three stains were isolated from the same individual. Its plasmid
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profile and REFP grouping are the same, however, the OMP profiles of 56 and 57 
differ from that of 55. These differences could be explained by a low concentration of 
proteins in strains 56 and 57.
MCA 9D4
The RTX toxins are related to each other in several ways (Welch et al, 1991; 
Strathdee & Lo, 1989; Iwase et al, 1990). It is therefore reasonable to expect that a 
MCA to the toxin from any of the RTX group members would react with purified 
leucotoxin or recognise the leucotoxin protein on nitrocellulose blots of separated 
proteins, if the epitope was to a conserved region.
Monoclonal antibodies to the leucotoxin of A.actinomycetemcomitans have been 
produced by several groups of workers (DiRienzo et al, 1985., Place, Scidmore and 
McArthur, 1988). They can be used in pathogenicity studies i.e. to neutralise the 
cytotoxic activity of the leucotoxin and recognise the toxin on nitrocellulose blots of 
separated proteins. DiRienzo et al (1985) described the use of MCA to the leucotoxin 
of A.actinomycetemcomitans to examine the distribution of the leucotoxin in oral 
strains of A.actinomycetemcomitans. They found that the MCA recognised 3 proteins 
with molecular weights which ranged from 115 to 135 kDa. No published results are 
available which describe the use of a MCA to one RTX toxin group member to 
identify toxic strains of another RTX group member.
The leucotoxin from A.actinomycetemcomitans has a higher percentage of amino acid 
sequence homology to the E.coli -haemolysin than to the B.pertussis adenylate cylase 
(Kraig et al, 1990; Hess et al, 1986). Therefore it might be expected that a MCA to 
the E.coli haemolysin would have greater homology to the A.actinomycetemcomitans 
leucotoxin than to adenylate cyclase of B.pertussis, depending upon the epitope. The 
MCA which was used in these experiments was one which was made available by the 
University of Glasgow Department of Microbiology. While it may not have been the 
optimal choice of MCA, it has demonstrated the principle that a MCA for one RTX
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leucotoxin can recognise another RTX toxin member.
All seventeen strains of A.actinomycetemcomitans reacted with the MCA to some 
degree. With the exception of strains 1 and 8, non-specific binding of the MCA to 
proteins was seen at approximately 35 kDa. All seventeen strains of 
A.actinomycetemcomitans reacted with the MCA to some degree. With the exception 
of strains 1 and 8, non-specific binding of the MCA to proteins was seen at 
approximately 35 kDa.
Specific binding of the MCA with a protein of approximately 116 kDa (the molecular 
weight of the A.actinomycetemcomitans leucotoxin) was seen in 8 strains, only 1 
(strain 24) of which is toxic to HL-60 cells (Chapter 7). Additional binding of the 
MCA was seen with proteins of 66, 95 and 97 kDa.
Strains from the same individual (54, 55 and 56) demonstrated minor differences to 
each other in both their total protein preparations (Figure 6.1) and purified outer 
membrane preparations. Some of these differences could be explained by 
electrophoretic variation in the SDS-PAGE gel.
Strains 74, 75 and 76 which were isolated from the same periodontal pocket, 
demonstrated minor differences in their total protein contents and minor differences 
were also seen in the outer membrane preparations, however when these proteins 
were probed with MCA 9D4, strains 55 and 56 reacted strongly to the MCA, whereas 
there was no reaction at all between the OMPs of strain 57.
Strains 74 and 75 were very similar; both demonstrated a very strong band at 
approximately 45 kDa. This band was not present in strain 76. Strain 76 showed a 
number of bands with molecular weights of approximately 116 kDa, which were not 
seen in either 74 or 75. Speculation that A.actinomycetemcomitans strain 76 could be 
leucotoxic to HL-60 cells were shown to be unfounded (Chapter 7).
Future work in this area could involve the use of a range of MCA and RTX toxins, to 
investigate homology between these. It would be interesting to examine differences in 
the specificity of different MCA to the RTX toxins since it is possible that one MCA
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reacts more strongly with the protein toxins than another. If the purified toxin was 
extracted from a range of bacteria and then allowed to cross-react with a panel of 
MCAs at different dilutions, it would be possible to answer this question relatively 
simply.
This method of detecting leucotoxicity is not accurate, as only one of the 8 strains 
(strain 24) which reacted to the MCA at approximately 116 kDa, was toxic to HL-60 
cells/ resulted in a reduction in chemiluminescence (Chapter 7). It was time consuming 
and requires large volumes of bacteria from which to purify the toxin. In this study no 
attempt was made to purify the leucotoxin from A.actinomycetemcomitans. Had this 
been done then it is likely that non-specific reactions between the MCA and the OMPs 
would not have occurred. As a result, any reaction between the MCA and proteins 
which did not have the correct molecular weight could therefore have been a reaction 
between the MCA and degradative products of the leucotoxin. However, had a MCA 
to the A.actinomycetemcomitans leucotoxin been available, these results may have 
differed, with all the toxic strains reacting to such a MCA.
These experiments demonstrated that
(i) there are variations in the total protein preparations of A.actinomycetemcomitans 
strains.
(ii) on the basis of OMPs, a number of groups can be described, which are unrelated 
to clinical origins, plasmid status, REFP group and leucotoxic status.
(iii) a protein with a molecular weight similar to that of the leucotoxin is present in the 
outer membrane of both toxic and non-toxic strain of A.actinomycetemcomitans
(iv) a MCA to a RTX toxin, adenylate cyclase, from B.pertussis would recognise the 
leucotoxin, despite the low (less than 50%) homology between the two toxins.
6.4.2 Future work
It would be of interest to use a panel of MCA to the RTX toxins against preparations 
of the OMPs and the purified toxin of A.actinomycetemcomitans to determine the
170
cross-reactivity (if any) between these MCA and the leucotoxin of 
A.actinomycetemcomitans. The reaction of purified toxin from each of the RTX 
members to MC As against all the toxins would also be of interest.
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CHAPTER 7
LEUCOTOXICITY 0 ¥  A.actinomycetemcomitans TO HL-60 CELLS AND
HUMAN PMNLS
CHAPTER 7
LEUCOTOXICITY OF A.Actinomycetemcomitans TO HL-60 CELLS AND
HUMAN PMNLS
7.1 INTRODUCTION
A.actinomycetemcomitans has several virulence factors (see 1.7), the most widely 
studied of which is the leucotoxin (see 1.8). A number of different assays, have been 
developed to investigate toxin production by A.actinomycetemcomitans. Whole 
bacterial cells, sonicates of whole cells or purified leucotoxin have been used with 
freshly isolated human polymorphonuclear cells (Baehni et al, 1979., Baehni et al, 
1981) or cultivated human tissue cell lines e.g. HL-60 (Zambon et al, 1983., Simpson, 
Berthold and Taichman, 1988). Cell death has been determined by trypan-blue 
exclusion (Ohta et al, 1987); lactate dehydrogenase release (Zambon et al, 1983); 
lysosomal elastase release (Tervahartiala et al, 1989); release of 51Cr (Simpson et al, 
1988) and fluorescent spectroscopy (Ohta et al, 1991).
Each method poses different problems, e.g.51 Cr relies upon the release of a radioactive 
labelled element, while dye exclusion relies upon visual identification of dead/ live 
cells, where great care must be taken to ensure random sampling of cells.
In this thesis the leucotoxic activity of A.actinomycetemcomitans was investigated by 
two different techniques. The first used HL-60 cells, which were exposed to whole 
cells of A.actinomycetemcomitans, with or without sonication, a method previously 
used by Zambon et al (1983) and Simpson et al (1988). The second method measured 
the change in light emitted from human PMNLs exposed to A.actinomycetemcomitans 
(i.e. chemiluminescence), a method which had been used previously to investigate the 
toxic effect of the B.pertussis toxin adenylate cyclase, but which had not been 
previously employed to measure the leucotoxic activity of A.actinomycetemcomitans. 
The aim of these experiments was to obtain a rapid, but accurate, method for the 
determination of the toxic status of strains of A.actinomycetemcomitans held at
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Glasgow Dental Hospital and School.
7.2 MATERIALS AND METHODS
7.2.1 Toxic effect of whole cells and sonicates of A.actinomycetemcomitans on 
HL-60 cells
7.2.1.1 Preparation of A. actinomycetemcomitans
Duplicate, 20 ml, overnight cultures of the 17 strains of A.actinomycetemcomitans 
under investigation (Table 2.2) were prepared as previously described (2.1.2). The 
bacterial cells were pelleted by centrifugation at 4000 rpm for 10 minutes followed by 
resuspension in 10 ml ice-cold PBS, pH 7.3 (Appendix 1.5). Cells were washed in this 
way on 2 occasions, then the duplicate cultures (A and B) were treated as follows : 
Culture A was resuspended in 5 ml ice-cold PBS and the concentration adjusted to 
give 1 X 109 cells per ml, using the formula of Lai et al (1983). This states that 1 X 
109 A.actinomycetemcomitans per ml, has an optical density equivalent to 0.3 when 
read at 540 nm. The formula is set out as follows :
OD540
  - 1 X 5  = Volume of PBS needed to
0.3 adjust suspension volume to an optical density of
0.3 at 540 nm.
The optical density was measured in a SP8-100 UV/ I VS spectrophotometer (Pye/ 
Unicam, Cambridge). The dilution of the bacterial cells in PBS was repeated until an 
optical density of 0.3 was achieved. From the final suspension, 3 aliquots of 1 ml were 
added to separate bijoux bottles labelled Al, A2 and A3, which had been stored 
overnight at 4°C. These samples were stored on iced-water until required. The 
remaining cells were discarded.
Culture B was resuspended in 3 ml ice-cold PBS, then aliquoted into 3 x 1 ml 
volumes, in bijoux bottles labelled Bl, B2 and B3, which had been stored as before. 
All samples were stored on iced-water at 4°C until required.
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These methods of preparation produced cell concentrations of approximately 8.0 - 9.0 
X 108 (A) and between 9.0 X 109 and 1.0 X 1010 (B), which was calculated as 
described below. The method described by Lai et al (1983) thus proved to be 
inaccurate in the calculation of A.actinomycetmcomtians cell numbers and was not 
used in the cytotoxicity experiments.
Al/Bl : whole cell fraction.
Both bijoux bottles were shaken by hand to mix the cells and 50 pi was removed 
which was serially diluted in ice-cold PBS to 1.0 x 10'3, 1.0 x 10A (A only) and 1.0 x 
10'5, 1.0 x 10'6 (B only). Each diluted fraction was then spiral plated (Don Whitley 
Sciences, Yorkshire, England) onto CBA and incubated at 37°C and 5% C02, in air 
for 48 hours. The number of colonies were counted using a manual counting grid and 
the colony forming units per ml calculated.
The remaining undiluted cells were left on iced water, at 4°C, until required for the 
HL-60 assay.
A2/B2 : Whole cells sonicated for 15 seconds
The cells were sonicated in the bijoux by introducing the probe that delivered 20% 
power output (Heatsystems Inc., New York, USA.) for 15 seconds. The bottles were 
enclosed in iced water and after sonication left in iced water at 4°C until required for 
the HL-60 assay. Serial dilutions and spiral plating of the sonicated fractions were 
made, as for fractions Al/Bl.
A3/B3 : Whole cells sonicated for 5 minutes
The cells were sonicated in the bijoux over iced water for 5 minutes and serial 
dilutions were prepared as above. The bottles were left on iced water at 4°C until 
required for the HL-60 assay. Serial dilutions and spiral plating of the sonicated 
fractions were made, as above.
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The number of viable A.actinomycetemcomitans cells used in each experiment was 
measured on three occasions and the mean value recorded. The results were 
subsequently expressed as the mean Log10 viable cell counts.
Cells were sonicated in the order 1 x 10~6, 105, 10-4, 10'3 to ensure that the least dilute 
cells did not become contaminated by the more concentrated suspension. Between 
different strains, the sonicator probe was wiped with an "Azo wipe" to reduce the 
chance of cross contamination to negligible levels.
7.2.1.2 Preparation of HL-60 cells
HL-60 cells, cultured as previously described (2.3.4), were aseptically decanted into 
sterile plastic universals and pelleted by centrifugation at 500 rpm for 10 minutes. The 
cells were washed 3 times in PBS at room temperature. After the 3rd wash, the cells 
were resuspended in 1 ml PBS. Fifty microlitres were removed and diluted 1 in 20 in 
PBS with 0.1% trypan blue (Appendix 1.5). The cells were counted in a 
haemocytometer as described previously (2.5), to find the total number and the 
percentage of viable HL-60 cells present. Cells were diluted to give a final 
concentration of 1.0 x 107 cells ml'1. Only cell suspensions with 95% or greater 
viability were used.
7.2.1.3 Determination of Toxicity
The percentage HL-60 cell death at which an A.actinomycetemcomitans strain was 
designated toxic was taken to be at an arbitrary level of 25%. Any strain of 
A.actinomycetemcomitans which resulted in HL-60 cell death of 25% or greater, 
irrespective of either the bacterial cell numbers or the treatment to the 
A.actinomycetemcomitans, was considered to be toxic.
7.2.1.4 Cytotoxicity assay of A. actinomycetemcomitans
Two hundred microlitres of each A.actinomycetemcomitans suspension (A1-A3/
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B1-B3), which had been stored in ice-water, were pipetted after mixing, into a bijoux, 
to which 200 pi of the HL-60 cells at 1.0 x 107 cells ml'1 were added, giving a total 
volume of 400 pi. Two sets of controls were used; (i) a positive control, where 100% 
cell death of HL-60 cells was achieved by the addition of 200 pi Triton X-100 
(Sigma), diluted 1 in 100 in PBS, pH 7.2, from the neat stock solution, to 200 pi of 
the HL-60 cells at 1.0 x 107 cells ml*1 and (ii) a negative, viability, control where 200pl 
of HL-60 cells were suspended in 200 pi of PBS.
The bijoux bottles were then shaken at 37°C, for 60 minutes in a waterbath (Heto, 
Denmark) at full power, after which they were placed on iced water at 4°C to stop any 
further reaction, before counting.
7.2.1.5 Counting of HL-60 cells
The contents of each bijoux were mixed thoroughly by hand, and 50 pi removed to a 
labelled eppendorf tube and diluted 1 in 1 with 0.1% trypan blue. Fifty microlitres of 
this mixture was then transferred to a microscope slide, a coverslip placed on top and 
the slide examined at 100X and 400X magnification using an Olympus (Japan) 
microscope.
Slides were examined first at 100X magnification to ensure that the concentration of 
cells was neither too great (i.e a confluent carpet of cells in which individual cells 
could not be easily distinguished or counted) nor too low (i.e less than 50 cells in each 
field of view). Magnification was then increased to 400X, and the central area of the 
coverslip examined. Fields of view which contained between 20 to 30 HL-60 cells 
were counted. The microscope slide was moved to the right for two fields of view, 
upwards for two fields of view, right for two, then down for two. This motion was 
repeated until 300 HL-60 cells had been counted and ensured that no HL-60 cell was 
counted on more than one occasion.
The number of dead cells in the PBS viability control was subtracted from the total 
dead cell count obtained for each test. The final result was expressed as the
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"percentage dead cells".
Total dead cells - PBS ’’background” x 100 = Percentage HL-60 dead 
-------------------------------------  cells
300
The assay was carried out in duplicate (i.e. 2 x Al, 2 x A2 etc) on 3 separate 
occasions for each strain and these values then expressed as the "mean percentage 
dead cells".
Figure 7.1 shows cells stained with 0.1% trypan blue, prior to exposure of HL-60 to 
A.actinomycetemcomitans, while Figure 7.2 shows cells stained with 0.1% trypan 
blue, after exposure of HL-60 to the leucotoxic strain of 88.
7.2.2 Toxic effect of sonicated A.actinomycetemcomitans on human PMNLs 
measured by chemiluminescence
7.2.2.1 Isolation of human PMNLs
Twenty millilitres of venous blood were obtained from 5 healthy individuals in 
separate 10 ml sterile plastic bottles (Sherwood, England) containing heparin (on no 
occasion were blood samples from any two individuals mixed.) The sample was then 
mixed with 2 ml of 5% dextran (molecular weight 229 000 kDa, Sigma) in PBS 
(Appendix 1.5) and the red blood cells allowed to sediment for at least 1 hour. The 
leukocyte rich plasma layer was removed and layered carefully onto 5 ml 
Ficoll-hypaque (Pharmacia). The leucocytes were pelleted by centrifugation at 2500 
rpm for 15 minutes, followed by one wash in 10 ml PBS, with 5 minutes 
centrifugation at 2500 rpm. Red blood cells were lysed by exposure of the aspirated 
cells to 0.2 ml distilled water for 30 seconds, followed by the addition of 10 ml PBS. 
PMNLs were centrifuged as described above and resuspended in PBS to give a final 
concentration of 1.0 x 106 cells ml'1, using a haemocytometer, as previously described 
in section 2.5.
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Figure 7.1 HL-60 cells stained with trypan blue, prior to exposure to 
A. actiriomycetemcomitcins
Figure 7.2 HL-60 cells stained with trypan blue, after exposure to
A.actinomycetemcomitans strain 88 at 37°C for 60 minutes in 
a shaking waterbath.
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7.2.2.2 Chemiluminescence Assay - Preliminary study to optimise the 
experimental conditions.
It became clear that the period of incubation of the PMNLs with 
A.actinomycetemcomitans prior to stimulation with phorbol-myristate-acetate (PMA) 
and measurement of chemiluminescence was critical - if too short a period then any 
reaction between the bacterial toxin and the PMNLs cell membrane would not occur; 
too long a period of incubation, and the natural activity of PMNLs would be reduced 
and little or no stimulation would be seen, after incubation with either toxic or 
non-toxic strains. It was also important that neither the sonicated bacterial cells nor 
the HL-60 cells were left for long periods of time before measuring the 
chemiluminescence as the activity of both would begin to decline naturally. For 
chemiluminescence studies, the optimum period of preincubation of PMNLs with 
sonicated cells of A.actinomycetemcomitans was first determined. Whole cells were
not used as previous experience within the Department of Microbiology, Glasgow
University had shown that these interfered with the test.
Chemiluminescence is light which is emitted as the result of a chemical reaction. 
Human PMNLs can be stimulated into producing light by the addition of PMA, which, 
although weak, can be enhanced by the addition of luminol. The resultant detectable 
levels can then be measured in a luminometer. Cells which are dead, cannot be 
stimulated into producing chemiluminescence. Therefore, incubation of toxic strains of 
A.actinomycetemcomitans with human PMNLs would result in a reduced level of 
chemiluminescence, whilst no significant change would occur if the strains were 
leucotoxin negative.
A preliminary study was performed with four strains of A.actinomycetemcomitans 
which were chosen on the basis of previously known leucotoxic status (7.3.1): 
A.actinomycetemcomitans 1 - Non-toxic to HL-60 cells
A.actinomycetemcomitans 33 - Moderately toxic to HL-60 cells
A.actinomycetemcomitans 24 - Toxic to HL-60 cells
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A.actinomycetemcomitans 88 - Highly toxic to HL-60 cells
7.2.2.3 Preparation of A.actinomycetemcomitans sonicates
The four strains under preliminary investigation were cultured in 20 ml of T SB and the 
cells harvested as previously described (7.2.1). The washed bacterial pellets were 
resuspended in ice cold PBS, giving a concentration of 1.0 x 109 cells per ml. Viable 
cells counts were estimated as described previously (7.2.1.1).
7.2.2.4 Chemiluminescence assay
The assay was carried out in 2 ml plastic test tubes (LKB, England) with a reaction 
volume of 1 ml (Table 7.1). One hundred microlitres of bacterial cells, removed from a 
volume of 5 ml of cells sonicated for 15 seconds, were preincubated with human 
PMNLs (100 pi) for 0, 10, 20 and 40 minutes at 37°C prior to the addition of luminol 
(200 pi - Sigma) at a concentration of 1.8 pgml'1, diluted in PBS from a stock solution 
of 1.8 mgml'1, prepared in dimethylsulphoxide (DMSO - Appendix 1.5). Immediately 
prior to reading in the luminometer, PMA diluted 1 in 1000 in PBS from a stock 
solution, prepared in DMSO (Appendix 1.5) was added and the reaction followed 
during the next 20 minutes.
Two controls were run (A) a PMA control that indicated the maximum stimulation of 
PMNLs when they were stimulated by the addition of PMA only and (B) a blank, 
which consisted of PMNLs and luminol only (see Table 7.1) which supplied a baseline. 
Each strain was assayed in duplicate, on three separate occasions and the results 
expressed as the mean of these.
Samples were read in an LKB Wallac luminometer (LKB, England) and all results 
were measured in millivolts. The luminometer was attached to an IBM computer and a 
graphical output obtained through "Multiuse" - the luminometer software package 
supplied by LKB. The results were obtained in a graphical and numerical form. The 
peak millivoltage value for each strain was calculated and expressed as a percentage of
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Reaction Volumes
Test Blank Control PMA Control
PBS 400 pi 700 pi 500 pi
PMA 200 pi — 200 pi
Luminol 200 pi 200 pi 200 pi
-Sonicate 100 pi — —
PMNLs 100 pi 100 pi 100 pi
Table 7.1 Reaction volume in chemiluminescence studies
-Sonicate : Sonicated whole cell A.actinomycetemcomitans at 
concentration of 1 x 107 cells per ml.
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the maximum stimulation obtained for the PMA stimulated cells (control A). The 
average result for each of the four strains, for each period of preincubation was 
calculated from the numerical output and the results plotted onto a single graph for 
each time period (Figures 7.3a to 7.3d) using the spreadsheet program Quattro Pro 
V . l .
A strain was designated toxic to PMNLs if it resulted in greater than 70% inhibition of 
the maximum chemiluminescence output. This value was purely an arbitrary one, 
which was used routinely as a measure of toxicity in the Microbiology Department of 
Glasgow University. The maximum light output varied from day-to-day, depending 
upon the source of the PMNLs. However, as the final result was a percentage of the 
maximum chemiluminescence output, i.e. the area under the graph, irrespective of the 
peak output, comparison between the strains could easily be made.
From the results shown in Figures 7.3a to 7.3d, it could be seen that the optimum 
period of preincubation for sonicated A.actinomycetemcomitans with PMNLs was 20 
minutes (Figure 7.1c). Between 10 and 20 minute preincubation, the light output 
reached its maximum; at 40 minutes, it had begun to decline, therefore a period of 20 
minutes was chosen as the maximum period of preincubation, prior to addition of 
PMA.
7.2.2.5 Toxic effect of A.actinomycetemcomitans on human PMNLs by 
Chemiluminescence
Sonicates of the remaining 13 A.actinomycetemcomitans strains under investigation 
(Table 2.2) not used in the optimisation studies were prepared as previously described 
(7.2.2.2) and the chemiluminescence assay performed as described in 7.2.2.3 - 
A.actinomycetemcomitans sonicates were preincubated with the PMNLs for 20 
minutes, since this produced maximal results.
Each strain was assayed in duplicate, on three separate occasions.
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7.2.2.6 Effect of heat and dilution upon toxicity of A.actinomycetemcomitans to 
PMNLs.
The leucotoxin from A.actinomycetemcomitans has been reported to be heat labile 
(Baehni et al, 1979). The effect of heat upon the activity of a sonicated suspension of 
two A.actinomycetemcomitans strains was investigated, in order to help determine 
that the effect seen was due to a toxin and not LPS, since the LPS found in the outer 
membrane of bacterial cell walls are known to be toxic to mammalian cells it was 
important to rule out LPS as the cause of PMNL cell death. Lipopolysaccharides have 
also been shown to have stimulatory effect upon PMNLs, which is dose dependent 
(Welch, 1991) and unaffected by heat.
Two strains of A.actinomycetemcomitans, 76 and 88 which had been shown to react 
differently with the PMNLs (7.3.2), were grown, harvested and sonicated for 15 
seconds as previously described (1.2.22). From each sonicated sample, 1 ml aliquots 
were removed, heated at 56°C for 30 minutes, then cooled on ice. The samples were 
serially diluted from 1 in 2 to 1 in 2112 and the toxicity assessed in duplicate, on two 
separate occasions.
7.2.2.7 Stimulatory effect of A. actinomycetemcomitans sonicates upon PMNLs
Many of the strains were shown to have a stimulatory effect upon the PMNLs (7.3.2)
i.e. the amount of light that was produced was greater than that of the PMA control. 
This effect was investigated by examination of two strains, one which had been shown 
previously to demonstrate this effect (strain 76) and a negative strain (88). These 
strains were grown, harvested and sonicated for 15 seconds as before (7.2.2.2) then 
serially diluted from 1 in 2 to 1 in 2112 in PBS. The toxicity of each was measured in 
the chemiluminescence assay as described before (7.2.2.3).
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7.3 RESULTS
7.3.1 Results of Cytotoxicity Assay
Seventeen A.actinomycetemcomitans strains were examined for their ability to kill 
HL-60 cells after 60 minutes incubation at 37°C.
On the basis of the criteria laid down for a strain to be designated toxic (greater than 
or equal to 25% HL-60 cell death, 7.2.1.3), the greatest number of strains (12 out of 
the 17 investigated) were shown to be non-toxic to HL-60 cells.
Tables 7.2a - 7.2g indicate the average percentage HL-60 cell death with the 
corresponding Log10 viable A.actinomycetemcomitans cells for all the toxic strains and 
a cross section of the non-toxic strains of A.actinomycetemcomitans studied.
Of the 17 strains which were studied, only strains 24, 79, 80, 81 and 88 were 
designated toxic. These results are given in Tables 7.2a to 7.2e.
Strains 32 and 74 were non-toxic and their results were typical for all non-toxic 
strains. These are shown in Tables 7.2f and 7.2g.
Amongst the toxic strains, the percentage HL-60 cell death decreased after 15 seconds 
sonication, and generally after an increase in sonication to 5 minutes cell death 
decreased further. There would appear to be an association between the number of 
viable cells for most toxic strains and HL-60 cell death e.g. strain 24; whole viable 
cells at a concentration of Logl0 8.1 resulted in the death of 32.9%, whereas counts of 
Log10 9.7 produced kills of 44.9 (Table 7.2a). On the other hand, non-toxic strains 
such as 32, had little effect on HL-60 cells at both very high (Log10 10.00) and low 
(Log10 7.8) concentrations.
Sonication did not affect the overall viability of the A.actinomycetemcomitans strains. 
The variation in the results between sonicated and non-sonicated preparations could 
be explained by the leucotoxin being removed from the bacterial cell surface, into 
solution.
Sonication has previously been shown to reduce cell clumping (5.3.5). The 
disassociation of A.actinomycetemcomitans cells by sonications resulted in an increase
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Average percentage 
HL-60 cell death ± S.D.
Logio viable bacterial 
cell counts ± *S.D.
Al 32.9 ± 10.2 8.1 ±0.4
A2 18.8 ±7.0 8.4 ±0.6
A3 12.9 ±4.8 8.3 ±0.6
B1 44.9 ±3.0 9.7 ±0.1
B2 34.6 ±3.2 9.8 ±0.1
B3 21.4 ±4.8 9.8 ±0.2
Table 7.2a Toxicity of whole cells and sonicates of 
A.actinomycetemconutans 24 to HL-60 cells, measured by dye exclusion
Average percentage 
HL-60 cell death ± S.D.
Log10 viable bacterial 
cell counts ± *S.D.
A l 18.6 ± 5.2 8.8 ±0.0
A2 12.3 ±3.4 8.8 ±0.0
A3 14.7 ± 1.4 8.8 ±0.9
B1 43.6 ±0.9 10.6 ±0.1
B2 32.0 ± 1.3 10.4 ±0.4
B3 23.9 ±2.3 10.0 ±0.5
Table 7.2b Toxicity of whole cells and sonicates of 
A,actinomycetemcomitans 79 to HL-60 cells, measured by dye exclusion
*S.D. Standard Deviation
A l 108 Whole cells
A2 10s Whole cells, sonicated for 15 seconds
A3 10s Whole cells, sonicated for 5 minutes
B1 > 109 Whole cells
B2 >109 Whole cells, sonicated for 15 seconds
B3 >109 Whole cells, sonicated for 5 minutes
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Average percentage 
HL-60 cell death ± S.D.
Log10 viable bacterial 
cell counts ± *S.D
A l 17.5 ±5.4 8.8 ±0.4
A2 10.1 ±6.9 8.5 ±0.3
A3 11.0 ± 6.2 8.2 ±0.3
B1 28.0 ±3.6 10.0 ±0.3
B2 12.5 ±3.0 10.4 ±0.0
B3 15.1 ± 1.1 10.2 ±0.8
Table 7.2c Toxicity of whole cells and sonicates of 
A.actinomycetemcomitans 80 to HL-60 cells, measured by dye exclusion
Average percentage 
HL-60 cell death ± S.D.
Log10 viable bacterial 
cell counts ± *S.D
A l 26.7 ±5.2 8.6 ±0.4
A2 16.1 ±2.6 8.6 ±0.5
A3 15.9 ± 3.0 8.4 ±0.3
B1 30.2 ±4.6 9.8 ±0.3
B2 24.7 ± 1.9 10.2 ±0.1
B3 19.1 ± 1.6 10.1 ±0.2
Table 7.2d Toxicity of whole cells and sonicates of 
A.actinomycetemcomitans 81 to HL-60 cells, measured by dye exclusion
*S.D. Standard Deviation
A l 108 Whole cells
A2 10s Whole cells, sonicated for 15 seconds
A3 108 Whole cells, sonicated for 5 minutes
B1 > 109 Whole cells
B2 >109 Whole cells, sonicated for 15 seconds
B3 >109 Whole cells, sonicated for 5 minutes
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Average percentage 
HL-60 cell death ± S.D.
Log10 viable bacterial 
cell counts ± *S.D
A l 31.7 ± 2.4 7.6 ±0.6
A2 25.9 ±9.8 9.0 ±0.5
A3 13.5 ± 1.7 8.8 ±0.1
B1 38.3 ±5.0 9.9 ±0.4
B2 36.5 ±2.3 10.0 ±0.4
B3 36.8 ±6.1 9.9 ±0.2
Table 7.2e Toxicity of whole cells and sonicates of 
A.actinomycetemcomitans 88 to HL-60 cells, measured by dye exclusion
Average percentage 
HL-60 cell death ± S.D.
Log10 viable bacterial 
cell counts ± *S.D
A l 1.1 ±0.9 7.8 ±0.7
A2 1.0 ± 1.4 8.4 ±0.4
A3 0.5 ±0.3 7.8 ±0.4
B1 2.2 ± 0.6 10.0 ±0.2
B2 8.0 ±5.4 9.8 ±0.4
B3 3.2 ± 1.5 9.2 ±0.5
Table 7.2f Toxicity of whole cells and sonicates of 
A.actinomycetemcomitans 32 to HL-60 cells, measured by dye exclusion
*S.D. Standard Deviation
Al 108 Whole cells
A2 10s Whole cells, sonicated for 15 seconds
A3 10s Whole cells, sonicated for 5 minutes
B1 > 109 Whole cells
B2 >109 Whole cells, sonicated for 15 seconds
B3 >109 Whole cells, sonicated for 5 minutes
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Average percentage 
HL-60 cell death ± S.D.
Log10 viable bacterial 
cell counts ± *S.D
A l 0.6 ±0.8 8.3 ±0.3
A2 1.3 ± 1.0 8.4 ±0.3
A3 1.4 ± 1.4 8.0 ±0.3
B1 2.0 ±0.9 9.4 ±0.5
B2 2.2 ± 1.3 9.6 ±0.3
B3 3.2 ±2.3 9.3 ±0.5
Table 7.2g Toxicity of whole cells and sonicates of 
A.actinomycetemcomitans 74 to HL-60 cells, measured by dye exclusion
*S.D. : Standard Deviation
A l : 109 Whole cells
A2 : 109 Whole cells, sonicated for 15 seconds
A3 : 109 Whole cells, sonicated for 5 minutes
B1 : > 109 Whole cells
B2 : >109 Whole cells, sonicated for 15 seconds
B3 : >109 Whole cells, sonicated for 5 minutes
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in the number of viable cells, but with no increase in the leucotoxicity of the bacterial 
strains.
Overall, these results suggest that whole viable bacterial cells demonstrated the 
greatest degree of leucotoxicity in the trypan blue dye exclusion assay with HL-60 
cells and the cell numbers varied depending upon the strain tested.
7.3.2 Chemiluminescence - preliminary study to optimise the experimental 
conditions
The results for the 4 strains of A.actinomycetemcomitans selected for the preliminary 
experiments to optimise the experimental conditions for the chemiluminescence assay 
are presented in Figures 7.3a - 7.3d.
Incubation of the PMNLs and whole sonicated cells for 0 minutes prior to the addition 
of PMA, resulted in different peaks of activity for the different strains of 
A.actinomycetemcomitans investigated (Figure 7.3a). Strains 1 and 33 (both non-toxic 
by dye-exclusion) produced peaks greater than the PMA stimulated control cells and 
this level of activity was maintained for most of the experimental period. Strain 24 
(toxic by dye exclusion) resulted in a very shallow peak after 103 seconds, which was 
then reduced to the baseline reading of non-stimulated cells of 0 mV. Thus the toxic 
effect of strain 24 upon PMNLs was almost instantaneous although it failed to depress 
PMA activity completely. Strain 88 (toxic by dye exclusion) resulted in the complete 
depression of chemiluminescence: this indicated that the PMNLs did not respond to 
PMA stimulation and were therefore probably dead. The toxic effect of strain 88 upon 
PMNLs was therefore almost instantaneous.
The results for 10 minutes preincubation (Figure 7.3b) at 37°C, are very similar to 
those described above when no preincubation period was used. There was, however a 
reduction in the activity of PMNLs incubated with strains 1 and 33, whilst there was 
an increase in the activity of PMNLs incubated with A.actinomycetemcomitans strain 
24. No activity was measured at all for PMNLs which were incubated with
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Figure 7.3a Result of chemiluminescence assay for sonicates of 4 selected
strains of A. actinomycetemcomitans, that were preincubated for 
0 minutes with PMNLs, prior to stimulation with PMA
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Figure 7.3b Result of chemiluminescence assay for sonicates of 4 selected
strains of A.actinomycetemcomitans, that were preincubated for 
10 minutes with PMNLs, prior to stimulation with PMA
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Table 7.3c Result of chemiluminescence assay for sonicates of 4 selected
strains of A.actinomycetemcomitans, that were preincubated for 
20 minutes with PMNLs, prior to stimulation with PMA
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Table 7.3d Result of chemiluminescence assay for sonicates of 4 selected
strains of A.actinomycetemcomitans, that were preincubated for 
40 minutes with PMNLs, prior to stimulation with PMA
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A.actinomycetemcomitans strain 88.
The results for 20 (Figure 7.3c) and 40 minutes (Figure 7.3d) preincubation did not 
vary greatly, but did show some differences compared with those for 0 and 10 minutes 
preincubation: the level of activity began to drop shown by the reduction in the 
maximum mV recorded after 40 minutes.
It was decided that the period of incubation of the A.actinomycetemcomitans strains 
with human PMNLs, prior to the addition of luminol and PMA would be 20 minutes 
as this appeared to be the point when maximum values were seen.
7.3.3 Toxic effect A.actinomycetemcomitans
Figures 7.4a - 7.4d, show the variation in the effect of 14 A.actinomycetemcomitans 
strains on PMNLs, when preincubated for 20 minutes before stimulation with PMA. 
Several of the strains resulted in reduced PMNL activity e.g. strain 79 shown in Figure 
7.4c and strains 80 and 81 in Figure 7.4d, thus indicating leucotoxic activity. Several 
of the strains resulted in a peak mV greater than that of the PMA peak, for example 
strains 8, 74 and 75 (Figure 7.4a) indeed, A.actinomycetemcomitans strain 74 resulted 
in a peak mV 1.75 times greater than the PMA control peak. The mean peak 
percentage values for all the strains are presented in Table 7.3.
7.3.4 Effect of heat and dilution upon toxicity of A.actinomycetemcomitans to 
PMNLs.
The effect of heat and dilution on serially diluted sonicates of two strains of 
A.actinomycetemcomitans are shown in Figures 7.5a to 7.5f. After 20 minutes 
incubation of the unheated sonicated whole cells of A.actinomycetemcomitans strain 
88, no PMNL activity (Figure 7.5a) was noted. As the unheated sample was diluted, 
activity began to increase (Figures 7.5a and 7.5b) to levels approaching those of 
maximum expected from PMA stimulated cells. A maximum stimulation seen was at a 
serial dilution of 1 .2112 (Figure 7.5b), when the output reached that of PMA
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Table 7.4a Result of chemiluminescence assay for sonicates of 3 selected
strains of A.actinomycetemcomitans, that were preincubated for 
20 minutes with PMNLs, prior to stimulation with PMA
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Table 7.4c Result of chemiluminescence assay for sonicates of 4 selected
strains of A.actinomycetemcomitans, that were preincubated for 
20 minutes with PMNLs, prior to stimulation with PMA
Time (seconds)
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Table 7.4d Result of chemiluminescence assay for sonicates of 3 selected
strains of A.actinomycetemcomitans, that were preincubated for 
20 minutes with PMNLs, prior to stimulation with PMA
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A. actinomycetemcomitans 
Isolate Number
Mean Percentage 
Chemiluminescence 
Produced by Isolate
1 118.0%
8 107.6%
24 10.2%
32 81.8%
33 106.9%
36 66.1%
55 95.5%
56 39.8%
57 48.7%
74 43.0%
75 138.8%
76 135.5%
79 20.5%
80 29.7%
81 15.5%
83 111.1%
88 0.2%
Table 7.3 Chemiluminescence produced by A.actinomycetemcomitans strains as a 
percentage of the light produced by stimulating PMNL cells with PMA
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stimulated cells. When the sonicated sample from the same strain was heated at 56°C 
for 30 minutes, prior to incubation the opposite result was seen. Samples which 
contained the undiluted cells, produced a peak which was approximately 54% greater 
than that expected for PMA stimulated cells only (Figure 7.5c). Only after dilution to 
1 : 32, did the stimulation reduce to a level below that of PMA stimulated cells.
When compared to A.actinomycetemcomitans strain 76, the unheated, undiluted 
sonicate sample ("neat") gave a moderately high reading, approximately 75% that of 
the PMA control (Figure 7.5d). However as the sample was diluted, there was an 
increase in the level of light output; dilutions of 1 in 2 to 1 in 8 all produced peaks one 
third greater than that of the PMA stimulated control (Figure 7.5d). Thereafter, as the 
sample was diluted, there was a decrease in chemiluminescence.
When the heated A.actinomycetemcomitans strain 76 was preincubated for 20 
minutes prior to the addition of PMA, the undiluted sample, gave a peak 
approximately 75% that of the maximum PMA control. However, as this sample was 
diluted, peak values increased, to a maximum at a dilution of 1 in 4, approximately 2.5 
times that of the PMA control (Figure 7.5e). As the sonicated sample was diluted the 
voltage output fell, but at a dilution of 1 in 64, the mV output began to rise again 
(Figures 7.5e and 7.5f).
7.3.5 Cytotoxicity Assay versus Chemiluminescence
The cytotoxicity and chemiluminescence assays identified the same strains of 
A.actinomycetemcomitans as leucotoxic, however, when the rank orders were 
compared, variation was seen (Table 7.4). The chemiluminescence assay used only 
whole cells which had been sonicated for 15 seconds, while the cytotoxicity assay 
used a wide variety of differently treated cells. As the rank order for the cytotoxicity 
assay was found as an average of all the results, this could explain the apparent 
discrepancies in the order of the strains.
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Result of chemiluminescence assay for unheated sonicates of 
A.actinomycetemcomitans strain 88, diluted to 1 in32, preincubated for 
20 minutes with PMNLs, prior to stimulation with PMA
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Figure 7.5b Result of chemiluminescence assay for unheated sonicates of 
A.actinomycetemcomitans 88, diluted to 1 in 2112, 
preincubated for 20 minutes, prior to stimulation with PMA
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Figure 7.5c Result of chemiluminescence assay for sonicates of
A.actinomycetemcomitans 88, heated at 56°C for 3 t  -
diluted to 1 in 32, then preincubated for 20 minutes, prior to 
stimulation with PMA
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Figure 7.5d Result of chemiluminescence assay for unheated sonicates of 
A.actinomycetemcomitans 76 diluted to 1 in 64, preincubated 
for 20 minutes, prior to stimulation with PMA
205
Time of preincubation : 20 minutes
500
400
300
200
100
0 234 568 852 1136 1420
Time (seconds)
No PMA 
Plus PMA
Neat
1 in 2
s -
1 in 4
-B-
1 in 8 
1 in 16 
1 in 32 
1 in 64
Figure 7.5e Result of chemiluminescence assay for sonicates of
A.actinomycetemcomitans 76, heated at 55°C for 30 minutes, 
diluted to 1 in 64, preincubated for 20 minutes, prior to 
stimulation with PMA
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Figure 7.5f Result of chemiluminescence assay for sonicate of
A.actinomycetemcomitans 76, heated at 55°C for 30 minutes, 
diluted to 1 in 2112, preincubated for 20 minutes, prior to 
stimulation with PMA
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Rank Order of toxic A.actinomycetemcomitans strains measured by 
HL-60 cell death Chemiluminescence
HL-60 cell death greater Chemiluminescence less than
than 25% 30% that of maximum
88 88
79 24
24 80
80 79
81 81
HL-60 cell death less Chemiluminescence greater
than 25% than 30% that of maximum
33 56
83 74
36 57
57 36
1 32
75 55
55 33
32 8
56 83
8 1
76 76
74 75
Table 7.4 A.actinomycetemcomitans strains ordered, in decreasing toxicity. The 
order for the two methods compared.
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7.4 DISCUSSION
7.4.1 Effect of A.actinomycetemcomitans strains on HL-60 cells.
There are several possible different methods to measure the toxicity of 
A.actinomycetemcomitans. The majority of assays measure the effect of the toxin on 
susceptible viable cells e.g. LDH release, while others rely upon the purification and 
assay of the leucotoxin itself. The major advantages of purification of the leucotoxin, 
would include characterisation of the toxin which is being investigated and accurate 
comparisons would be possible between leucotoxins from different 
A.actinomycetemcomitans strains. However, before the leucotoxin can be purified, the 
toxic status of that strain must first be determined.
Previous authors (Zambon etal, 1983., Simpson, Berthold and Taichman, 1988) have 
used HL-60 cells to measure the leucotoxic effect of A.actinomycetemcomitans. 
Different methods have been employed to determine cell death e.g. trypan blue 
exclusion, LDH and radioactive Cr release (Zambon et al, 1983 and Tsai et al, 1979). 
Target cells (human PMNL and HL-60) have been exposed to whole cells of 
A.actinomycetemcomitans (Zambon etal, 1983); sonicated A.actinomycetemcomitans 
cells (Tsai et al, 1979) and purified leucotoxin (Tsai et al, 1984., Taichman et al, 
1991).
In this investigation, the toxicity of A.actinomycetemcomitans strains for HL-60 cells, 
at different concentrations and after different periods of sonication was investigated 
and cell death measured by trypan blue exclusion, which was previously demonstrated 
by Ohta et al (1987). The HL-60 cell-line was originally derived from the peripheral 
blood of a patient with acute promyelocytic leukaemia (Collins, Gallo and Gallagher,
1977., Gallagher et al, 1979). The most commonly used cells in leucotoxicity assays 
were freshly isolated PMNLs (Tsai et al, 1979., Baehni et al, 1979., Baehni et al,
1981., Ohta et al, 1987). However, Zambon et al (1983) compared the leucotoxic 
nature of A.actinomycetemcomitans strains to both PMNLs and HL-60 cells but did 
not compare the two techniques. They measured the cytotoxicity of several strains of
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A.actinomycetemcomitans to HL-60 by LDH release.
Strain 24 was previously tested for its toxic effect to HL-60 cells (Taher, 1990), while 
several of the Type strains have been previously investigated by other workers (Tsai et 
al, 1979., Baehni et al, 1979., Baehni et al, 1981., Ohta et al, 1987). The results of 
this study agree with results previously published, however, variation exists regarding 
the point at which a strain of A.actinomycetemcomitans is labelled toxic due to the 
different methods used to detect toxicity. The majority of authors described the 
measurement of LDH or 51Cr release to determine toxicity. Trypan blue exclusion was 
often used as a secondary method, but rarely were the results of HL-60/ PMNL cell 
death given. When results were given cell deaths of either 20 or 25 percent were 
reported as the toxic threshold. In this investigation, a strain of 
A.actinomycetemcomitans was recorded as toxic to HL-60 cells, if the whole cells 
resulted in HL-60 cell death of greater than or equal to 25%. This value was arbitrary, 
but has been used by the Oral Microbiology Unit, Glasgow Dental Hospital and 
School to identify toxic strains. Had this value been increase to, say 30% HL-60 cell 
death, the the number of toxic strains would have reduced by 1 (strain 80 would no 
longer have been toxic). However, unless the level had been reduced to 15%, there 
would have been no increase in the number of toxic strains. Had the percentage cell 
death been raised to 50% (equivalent to LD50), however, even the highly toxic strain 
88 would have been designated as non-toxic.
The effect of variation in the number of A.actinomycetemcomitans cells was also 
investigated. Strains which were toxic to HL-60 cells e.g. 88 and 24, at a lower 
concentration of cells, were shown to have an increased killing effect when the 
number of A.actinomycetemcomitans cells increased. A similar effect was reported by 
Zambon et al (1983) with HL-60 cells, although toxicity was measured by LDH 
release. However, in no instance did a non-toxic strain becoming toxigenic when the 
concentration of bacterial product was increased.
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Single Strains/ Isolates
Strains of A.actinomycetemcomitans isolated from unrelated individuals were all 
shown to be non-toxic, with the exception of A.actinomycetemcomitans strain 
designated 24. This strain demonstrated a high degree of toxicity to HL-60 cells 
(44.9% at the higher concentration of cells and 33% at the lower. Table 7.2a). It has 
been suggested by Haubek et al (1995) that there are very few toxic strains of 
A.actinomycetemcomitans in Northern Europe, compared to America and the results 
presented here would agree with this, as 24 was the only toxic wild strain out of 12 
wild strains.
Multiple Strains/ Isolates
Strains of A.actinomycetemcomitans isolated from the same periodontal pocket, or 
from a different pocket but the same individual, were shown to be non-toxic to HL-60 
cells, although, there was some variation in the exact levels of cell death seen between 
the strains. There have been no reports of multiple strains from an individual, having a 
different toxic status to each other.
Type Strains
Type strains of A.actinomycetemcomitans (coded 79, 80, 81, 83 and 88) could be 
grouped according to toxicity status; highly toxic {A.actinomycetemcomitans 79 and 
88 - 43.6 and 38.3 percent respectively); moderately toxic {A.actinomycetemcomitans 
81 - 30.2% HL-60 cell death); at the lower limits of toxic {A.actinomycetemcomitans 
80 - 28.0% HL-60 cell death) or at the lower limits of non-toxic 
{A.actinomycetemcomitans 83 - 6.0% HL-60 cell death. Results not shown).
These results can be compared to previously published results. Strain designated 79 
(ATCC 29523 - Table 2.2) has been shown to be both non-toxic (Baehni et al, 1981 
and Zambon et al, 1983) and toxic (Spitznagel et al, 1991 and Zambon, 1985). 
Spitznagel et al (1991) suggested that this was related to the amount of mRNA
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produced. They further suggested that the expression of the leucotoxin varied 
throughout the growth cycle and that this could explain the variable toxic nature of 
ATCC 29523, as reported in the literature (Baehni et al, 1981,. Zambon et al, 1983,. 
Zambon, 1985 and Spitznagel et al, 1991). The results of this study correlate with the 
previously published work of Zambon (1985) and Spitznagel et al (1991), that strain 
29 is toxic.
Strains 80 and 81 (ATCC 29524 and Y4) were shown to be toxic to HL-60 cells, 
measured by LDH release (Baehni et al, 1981., Zambon et al, 1983., Tsai et al, 1984., 
Ohta et al, 1987). The results presented in this work correlate with previously 
published work - strains 80 and 81 were found to be toxic to HL-60 cells. 
A.actinomycetemcomitans strain designated 88 (JP2) has been shown previously to be 
very toxic to both PMNLs and HL-60 cells (Tsai et al, 1984., Iwase et al, 1990., 
Mangan et al 1991). In the study reported here, this strain was shown to be the most 
consistently toxic of all the strains investigated (Table 7.2g). Strain 24 was less toxic 
than either 79 or 88, but more toxic than 80 and 81.
7.4.2 Effect of A.actinomycetemcomitans strains on human PMNL measured by 
chemiluminescence
Phagocytosis is the process by which bacteria are ingested and killed by white blood 
cells such as PMNLs and the macrophages. This defence mechanism is important in 
the protection of the host against bacterial infection. Before bacteria are ingested they 
must first be coated with either a serum antibody or complement. This process is 
called opsonisation and allows white cells to recognise and phagocytose bacteria. 
(Technical notes, LKB)
Opsonised bacteria are ingested by PMNLs, then killed by the production of 
superoxide anion, hydrogen peroxide, singlet oxygen and hydroxyl radicals (Figure 
7.6). This process is termed the "oxidative respiratory burst" and is one of the 
principal mechanisms by which PMNLs kill ingested bacteria (Technical notes, LKB).
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A flash of light is associated with the release of the oxidising species and this 
chemiluminescence is very weak, but can be enhanced by the addition of luminol 
(5-amino-2, 3-hydro-1, 4-phthalazinedione) to phagocytosing cells. The luminol reacts 
with the oxidising species to produce a much larger and measurable amount of light 
(Figure 7.7) at a wavelength of 425 nm. Chemiluminescence can be produced in the 
absence of particulate matter by the addition of phorbol-myrisate-acetate (PMA), 
which is an irreversible activator of protein kinase C and results in the release of 
oxidising species, which causes light to be produced.
The process of phagocytosis can be monitored with a luminometer, which provides an 
effective technique for the study of this aspect of host-bacterial interactions. If no 
chemiluminescence is seen, compared with controls, it would indicate some inherent 
or induced deficiency in cellular metabolism. The B.pertussis toxin, adenylate cylase, 
has been shown to disrupt the cell membrane of PMNL (Friedman et al, 1987., 
Parton, 1989), which results in a reduction in chemiluminescence (Friedman et al, 
1987). As the target cell for the A.actinomycetemcomitans leucotoxin is the PMNL, it 
is possible that chemiluminescence will provide a rapid method of identification of 
toxic and non-toxic strains, by measuring the amount of light which is produced when 
PMNLs are incubated with sonicates of A.actinomycetemcomitans before stimulation 
with PMA. A decrease in chemiluminescence produced by PMNLs exposed to 
bacterial products compared with cells stimulated only with PMA, would indicate that 
the oxidative respiratory burst pathway was disrupted in some way. Although 
Ashkenazi, White and Dennison (1992) have used PMA stimulation to investigate the 
effects of A.actinomycetemcomitans upon the chemotactic activity of PMNLs this 
method has not been used previously for the detection of the toxicity of 
A. actinomycetemcomitans.
In this study, strains of A.actinomycetemcomitans were considered to be toxic to 
PMNLs if they inhibited chemiluminescence by 70% i.e. strains with values less than 
30% of the peak chemiluminescence were designated toxic. This value was purely an
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arbitrary one, which was used routinely as a measure of toxicity in the Microbiology 
Department of Glasgow University. Had this value been altered to, say 50% 
(equivalent to LD50), then the number of toxic strains would have increased to 8 
(Table 7.3) and perhaps this should be the value that should be chosen in future.
With both the dye exclusion and chemiluminescence assays A.actinomycetemcomitans 
strains 88 (JP2), 79 and 24 (Table 7.4) were most toxic. Strains 88 and 24 were 
originally obtained from patients with juvenile periodontitis. The degree of toxicity of 
the other 2 strains, 80 and 81, varied slightly when tested in the two assay methods. 
Superoxidase generation has been used previously (Keane et al, 1987. Bhakdi and 
Martin, 1991) in the investigation of other RTX toxins. The results obtained in the 
present experiments suggest that it could be used equally well to study the leucotoxin 
of A. actinomycetemcomitans.
7.4.3 Effect of heating and dilution upon toxic activity of 
A, actinomycetemcomitans to PMNLs.
Welch (1991) suggested that lipopolysaccharides have the effect of priming and 
stimulating the neutrophils. This was also suggested by both Friedman et al (1987) 
and Hewlett et al (1989) who indicated that the effect was dose dependent. Baehni et 
al (1979) demonstrated the toxic effect of Y4 was heat sensitive - heating to 56°C for 
50 minutes inactivated the toxin. When the reaction was carried out at 4°C, no toxic 
effect was observed. Interestingly, Spitznagel eta l (1991) demonstrated that strain 79 
(ATCC 29523) was partially heat resistant. When the crude lysate was heated at 65°C 
for 30 minutes, leucotoxic activity was detected. Heating for greater periods of time, 
subsequently reduced the activity to the background level. Investigation into the effect 
of heating and dilution, in the experiments reported here, were carried out on only 
strains 88 and 76 and therefore no further information is available related to the 
observation of Spitznagel etal {1991).
214
CO, NADPH + H
HMP SHUNT 
DEHYDROGENASE
GLUCOSE NADP+
MEMBRANE
f NADP ' 
OXIDASE,
H +
•OzH 
(pk=4.5 ~ 4.3)
O2
Figure 7.6 The production of bacterial oxidants on the inner surface of the
phagolysosome
oN
Light at 
~425nm
Figure 7.7 The interaction of luminol with oxidants to produce light
When strain 76 was heated and diluted, chemiluminescence increased and peaked at a 
dilution of 1 in 4 (Figure 7.5e). Thereafter it fell, although it never reached the level of 
the PMA control. This is consistent with the effect expected with a dose dependent 
LPS stimulation.
When a highly toxic strain 88 (JP2) was heated at 56°C for 30 minutes no toxicity was 
recorded, instead a stimulatory effect was observed for the neat to 1 : 16 dilution, 
which indicated that the stimulation could be due to the action of LPS, which is heat 
resistant. Furthermore, it would suggest that the stimulatory effect observed was not 
due to low doses of the toxin protein, but rather a dose dependent effect by LPS. 
Several of the strains e.g. 1, 8, 74, 75 and 76 appeared to have a stimulatory effect. It 
was suggested previously by Welch (1991) and Glasser et al (1991) that the 
stimulatory effect might be anticipated at very low doses of an RTX toxin. Keane et al 
(1987) demonstrated a 14-fold increase in superoxidase production with sublytic 
doses of the E.coli haemolysin exposed to rat renal tubular cells. This supports the 
view that alteration of the cell function of animal cells could occur upon exposure to 
sublytic or subtoxic doses of RTX toxins.
7.4.4 Effect of PMNLs
A group of 5 volunteers were used throughout these experiments to donate blood 
which was collected from different individuals on a daily basis. The peak 
chemiluminescence values for control cells varied from day-to-day which may have 
been the result of natural variation in the PMNLs. All donors were healthy and none 
were bled more frequently than once ever four days. The effect of various factors (e.g. 
alcohol intake the previous day/ night) on the responsiveness of the PMNLs to 
stimulation by PMA and/ or bacteria was not considered.
The time which elapsed between the preparation of the PMNLs and their use was also 
controlled. Blood was collected from donors at the Glasgow Dental Hospital and 
School, then transported as quickly as possible on ice to the Department of Cell
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Biology, Glasgow University, where the PMNLs were prepared, before transport to 
the Department of Microbiology. Unfortunately no one site had all the equipment 
required to carry out all aspects of the chemiluminescence assay. Initial pilot 
experiments allowed periods of potential delay e.g. isolation of PMNLs and their 
transport between Oral Microbiology and the University, as well as the booking of 
equipment in the Departments of Cell Biology and Microbiology, to be highlighted 
and the appropriate action taken to ensure that once the experiments had commenced, 
delay did not occur at these points.
7.4.5 Effect of sonication versus whole cells
The leucotoxin of A.actinomycetemcomitans has been found in association with the 
outer membrane (Lally et al, 1991), therefore it would seem reasonable to assume that 
sonication of the whole cells for a short period of time would remove the toxin from 
the outer membrane of the cell and leave it free in solution. Additionally, if 
A.actinomycetemcomitans cells have clumped together, sonication would dissociate 
the cells, resulting in a larger surface area and thus potentially more toxin. This would 
not appear to be the case. Sonication for 15 seconds, in all cases, resulted in a 
decrease in toxicity, from the whole cell level. One possible reason for this could be 
that sonication for 15 seconds disrupts or destroys the toxin, however, this theory is 
disproved by previously published data e.g. Baehni et al (1981), who demonstrated 
toxicity to PMNLs with a sonic extract from A.actinomycetemcomitans strain Y4 
(81).
Only sonicated cells could be used in the chemiluminescence assay, as previous 
experience within the University of Glasgow Microbiology Department had shown the 
use of whole cells to result in inaccuracies in the results. However it would appear 
that the sonication of whole cells for 15 seconds did not result in the designation of 
fewer toxic strains; the results for both experiments were comparable.
HL-60 cells are a cell-line, derived from an acute promyelocytic leukaemia patient,
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whereas PMNLs are freshly harvested, immediately prior to use. If PMNLs are not as 
viable as the HL-60 cell line, then it is possible that PMNLs will require less toxin to 
be killed, than HL-60 cells. Thus, sonicated cells which would result in only the 
moderate killing of HL-60 cells, will kill PMNLs more easily and to a higher degree.
7.4.6 Cytotoxicity assay versus Chemiluminescence
Minor discrepancies exist between the results of the two methods i.e. the order of 
non-toxic strains differs however strains designated toxic by the cytotoxicity assay 
were also toxic by chemiluminescence, in spite of the different host target cells 
involved.
There are advantages and disadvantages associated with both methods : HL-60 and 
A.actinomycetemcomitans cells can be grown to order in a standardised way - whilst 
PMNLs are dependent on the availability of volunteers and standardisation of the cells 
cannot be guaranteed due to factors such as the health of the individual.
The cytotoxicity assay is observer dependent, rather tedious and relies upon the 
supposition that randomised selected microscopic fields will supply data that is 
representative of the entire sample.
The chemiluminescence assay is a faster and more accurate method - once the assay 
has been set up, subsequent measurements and calculations are performed by the 
computer and provided the assay has been set up correctly, this should eliminate 
operator error.
Cost is an important factor and unless access to a luminometer is possible, the capital 
cost of the machine may be prohibitive. Although the computer could be used for 
other items of equipment, the luminometer is a dedicated machine and to recoup its 
cost investigations involving a large number of strains would be necessary. A 
luminometer could also be used to investigate phagocytosis in addition to toxicity and 
in a busy research laboratory it may well be heavily used.
The chemicals required for the luminometer are potentially carcinogenic, which is not
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the case for the cytotoxicity assay and great care must therefore be taken.
Unless care is taken, contamination of tissue culture cells may occur, but with good 
laboratory technique, this should not happen. The chemicals required for the 
luminometer are costly, although very small amounts are used. This is not the case 
with the cytotoxicity assay, where the chemicals are cheaper, although more are 
required.
Overall, cost wise, the luminometer assay is more expensive than the cytotoxicity 
assay, although the results with the luminometer are more accurate as they are not 
dependent upon subjective measurements. The chemiluminescence assay does not only 
give the final results, but it also allows the operator to have an insight into the reaction 
process itself.
7.5 CONCLUSIONS
It would appear that the collection of A.actinomycetemcomitans strains held at the 
Glasgow Dental Hospital and School is composed of a mixed population of toxic and 
non-toxic strains. Strains of A.actinomycetemcomitans which were designated toxic to 
HL-60 cells in a cytotoxicity assay, were also shown to be toxic to PMNLs in a 
chemiluminescence assay.
From the subset of 17 strains investigated, only 1 out of 12 wild strains demonstrated 
any toxicity to either HL-60 cells or PMNLs. In contrast however, 4 out of 5 Type 
strains were toxic in both the cytotoxicity and luminescence assays. It could therefore 
be hypothesised, that the majority of the collection is non-toxic to either HL-60 cells 
or PMNLs, however, in order for this hypothesis to be disproved, the remainder of the 
strains within the collection require to be tested for their toxic activity. If the majority 
of the collection is demonstrated to be non-toxic, this would be in agreement with the 
work of Haubek et al (1995) who suggested that there are very few toxic strains of 
A.actinomycetemcomitans in Northern Europe, compared to America.
Multiple strains of A.actinomycetemcomitans from the one individual/ individual
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pocket, w ere all shown to  be non-toxic.
Both assays studied gave reproducible and comparable results - both designated the 
same five strains to be toxic, although there was variation in the rank order between 
the methods, which could perhaps be explained by the differently treated cells.
There were advantages and disadvantages associated with each assay, however, the 
chemiluminescence assay gave good reproducible results, which were not dependent 
upon operator interpretation and if a luminometer was made available, then this should 
be the assay of choice.
221
CHAPTER 8 
GENERAL DISCUSSION
CHAPTER 8 
GENERAL DISCUSSION
Overall, a range of diverse experimental approaches have been used to investigate 
A.actinomycetemcomitans.
The strain diversity of the collection of A.actinomycetemcomitans strains was initially 
investigated by examination for the prevalence of plasmids (Chapter 3). Of the 96 
strains held in the Glasgow Dental Hospital and School collection, 43.2% were 
shown to be plasmid positive (Table 3.1). The size of the plasmids ranged from 5 to 
140 kb and the number of differently sized plasmids varied between 1 and 3; 73% of 
plasmid positive strains harboured 1 plasmid.
There are very few comparable studies in the literature; although Poulsen et al (1994) 
studied a collection of 97 strains, only 2 plasmid positive strains were found. Preus 
and Olsen (1989) demonstrated plasmids in 10 freshly isolated strains - however the 
sample population size was relatively small. Type strains, in this study, were generally 
found to be plasmid negative, with the exception of strain 79 (ATCC 29523), which 
was found to have a plasmid of approximately 5 kb.
The results presented therefore demonstrate, that in the Glasgow Dental Hospital and 
School collection, the occurrence of plasmids is more common than the literature 
would suggest. Possible reasons for the apparent lack of plasmids in previous studies 
include the suggestion by Poulsen et al (1994) that plasmids are lost through 
continued sub-culturing. An alternative explanation could be that 
A.actinomycetemcomitans strains from different continents reflect their different 
clonal origins. Preus and Olsen (1989) studied Norwegian strains of 
A.actinomycetemcomitans, whereas Poulsen et al (1994) investigated American 
strains. The study reported here demonstrated that strains isolated in the West of 
Scotland harboured plasmids. Although the ethnic origin of the individuals is not 
known, it could be hypothesised that if the patients were from the West of Scotland,
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then European strains have a separate clonal origin to American strains, as suggested 
by other work in this study.
Investigations into the strain diversity of A.actinomycetemcomitans strains using 
RFLP techniques, have generally been conducted by American research groups, using 
freshly isolated clinical strains and Type strains, which have generally been isolated in 
America (DiRienzo & Slots, 1990., Zambon et al, 1990., Genco & Loos, 1991., Han 
et al, 1991.), although there have been a number of European studies (Lawon et al,
1990., van Steenbergen et al, 1991., Haubek et al, 1995). The results have often been 
contradictory: Zambon et al (1990) and Han et al (1991) linked restriction patterns to 
serotypes, whereas DiRienzo (1990) reported no link between restriction patterns and 
serotypes.
The 17 strains of A.actinomycetemcomitans studied could be shown to belong to one 
of eleven clonal types on the basis of REFPs, using three different enzymes. The large 
number of clonal types seen, relative to the small population size is not unusual: Han 
et al (1991) demonstrated 10 different clonal types from 12 different strains. It was 
not possible to relate the strain diversity of individual strains to their serotypes, as the 
serotypes of strains within the collection is not known.
Despite repeated attempts, the generation of a reproducible method for the 
production of plasmid profiles was not possible. Protocols were devised to remove 
potential contaminants and inhibitors: DNA was scanned in a UV-spectrophotometer, 
however, the exact nature of the contaminant/ inhibitor could not be detected.
The results of the study reported in this thesis are in agreement with the work of 
Haubek et al (1995), who suggested that different epidemiological situations exist in 
America and Europe - it would appear that A.actinomycetemcomitans strains isolated 
on different continents have a different clonal origin.
Future studies into the strain diversity of A.actinomycetemcomitans, should include 
polymerase chain reaction (PCR), a rapid and relatively straightforward method to 
discriminate between strains, in large scale epidemiological studies.
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The characteristics of OMPs from A.actinomycetemcomitans have been investigated 
by other researchers (Bolstad et al, 1990., Wilson, 1991b). Bolstad et al (1990), 
showed very limited variation in the expression of the main patterns of OMPs from 
both wild and Type strains of A.actinomycetemcomitans. Additionally, Bolstad et al 
(1990) demonstrated a protein of 34 kDa, whereas Wilson demonstrated a protein of 
29 kDa: both proteins were heat-modifiable.
The OMP preparations in this study, revealed little variation between the strains, 
which is supported by the results of Bolstad et al (1990). Despite this apparent lack 
of major variation, the OMP profiles of the 17 strains of A.actinomycetemcomitans, 
were grouped to give 8 different profiles. In this study, major proteins, common to all 
17 strains, were seen with molecular weights of approximately 41 and 38 kDa. Other 
common proteins, had molecular weights of approximately 100, 97, 70 and 29 kDa. 
Several of the strains expressed a protein with a molecular weight within 10% of 116 
kDa (the molecular weight of the leucotoxin), however only 3 of these strains were 
toxic to HL-60 cells/ inhibited chemiluminescence. These proteins could represent 
non-functional leucotoxin, equally, they could be unrelated to the leucotoxin protein. 
Bolstad et al (1990) reported proteins, with weights of 70, 43 kDa and 39 kDa. A 
protein of 34 kDa was found as well as a protein of 29 kDa. Wilson (1991) reported a 
heat modifiable protein with a molecular weight of 29 kDa.
Outer membrane proteins have been used to assess strain diversity (Davies, 1991a, 
1991b). However their use in this context is severely limited. Fluctuations in 
temperature, growth media and atmospheric conditions can alter the expression of 1 
or more proteins and thus alter the profile. However, if the limitations are understood 
and they are not used as the sole means of assigning strain diversity, then OMPs can 
be a useful additional means of investigation.
The OMP group to which a strain was assigned was not related to leucotoxic status, 
clinical origin or clonal group, on the basis of REFP analysis. From this limited study, 
the usefulness of OMPs, in assigning strain diversity is, tor A.actinomycetemcomitans,
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therefore restricted.
The leucotoxin of A.actinomycetemcomitans is known to be found in the outer 
membrane of the bacterial cell and is a member of a group of related toxins, RTX, to 
which adenylate cyclase belongs. However, there have been no reports in the 
literature of a MCA to one RTX toxin, reacting with the OMP proteins of a species in 
another genus. In this study, the MCA, 9D4, was shown to react with all the strains 
of A.actinomycetemcomitans with the exception of 1 and 8 (Table 8.1). A number of 
reactions between the MCA and OMPs were observed : 116 (the approximate 
molecular weight of the A.actinomycetemcomitans leucotoxin), 97, 95 and 66 kDa. 
Five strains (24, 33, 74, 75 and 76) demonstrated an antigenic reaction between a 
protein of approximately 116 kDa and the MCA. Only 1 of these strains (24), was 
toxic. The reaction between the MCA with separated proteins of approximately 116 
kDa, in non-toxic strains, could be due to an antigenic binding between the 
non-functional leucotoxin and the MCA.
In future experiments, the non-specific binding seen, could be removed by increasing 
the stringency of the post hybridisation-washes, however care would be needed to 
ensure that the washes were not so stringent as to completely remove the bound 
antibody. Purification of the toxin and its reaction to the MCA, would provide further 
confirmation. The response of the various RTX toxins to MCAs against other RTX 
toxins, would be of interest. Do toxins which have a greater genetic homology to 
each other, have a stronger reaction to each other, than to other RTX MCA, where 
the homology is less?
The leucotoxicity of the A.actinomycetemcomitans collection was investigated using 
a well tested method (HL-60 cells exposed to whole and sonicated whole bacterial 
cells, with cell death measured by trypan blue exclusion) and a novel method - 
chemiluminescence.
Overall, only 1 (1224/86) of the clinical strains was shown to be toxic to either HL-60 
cells or freshly prepared human PMNL Ls, whereas 4 out of 5 Type strains
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investigated demonstrated toxicity. It is therefore possible that the majority of the 
remaining clinical A.actinomycetemcomitans strains, untested for toxicity, could be 
negative. If this hypothesis is true, then this would again agree with the result of 
Haubek et al (1995), who suggested that European strains of 
A.actinomycetemcomitans were less virulent than American strains.
There did not appear to be any correlation between the leucotoxicity status of the 
A.actinomycetemcomitans strains and clinical origin of the strains (Table 8.1).
The chemiluminescence assay gave the most objective data. The results were 
presented as a visual and numerical output: it could be clearly seen which strains were 
toxic and which were not. The recording of the results was not dependent upon the 
operator and therefore potential error in reading HL-60 cells were eliminated.
The choice of 25% HL-60 cell death and chemiluminescence inhibition at 70% as the 
levels at which a strain was designated toxic, were purely arbitrary and both were set 
prior to the commencement of the experimental work, based upon previous studies. 
The number of toxic strains in the collection could have been increased or decreased 
merely by altering the level at which a strain was designated toxic was set. However, 
both methods confirmed the same 5 strains as toxic, which therefore suggests that 
25% HL-60 cell death and 70% chemiluminescence inhibition were convenient points 
at which to designate toxicity.
Until the work of Haubek et al (1995), leucotoxicity was considered to be the most 
important virulence factor of A.actinomycetemcomitans and most research has 
focused on this area. The majority of previous studies were carried out in America 
and Haubek et al (1995) hypothesised that the northern European population of 
A.actinomycetemcomitans strains were avirulent, whereas those from America were 
virulent. The results presented in this thesis support this hypothesis, which brings into 
doubt the value of future research into the toxin since juvenile periodontal disease is 
found in Europe, just as in America. If the toxin produced by 
A.actinomycetemcomitans is not a significant virulence factor in the aetiology of the
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juvenile periodontitis, then some factor common to all strains, irrespective of 
geographical and temporal isolation, must be responsible for the bacterial involvement 
in the disease. However, the hypothesis cannot be confirmed or rejected until a larger 
number of strains (ideally, the remainder of the Glasgow Dental Hospital and School 
collection) have been tested for their toxic effect upon either HL-60 cells or PMNLs, 
using one of the methods described above, preferably the chemiluminescence assay.
The results did not reveal any obvious correlation patterns. Plasmid status was not 
linked to disease, OMP group, REFP group (clone), leucotoxic status or reaction to 
MCA, 9D4.
All the Type strains, including the Danish strain (83), were leucotoxic. All belonged 
to different clones, although 3 belonged to the same OMP group. Only 1 of the Type 
(79) strains harboured plasmids.
Two clones contained both wild and Type strains. Strain 24 and 80 clustered 
together; both were toxic to HL-60 cells/ PMNLs. Additionally, 74, 75, 76 and 81 
clustered together. Interestingly the wild strains were non-toxic. The Danish Type 
strain (83) did not cluster with any other strain of A.actinomycetemcomitans. It is 
therefore possible that the bacteria within these two clones share a common origin 
and that some event has resulted in the loss of leucotoxic activity for strains 74, 75 
and 76, whereas strain 24 has retained its toxic effect. If these strains do share a 
common origin and there has been the loss of the leucotoxin for 3 of the European 
strains, then this represents an important result, as all four strains were isolated from 
juvenile periodontal lesions. This result, therefore confirms the work of Haubek et al 
(1995) who have suggested that the Northern European strains are less virulent than 
the American strains.
Two strains (32 and 33) from different clinical sources, were very similar to each 
other; whereas 2 strains (1 and 8) which were isolated from patients with the same 
disease shared a common plasmid and leucotoxic status and reaction to MCA 9D4,
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but had different OMP and REFP profiles.
Strains from the same individual (55, 56 and 57; 74, 75 and 76) shared common 
plasmid profiles. The only variation between strains 55, 56 and 57 related to the OMP 
profiles - variation was seen in the OMP profile of 55, which could be an artifact of 
the gel. This was also the case with 74, 75 and 76 : 74 varied slightly in its OMP 
profile compared to 75 and 76.
In many ways the lack of any pattern in the results, linking strains together is 
disappointing, however, given the complex nature of the bacteria, it is not at all 
unexpected. Also, the number of strains investigated was very small and the study of 
a larger population, at least the size of the entire collection, would yield more 
information.
Given the problems associated with plasmid and whole genomic preparations it would 
perhaps be more appropriate in future work to use Polymerase Chain Reaction (PCR) 
based technologies. Griffen, Leys & Fuerst, 1992. Saarela et al, 1995), which are 
rapid and relatively straight-forward for use in discriminating between strains in large 
scale epidemiological studies.
Determination of the serotypes of the strains of A.actinomycetemcomitans held at the 
Glasgow Dental Hospital and School would be of interest, as several different authors 
have related the clonal type of a strain to its serotype.
If European strains of A.actinomycetemcomitans are less virulent than the American 
strains, as suggested by Haubek et al (1995), then future areas of research should 
include investigations into the other virulence factors, which appear to have been 
neglected in favour of the leucotoxin. These factors include collagenase activity - 
(Robertson et al, 1982. Uitto, Suomalainen and Sorsa, 1990) and adhesion (Winkler 
et al, 1988). The contribution of these factors to virulence of European strains in 
comparison to American strains would be of interest. For example, is the collagenase 
activity of European A.actinomycetemcomitans less, more than or equal to that of
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American strains?
The results from plasmid profiles and the REFPs of whole cell DNA preparations, 
suggest that the population of A.actinomycetemcomitans strains studied is remarkably 
diverse and comprised a large number of distinct clones, which, on the basis of 
plasmid profiles and leucotoxicity status would appear to have more in common with 
the European than American strains of A.actinomycetemcomitans. However, until the 
strain diversity and the leucotoxic status of the entire population has been fully 
investigated, this hypothesis will remain unanswered.
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APPENDICES
APPENDIX 1.1
General Methods (Chapter 2)
Columbia Blood Agar (CBA) per litre
Columbia Blood Agar base 44.0 g
Defibrinated horse blood (7.5%) 75.0 ml
Vitamin K/ Haemin (1.0%) 10.0 ml
Distilled water 1.01
pH 7.3
The CBA powder was dissolved by boiling and frequent mixing. It was then 
autoclaved at 121°C for 15 minutes. After cooling to blood heat, the horse blood was 
added with the Vitamin K/ Haemin solutions and mixed by swirling to avoid bubbles 
and the plates then carefully poured.
Tryptic Soy Broth per litre
TSB powder 30.0 g
distilled water 1.01
pH 7.3 ± 0.2
The powder was dissolved in the distilled water and aliquoted into 100 or 400 ml 
volumes prior to being autoclaved at 121°C for 14 minutes. It was stored at room 
temperature until require.
Constituents of TSB g/ litre
Peptone 140 17.0
Peptone 110 3.0
NaCl 5.0
K2HP04 2.5
Dextrose 2.5
Constituents of RPM I1640 MEDIUM mg/ litre
Calcium nitrate 100.0
Potassium chloride 400.0
Magnesium sulphate 100.0
Sodium chloride 6000.0
Sodium hydrogen chloride 2000.0
Sodium phosphate (anhydrous) 800.0
D-Glucose 2000.0
Glutathione (reduced) 1.0
Phenol Red 5.0
L-Arginine HC1 200.0
L-Asparagine 50.0
L-Aspartic Acid 20.0
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Constituents RPMI1640 Medium continued../
L-Cy stine 50.0
L-Glutamic Acid 20.0
L-Glutamine 300.0
Glycine 10.0
L-Histidine (free base) 15.0
L-Hydroproline 20.0
L-Isoleucine (alio free) 50.0
L-Leucine (methonine free) 50.0
L-Lysine.HCl 400.0
L-Methionone 15.0
L-Phenylalanine 15.0
L-Proline (hydroxy L-proline free) 20.0
L-Serine 30.0
L-Threonine (alio free) 20.0
L-Trytophan 5.0
L-Tyrosine 20.0
L-Valine 20.0
Biotin 0.2
D-Ca Pantothenate 0.3
Choline Chloride 3.0
Folic acid 1.0
i-Insitol 35.0
Nicotinamide 1.0
Para-animobenzoic acid 1.0
PyridoxalHCl 1.0
Riboflavin 0.2
Thiamine HC1 1.0
Vitamin B 12 0.005
Foetal Calf Serum (FCS)
This was heated to 56°C for 60 minutes then aliquoted into 10 and 20 ml volumes for 
storage at -20°C, until required.
RPMI 1640/ FCS ml/ 100 ml
RPMI 1640 90.0
FCS 10.0
The FCS was defrosted then, both the RPMI 1640 and the FCS were allowed to reach
room temperature before mixing. From the mixed solution, 5 ml was removed and the 
pelleted cells resuspended in this volume, then returned to the original 100 ml. Cells 
were incubated at 37°C as previously described.
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APPENDIX 1.2
Prevalence of Plasmids (Chapter 3)
Tris Borate buffer (TBE) g/ 5 litres
Tris - 89 mM 53.9
Boric acid - 89 mM 27.5
EDTA (disodium) - 1.2 mM 2.3
pH 8.2
The dry chemicals were weighed out, mixed and stored at room temperature until 
required. This mixture was then added to 1 litre of distilled water and dissolved by 
stirring and heat. After making up to 5 litres, the buffer was stored at room 
temperature.
10% Sodium dodecyl sulphate (SDS)
SDS 10 g
TBE up to 100 ml
CAUTION : SDS is an irritant to both the skin and respiratory system.
Disposable gloves and mask were worn to avoid contact with the powder.
The SDS was dissolved in 50 ml TBE, then made up to 100 ml. The solution was 
stored at room temperature.
Gel loading buffer per 100 ml
Sucrose 23 g
Sodium acetate 60 mg
SDS 100 mg
Bromophenol blue 50 mg
Distilled water up to 100 ml
The dry chemicals were dissolved in distilled water and stored at room temperature.
Agarose gels - 0.7%
Agarose type II 0.9 g
TBE 125.0 ml
The agarose was melted in 125 ml TBE for each vertical gel and allowed to cool 
slightly before casting.
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Ethidium bromide - stock solution
Ethidium bromide - 0.495 mM 0.39 g
Distilled water 200.0 ml
CAUTION : ETHIDIUM BROMIDE is a suspected carcinogen
Disposable gloves and mask were worn to avoid contact with the powder. Disposable
gloves were worn to avoid contact with the solution.
The ethidium bromide was made up in 200 ml distilled water and left at 37°C 
overnight to aid solution. It was then stored at +4°C in the dark until required.
Tris/ EDTA/ Salt (TES) Stock solution : 10 X concentrate
per 10 litres
Tris (50 mM) 0.6 g
Sodium chloride (50 mM) 29.2 g
EDTA (disodium) 18.6 g
Distilled water upto 11
Hydrochloric acid - concentrated 
pH 8.0
The dry chemicals for 10 litres were dissolved in 900 ml distilled water. The pH was 
adjusted with the concentrated hydrochloric acid and made up to 1 litre. This stock 
solution was stored at +4°C, then diluted 1 in 10 with distilled water to give IX 
working solution as required.
Ethidium bromide - staining of gels
0.5 ml of the stock ethidium bromide solution was diluted in 300 ml 1 X TES and 
stored at room temperature.
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APPENDIX 1.3
Strain Diversity of A.actinomycetemcomitans (Chapters 4 and 5)
Tris EDTA (TE) g/ 500 ml
Tris 10 mM 0.6 g
EDTA 1 mM 0.186 g
Glacial acetic acid 
pH 7.4
The dry chemicals were dissolved in distilled water and the pH adjusted to 7.4 with 1 - 
2 ml glacial acetic acid.
TE10 per 500 ml
Tris 10 mM 0.60 g
EDTA 10 mM 1-86 g
Distilled water up to 500 ml
Glacial acetic acid 
pH 7.8
The Tris and EDTA were dissolved in 400 ml distilled water then the pH adjusted to
7.8 with the glacial acetic acid. After autoclaving at 121°C for 15 minutes, the buffer 
was stored at room temperature.
TE50 per 500 ml
Tris 50 mM 3.25 g
EDTA 50 mM 9.3 g
Distilled water up to 500 ml
Glacial acetic acid 
pH 7.8
The Tris and EDTA were dissolved in 400 ml distilled water then the pH adjusted to
7.8 with the glacial acetic acid. After autoclaving at 121°C for 15 minutes, the buffer 
was stored at room temperature.
2M Sodium hydroxide (with care) per 100 ml
Sodium hydroxide 8.0 g
Distilled water up to 100 ml
The sodium hydroxide was dissolved in the distilled water, then autoclaved at 121°C 
for 15 minutes before storing at room temperature.
10% SDS per 100 ml
SDS 10.0 g
Distilled water up to 100 ml
The SDS was dissolved in 50 ml distilled water then the volume made up to 100 ml. 
The solution was stored at room temperature.
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20% SDS per 100 ml
SDS 20.0 g
Distilled water up to 100 ml
The SDS was dissolved in 50 ml distilled water then the volume made up to 100 ml. 
The solution was stored at room temperature.
Alkaline SDS per 10 ml
10% SDS 1.0 ml
2M Sodium hydroxide 1.0 ml
Distilled water 8.0 ml
This solution was prepared fresh immediately prior to use. Any unused portions were 
discarded.
Lysozyme - TE
lysozyme 25 mg
TE 5 ml
The lysozyme powder was dissolved in the TE buffer immediately prior to use.
3M Sodium acetate per 500 ml
Sodium acetate 123.0 g
Distilled water 500.0 ml
Glacial acetic acid 
pH 4.8
The sodium acetate was dissolved in 100 ml of distilled water and the pH adjusted to
4.8 with the glacial acetic acid. After the volume was adjusted to 500 ml, the solution 
was autoclaved at 121°C for 15 minutes then stored at room temperature.
Proteinase K (10 mgml'1)
Proteinase K 100 mg
Distilled water 10 ml
The proteinase K was dissolved in the distilled water, then stored in 500 pi volumes at 
-20°C until required. It was defrosted immediately prior to use and any unused 
Proteinase K from the defrosted volume was discarded.
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Tris EDTA glucose (TGE) 
Tris - 25 mM 
EDTA - 10 mM 
Glucose - 50 mM
1-5 g 
1.85 g 
4.5 g
per 500 ml
Hydrochloric acid 
pH 7.4
The tris and EDTA were dissolved in 100 ml of distilled water and the pH adjusted 
with the concentrated hydrochloric acid. The volume was then made up to 500 ml and 
autoclaved at 12 PC for 15 minutes, after which 5 - 10 ml was aseptically removed. 
The glucose was dissolved in this volume and then added to the the autoclaved 
solution by filtering through a 0.2 pm filter.
Phenol/ Chloroform per 250 ml
Phenol 250 g
Chloroform 250 ml
TGE 50 ml
CAUTION : PHENOL IS HIGHLY TOXIC
Disposable gloves and mask were worn to avoid contact with the phenol powder. 
Disposable gloves were worn to avoid contact with the solution.
The phenol was dissolved in the chloroform by leaving overnight at room temperature. 
TGE was added and mixed well. After the aqueous layer had separated, the solution 
was stored in the dark at +4°C.
7.5 M Ammonium acetate per 100 ml
Ammonium acetate 5 7.8 g
Distilled water up to 100 ml
Glacial acetic acid 
pH 8.0
The ammonium acetate was dissolved in 40 ml of distilled water and the pH adjusted 
with glacial acetic acid. The volume was then made up to 100 ml and the solution 
stored at room temperature.
RNAase (1 mgrnl1)
RNAase 3 mg
Distilled water 3 ml
The RNAase was dissolved in the distilled water then heated at 100°C in a boiling 
water bath for 10 minutes. It was stored at +4°C.
268
RNAase (10 mgml1)
RNAase 30 mg
Distilled water 3 ml
The RNAase was dissolved in the distilled water then heated at 100°C in a boiling 
water bath for 10 minutes. It was stored at +4°C.
2.5M Sodium chloride
Sodium chloride 14.6 g
Distilled water up to 100.0 ml
The sodium chloride was dissolved in 50.0 ml of distilled water then made up to 100 
ml. After autoclaving at 121°C for 15 minutes it was stored at room temperature.
TBE plus Ethidium bromide
0.5 ml Ethidium bromide stock was diluted in 3 litres of TBE and stored at room 
temperature.
Agarose gels - 0.8% (plasmid)
Agarose Type II 0.8 g
TBE plus ethidium bromide 100 ml
The agarose was melted in TBE containing ethidium bromide and allowed to cool 
slightly before casting. Once set, the tank was flooded with TBE containing ethidium 
bromide and the comb removed.
Agarose gels - 0.6% (genomic)
Agarose Type II 1.8 g
TBE 300 ml
The agarose was melted in TBE and allowed to cool slightly before casting. Once set, 
the tank was flooded with TBE and the comb removed.
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APPENDIX 1.4
Monoclonal Antibody, 9D4, and its Possible Cross Reaction with 
A. actinomycetemcomitans Proteins (Chapter 6)
20 mM Tris HC1 per 250 ml
Tris HC1 0.8 g
Distilled water up to 250 ml
Hydrochloric acid - concentrated 
pH 7.2
The Tris was dissolved in 150 ml distilled water then the pH adjusted to pH 7.2 with 
the concentrated hydrochloric acid. The buffer was made up to 250 ml with distilled 
water, autoclaved at 121°C for 15 minutes and stored at room temperature.
10 mM EDTA/ 20 mM Tris per 100 ml
Tris HC1 0.32 g
EDTA 0.37 g
Hydrochloric acid - concentrated 
pH 7.2
The Tris was dissolved in 150 ml distilled water, then the pH adjusted to pH 7.2 with 
the concentrated hydrochloric acid. The buffer was then made up to 250 ml with 
distilled water, autoclaved at 12 PC for 15 minutes and stored at room temperature.
0.5 %  Sarkosyl per 50 ml
Sodium N-lauroyl sarcosinate 0.25 g
Distilled water up to 50 ml
The sarkosyl was dissolved in 30 ml distilled water then the volume made up to 50 ml.
This was stored at room temperature.
Protein determination : modified Lowry procedure 
Reagent A per 100 ml
Sodium carbonate (2%) 2.0 g
Sodium hydroxide (0.4%) 0.4 g
Sodium tartrate (0.16%) 0.16 g
SDS (1%) 1.0 g
Distilled water up to 100 ml
The reagents were dissolved in 70 ml of distilled water and the volume made up to 
100 ml. This was stored at room temperature.
Reagent B per 100 ml
Copper sulphate (*5H20) 4.0 g
Distilled water up to 100 ml
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The copper sulphate was dissolved in the distilled water and the volume made up to 
100 ml. It was stored at room temperature.
Folin-Ciocalteu
Diluted 1 in 1 with distilled water as required, immediately prior to use.
Acrylamide : Bis (30% : 2.67%)
Acrylamide
NrN" - Bis methene acrylamide 
Distilled water
per 100 ml
29.2 g
0.8 g
up to 100 ml
CAUTION : ACRYLAMIDE IS A NEUROTOXIN
Disposable gloves and mask were worn to avoid contact with the powder. Disposable 
gloves were worn to avoid contact with the solution.
The acrylamide and bisacrylamide were dissolved in 50 ml of distilled water then the 
volume made up to 100 ml. After filtering, the solution was stored at +4°C in a dark 
bottle for a maximum of 1 month.
1.5M Tris-HCl per 100 ml
Tris-HCl 18.15 g
Distilled water up to 100 ml
Hydrochloric acid - concentrated 
pH 8.8
The Tris-HCl was dissolved in 50 ml distilled water and the pH adjusted with the 
concentrated hydrochloric acid before the volume was made up to 100 ml. The buffer 
was stored at +4°C.
0.5M Tris-HCl per 50 ml
Tris-HCl 3.0 g
Distilled water
Hydrochloric acid - concentrated 
pH 6.8
The Tris-HCl was dissolved in 30 ml distilled water and the pH adjusted with the 
concentrated hydrochloric acid before the volume was made up to 100 ml. The buffer 
was stored at +4°C.
10% SDS per 50 ml
SDS 5.0 g
Distilled water
The SDS was dissolved in 30 ml distilled water the volume made up to 50 ml. It was 
stored at room temperature until required.
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N,N.N’,N’ - tctra methyl-ethlene diamine (TEMED)
Undiluted stock was used.
10% Ammonium persulphate
Ammonium persulphate 50.0 jug
Distilled water 0.5 ml
This was prepared freshly as required.
Running buffer - 2X Stock solution
Tris base 
Glycine 
SDS
Distilled water 
pH 8.3
The reagents were dissolved in 1 litre of water and the pH checked, although in 
practice it did not need to be adjusted. It was stored at +4°C until required, then 
diluted 1 in 1 before use, with distilled water.
per litre
6.0 g 
28.8 g
2.0 g
Sample Buffer 2X Stock solution
Distilled water 4.0 ml
Tris (0.5M) 1.0 ml
Glycerol 0.8 ml
SDS (10%) 1.6 ml
2-mercaptoethanol 0.4 ml
bromophenol blue (0.05%) 0.2 ml
The buffer was prepared and stored at +4°C until required. It was diluted 1 in 1 with 
the protein sample prior to boiling.
Separating gel - 10% GEL for 2 x 1.5 mm gels
Tris - 1.5M 20.0 ml*
SDS - 10% 0.8 ml**
Acrylamide : bis 26.6 ml*
ammonium persulphate 0.4 ml**
TEMED 40 pi**
distilled water 32.2 ml*
Chemicals marked * were mixed and degassed for 10 minutes, prior to the addition of 
the chemicals marked **. The mixture was mixed carefully to avoid bubbles before 
being poured.
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Stacking gel - 4% gel for 2 x 1.5 mm gels
Tris - 0.5M 5.0 ml*
SDS - 10% 0.2 ml**
Acrylamide : bis 2.6 ml*
Ammonium persulphate 0.1ml**
TEMED 20 pi**
Distilled water 12.2 ml*
Chemicals marked * were mixed and degassed for 10 minutes, prior to the addition of 
the chemicals marked **. The mixture was mixed carefully to avoid bubbles before 
being poured.
Coomassie Blue staining solution per 5 litres
Methanol 2.51
Glacial Acetic acid 0.5 1
Coomassie Brilliant Blue R 0.05 g
Distilled water 2.01
The Coomassie Brilliant Blue R was dissolved in the methanol, before the addition of 
the acetic acid and distilled water. This solution was stored at room temperature in a 
dark bottle.
Destaining solution per 2 litres
Methanol 600 ml
Acetic acid 200 ml
Distilled water 1200 ml
The three liquids were mixed together and stored at room temperature in a dark 
bottle.
Blotting buffer per 4 litres
Tris 12.12g
Glycine 57.60g
Distilled water up to 4 litres
pH 8.3
The tris and glycine were dissolved in 3 litres of distilled water and the pH checked, 
although in practice it did not need to be altered. The volume was then made up to 4 
litres and the buffer was stored at +4°C in a dark bottle until required.
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Phosphate buffer saline (PBS) 10 X solution per litre
Sodium chloride 87.66g
Sodium hydrogen phosphate (Anhydrous) 10.22g 
Disodium dihydrogen phosphate (*2H20) 4.37g
Distilled water up to 1 litre
pH 7.2
The sodium hydrogen phosphate and disodium dihydrogen phosphate were dissolved 
by heat and stirring in 200 ml of distilled water. The sodium chloride was then added 
and the volume made up to 1 litre after the pH had been checked. The buffer was then 
sterilised by autoclaving at 121°C for 15 minutes.
Blocking buffer per litre
PBS up to 1 litre
Skimmed milk powder 25g
Tween-20 1.5 ml
The milk powder was dissolved in the PBS by heating and stirring, then the Tween-20 
added. The solution was mixed carefully to ensure the Tween-20 dissolved fully and 
allowed to reach room temperature before use.
Washing buffer per litre
PBS up to 1 litre
Tween-20 1.5 ml
The Tween-20 was allowed to dissolve in the PBS by heating and stirring. It was then 
cooled to room temperature before use. This buffer could be stored overnight at +4°C, 
but before use it was allowed to reach room temperature.
1 %  Cobalt chloride solution per 100 ml
Cobalt chloride 1.0 g
Distilled water up to 100 ml
The cobalt chloride was dissolved in 50 ml distilled water and the volume made up to 
100 ml. It was stored at room temperature.
0.1 % Imido black solution per 100 ml
Imido black 0.1 g
Distilled water up to 100 ml
The imido black was dissolved in 50 ml distilled water and the volume made up to 100 
ml. It was stored at room temperature.
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Diaminobenzidine (DAB) substrate solution
3,3'-diaminobenzidine (DAB) 0.03 g
cobalt chloride - 1% 2.0 ml
PBS 98.0 ml
Hydrogen peroxide - 30% 0.1 ml
CAUTION : DAB is a suspected carcinogen.
Disposable gloves and mask were worn to avoid contact with the powder. Disposable 
gloves were worn to avoid contact with the solution.
The cobalt chloride and DAB were dissolved in the PBS. This was left at room 
temperature until the hydrogen peroxide was added immediately prior to use.
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Appendix 1.5 
Leucotoxic Activity (Chapter 7)
Phosphate buffered saline (PBS)
Phosphate buffered saline tablets, pH 7.3, were used. Each tablet was dissolved in 100 
ml distilled water, autoclaved at 121°C for 15 minutes and stored at room 
temperature.
Trypan Blue
Trypan blue 0.1 g
PBS 100 ml
The trypan blue powder was dissolved in the PBS, then filtered through Whatmann 
3MM paper. It was stored at room temperature.
5% Dextran
Dextran 5 g
PBS 100 ml
The dextran was dissolved in the PBS then stored at +4°C until required. Before use it 
was allowed to reach room temperature.
Phorbol-Myristate-Acetate (PMA) Stock solution
PMA 2 mg
PBS 1 ml
CAUTION : PMA IS HIGHLY TOXIC AND A SUSPECTED CARCINOGEN
Disposable gloves and mask were worn to avoid contact with the powder. Disposable
gloves were worn to avoid contact with the solution.
The PMA was dissolved in the PBS, then stored at -20°C until required. Before use it 
was brought to room temperature and diluted by the addition of 50 pi of the stock 
solution to 10 ml PBS.
Luminol Stock solution
Luminol 1.77 mg
Dimethyl sulphoxide 1.0 ml
The luminol was dissolved in the PBS, then stored at -20°C until required. Before use 
it was brought to room temperature and diluted by the addition of 10 pi of the stock 
solution to 10 ml PBS to give a working concentration of 10"4 M.
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SOURCE OF REAGENTS
Unless otherwise stated, all reagents and chemicals were obtained from 
Sigma : Chemical Company, Poole, Dorset 
BDH : Poole, Dorset
RPMI 1640 
CBA 
Vitamins 
FCS
API strips 
Protect beads
Life Technologies, Paisley 
Life Technologies, Paisley 
Life Technologies, Paisley 
Globepharm, Esher, Surrey 
BioMerieux, Basingstoke 
Lab M, Bury
Restriction Endonucleases : New England Biolabs, Bishop's Stortford
Skimmed milk powder: Boots The Chemist
